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REGULATION OF CA2+ HOMEOSTASIS
The maintenance of the body Ca2+ balance is of crucial importance for many vital
physiological functions including neuronal excitability, muscle contraction and
skeletal integrity. Total body Ca2+ homeostasis is tightly controlled by a concerted
action of intestine, kidney and bone. In the kidney, ~8g Ca2+ is filtered at the
glomerulus on a daily basis, of which less than 2% is excreted into the urine (1).
The majority of Ca2+ reabsorption occurs via passive paracellular transport in the
proximal tubules and the thick ascending loop of Henle (2). Approximately 15%
is reabsorbed via an active transcellular Ca2+ transport route in the distal part of
the nephron (2, 3). Similarly, intestinal Ca2+ absorption consists of a passive para-
cellular and an active transcellular pathway (4), whereas the molecular nature of
Ca2+ transport in bone remains largely elusive. The transcellular pathway is the
only target site for specific regulation of Ca2+ (re)absorption by various cal-
ciotrophic hormones (5-7). Transcellular Ca2+ transport can be divided in three
sequential steps (figure 1) (7). First, Ca2+ enters the cell from the luminal com-
partment. The second step is intracellular diffusion to the basolateral side of the
cell. During this process Ca2+ is bound to the Ca2+-binding proteins calbindin-
D9K and/or calbindin-D28K. Finally, Ca
2+ is extruded at the basolateral side of the
cell by two Ca2+ extrusion pathways: the plasma membrane Ca2+-ATPase
(PMCA1b) and the Na+/Ca2+ exchanger (NCX1) (7). The role of NCX1 in trans-
cellular Ca2+ transport is limited to the kidney, whereas PMCA1b is present in kid-
ney and intestine, although it has a more prominent function in the latter organ (8).
Apical Ca2+ influx is the initial step of the whole process and is, therefore, an effi-
cient target for regulation.
ROLE OF TRPV5 AND TRPV6 IN APICAL CA2+ ENTRY
The molecular identity of the apical Ca2+ entry pathway remained elusive until the
identification of the epithelial Ca2+ channel, initially named ECaC1 (9). Thereafter,
a second distinct, but highly homologous, epithelial Ca2+ channel was identified
from rat duodenum, and was named CaT1 or ECaC2 (10). These two channels
comprise a new subfamily of the Transient Receptor Potential (TRP) superfamily
and display the highest sequence homology with the vanilloid receptor subfamily
(TRPV) of these channels (figure 2). Therefore, ECaC1 and ECaC2 were recently
renamed into TRPV5 and TRPV6, respectively (11). TRPV5 and TRPV6 are
encoded by two genes, juxtaposed on human chromosome 7q35 and on mouse
chromosome 6 (12-15). The distinct genes comprise 15 exons encoding proteins
of approximately 730 amino acids. These channels share a predicted topology
consisting of large amino and carboxyl-terminal tails flanking 6 transmembrane
segments (TM) and an additional hydrophobic stretch between TM5 and TM6,
forming the pore-forming region (16) (figure 3A). Southern blot analysis, using the
conserved pore area as probe, demonstrated that the epithelial Ca2+ channel sub-
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family is restricted to these two members (17). Expression profiling of TRPV5 and
TRPV6 using Northern blotting, RT-PCR analysis and immunohistochemistry
showed expression in kidney, small intestine, placenta, prostate, pancreas, salivary
gland, brain, colon and rectum (9, 10, 15, 18, 19). An overview of the expression
of both channels is depicted in table 1. In general, TRPV5 seems to be the more
significant isoform in kidney, whereas TRPV6 is more ubiquitously expressed. In
all tissues, TRPV5 completely co-localized with the proteins known to be involved
in active Ca2+ transport, i.e. calbindin, PMCA1b and/or NCX1. TRPV5 has been
localized immunohistochemically to the apical domain of the late part of the dis-
tal convoluted tubule (DCT2) and connecting tubules (CNT) in the kidney cortex
(18). Loffing and coworkers demonstrated by immunohistochemistry that the
localization of TRPV5 shifted from a very prominent apical location in DCT2 to
a progressively weaker apical and, finally, to an exclusively cytoplasmic, location at
the end of the CNT (20). Intercalated cells, recognized by their prominent bind-
ing of peanut lectin (18) or antibodies against the vacuolar H+-ATPase (20), do not
express TRPV5. Immunohistological studies demonstrated the localization of
TRPV6 in the brush-border membrane of intestinal absorptive cells (21). These
findings hint at a role of these channels as the rate-limiting apical influx pathway
7
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Figure 1.
Integrated model of active Ca2+ (re)absorption. Apical Ca2+ influx is mediated by
TRPV5 and TRPV6, Ca2+ then binds to calbindin-D and is transported to the asolateral
membrane, where it is extruded by a plasma membrane Ca2+-ATPase (PMCA1b) and a
Na+/Ca2+ exchanger (NCX1). The active form of vitamin D, 1,25-dihydroxyvitamin D3
(1,25(OH)2D3) stimulates the individual steps of active Ca2+ transport by concertedly
increasing the expression levels of TRPV5/6, calbindin-D and the basolateral extrusion
mechanisms.
of active Ca2+ transport.
Studies using TRPV5 knockout mice have recently confirmed this physiological
role in vivo (22). Ablation of the TRPV5 gene seriously disturbs renal Ca2+ han-
dling and results in bone abnormalities. In addition, these mice show compensa-
tory increase in intestinal Ca2+ absorption, corresponding to an increased duode-
nal TRPV6 expression. Preliminary results of studies using TRPV6 knockout mice
show a defect in intestinal Ca2+ absorption, deficient renal reabsorption and a sig-
nificant decrease in bone mineral density (23). Understanding the regulation of
TRPV5 and TRPV6 is, therefore, instrumental for our insight in the molecular
mechanisms of hormonally regulated transcellular Ca2+ transport.
MOLECULAR FEATURES OF TRPV5 AND TRPV6
TRPV5 and TRPV6 display unique properties that distinguish them from other
TRP channels. First, TRPV5 and TRPV6 are constitutively active at low intracel-
lular Ca2+ concentrations and physiological membrane potentials (24). Other
members of the TRP family are activated by various stimuli including ligand bind-
ing, heat and cold (16). In addition, TRPV5 and TRPV6 are 100 times more selec-
tive for Ca2+ than for Na+, making them the most Ca2+-selective members of the
TRP superfamily (16, 24). In the physiological context, this property makes
TRPV5/6 particularly suited to transport Ca2+ in the presence of Na+. TRPV5
and TRPV6 exhibit a similar permeation sequence for divalent cations (Ca2+ >
Sr2+ ˜ Ba2+ > Mn2+) (24). In the absence of divalent cations, TRPV5 and TRPV6
permeate monovalent cations (24). Single channel measurements of Na+ currents
indicate a similar conductance of TRPV5 and TRPV6 of 40-70 pS (7). Current
voltage relationships show inward rectification of TRPV5 and TRPV6 both at the
level of single channels as well as whole cells (7).
Hoenderop and coworkers recently demonstrated that TRPV5/6 has a tetrameric
architecture (25), where the 4 subunits surround a single pore (figure 3B). It was
demonstrated that TRPV5/6 can form homo- and heterotetramers. The function-
al properties of these tetramers, including Ca2+-dependent inactivation, cation
selectivity and pharmacological blockade (see below) are dependent on the subunit
ratio of TRPV5 and TRPV6 (25). Niemeyer and co-workers identified the third
ankyrin repeat in the amino terminus as a stringent requirement for physical
assembly of TRPV6 subunits (26). It was proposed that this repeat initiates a
molecular zippering process that proceeds past the fifth ankyrin repeat and creates
an intracellular anchor that is necessary for functional subunit assembly. Chang and
coworkers confirmed the important role of the amino terminus in channel assem-
bly in general, and in particular demonstrated that the first ankyrin repeat is criti-
cal in the assembly process (27). Interestingly, a structural model of the outer pore
of TRPV5/6 was recently provided by Dodier et al. (28) and Voets et al (29),
respectively. Using cysteine scanning mutagenesis these authors indicated that the
main structural features of TRPV5 and TRPV6 are a pore helix followed by a non-
Chapter 1
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Figure 2.
Mammalian TRP family tree. The evolutionary distance is shown by the total branch
lengths in point accepted mutations (PAM) units, which is the mean number of substi-
tutions per 100 residues. (From Clapham (16)). 
Figure 3.
Predicted structural organization of TRPV5 and TRPV6. (A) Both channels contain a
core domain consisting of 6 transmembrane segments. This domain is flanked by an
intracellular amino- and carboxyl-terminus. Furthermore, between transmembrane
segment 5 and 6 there is a short hydrophobic stretch which forms the pore forming
region of these channels. Inner and outer leaflet of the membrane is depicted in yellow.
(B) Schematic representation of the tetrameric organization of the TRPV5/6 pore.
Depicted is the off-axis top view with the channel monomers in blue and a coordinated
Ca2+ ion in yellow/gold. Pore-forming regions of 4 TRPV5/6 monomers join to form a
single pore. At the narrowest point, formed by the  acidic side chains of Asp 541 of 4
monomers, the pore has a diameter of ~5.4 Å. 
A B
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Tissue
Adrenal gland
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References
TRPV5
-
-
-
-
-
-
-
ND
-
+
ND
-
-
ND
ND
-
-
-
-
-
ND
ND
ND
-
ND
-
ND
ND
-
-
(15)
TRPV6
+
+
+
+
+
+
-
+
+
+
ND
+
+
ND
+
+
+
+
+
+
ND
ND
ND
+
ND
+
+
ND
+
+
(15, 21)
Tissue expression of TRPV5 and TRPV6. 
TRPV5/6 expression or lack of expression is indicated with + and -, respectively.
Brackets indicate that studies report different findings. ND: not determined
TRPV6
ND
ND
-
-
(-)(+)
+
-
(-)(+)
+
(-)(+)
-
-
-
+
(-)(+)
ND
-
+
+
+
-
+
-
ND
(-)(+)
-
+
+
(-)(+)
-
(12, 17, 21, 82)
TRPV5
ND
ND
+
-
+
+
-
-
+
+
ND
-
-
ND
-
ND
+
+
+
-
ND
-
ND
-
-
-
ND
+
ND
(17, 82)
Table 1 Mouse Human
helical loop that forms the selectivity filter, similar to KcsA K+ channels (30).
Although all the above-described basic electrophysiological and structural proper-
ties of TRPV5 and TRPV6 are similar, several studies demonstrated differences
between these channels. For example, the relative Ba2+ permeation compared to
Ca2+ is higher for TRPV5 than for TRPV6 (31). In addition, TRPV5 is approxi-
mately 4-fold more sensitive to channel block by Cd2+ (25). Also some striking
pharmacological differences are present, e.g. ruthenium red is a 100-fold more
potent blocker for TRPV5 than TRPV6 (IC50 ~ 9 µM for TRPV6 and ~110 nM
for TRPV5 (17, 32). Furthermore, there are significant discrepancies in the regu-
lation of these two channels regarding the kinetics of Ca2+-dependent inactivation
(17), as will be discussed below.
HORMONAL REGULATION OF TRPV5 AND TRPV6
TRPV5 and TRPV6 expression levels are tightly regulated by various hormones,
including vitamin D, estrogen and the parathyroid hormone (PTH). The various
forms of regulation of TRPV5 and TRPV6 expression in kidney and intestine are
summarized in table 2.
Initial evidence for the vitamin D-sensitivity of TRPV5 was obtained in studies
where rats were raised on a vitamin D-depleting diet (33). Concurrently with the
serum 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) levels, mRNA and protein levels
of TRPV5 decreased significantly in these rats. Repletion of serum 1,25(OH)2D3,
via intraperitoneal injections, resulted in a significant upregulation of TRPV5 to
control levels. This was accompanied by a normalization of serum Ca2+ levels. In
a subsequent paper from Wood et al. the ability of 1,25(OH)2D3 to regulate the
expression of TRPV6 was described in Caco-2 cells, which are used as a human
intestinal cell culture model (34). Studies using various mouse models further con-
firm the vitamin D-dependent regulation of these Ca2+ transport proteins (35).
Vitamin D receptor (VDR) knockout mice display a phenotype similar to vitamin
D-resistant rickets (VDDR type II) including hypophosphatemia, growth retarda-
tion, and rickets or osteomalacia and are, therefore, commonly used mouse mod-
els to study the molecular mechanisms associated with this disease (36). Van
Cromphaut and coworkers demonstrated that duodenal expression of TRPV5 and
TRPV6 is drastically down-regulated in two independent VDR knockout mouse
models (35, 37). The expression levels of other Ca2+ transporting proteins are not
or only moderately decreased in the VDR knockout mice compared to wild-type
mice. Furthermore, Weber et al. showed that renal TRPV5 and duodenal TRPV6
expression levels are reduced in a VDR knockout mouse model (15). Together,
these data suggest that TRPV5 and TRPV6 can be crucial factors in the VDR
knockout mouse or the human VDDR-II phenotype. Furthermore, a 25-hydrox-
yvitamin D3-1alpha-hydroxylase (1α-Ohase) knockout mouse strains were gener-
ated by Dardenne et al. (38) and Panda et al. (39) by targeted inactivation of the
1α-OHase gene. This mouse is a valuable animal model for VDDR-I, as they dis-
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play undetectable levels of 1,25(OH)2D3, hypocalcemia and secondary hyper-
parathyroidism. Furthermore, they show pronounced histological evidence of
rickets. The 1α-OHase knockout mouse was used to investigate the regulation of
several Ca2+ transport proteins including TRPV5 and TRPV6, and their role in
Ca2+ homeostasis. Down-regulation of renal TRPV5 as well as intestinal TRPV6
expression was demonstrated in the knockout mice, compared to wild-type litter-
mates, suggesting a crucial role for TRPV5 and TRPV6 in the phenotype of this
model (40).
Furthermore, estrogen was identified as a second hormone regulating the TRPV5
and TRPV6 expression in kidney and intestine, respectively (41). Estrogen defien-
cy results in a negative Ca2+ balans and bone loss in postmenopausal women.
Using an ovarioectomized rat model, Van Abel et al. demonstrated that both
mRNA and protein levels of renal TRPV5 (41) and duodenal TRPV6 (42) increase
as a consequence of 17β-estradiol supplementation. The involvement of vitamin
D was excluded, because the observed effect of estrogen on both TRPV5 and
TRPV6 were also observed in the VDDR-I mouse model, which are unable to
produce the active metabolite of vitamin D (41, 42). Interestingly, TRPV5 and
TRPV6 upregulation in these mice is accompanied by a partial restoration of
serum Ca2+ levels, further in line with a crucial role of TRPV5 and TRPV6 in Ca2+
homeostasis (41). The role of estrogen in the transcriptional regulation of the
epithelial Ca2+ channels was further substantiated by Van Cromphaut and cowork-
ers, which reported that renal TRPV5 and duodenal TRPV6 expression is reduced
in estrogen receptor knockout mice and upregulated by estrogen treatment (43).
Peng and coworkers investigated the role of androgen on the expression of
TRPV6 in a prostate-derived cell line (19). In this study, treatment with dihy-
drotestosteron reduced the expression of TRPV6, whereas androgen receptor
blockade using the antagonist Casodex significantly enhanced TRPV6 expression
in these cells (19). Together, this suggests that androgen negatively regulates
TRPV6 expression. Currently, no information is available on the role of androgen
on the regulation of TRPV5.
Recently, Van Abel and coworkers suggested that PTH directly stimulates renal
TRPV5 expression (44). PTH is secreted by the parathyroid glands within minutes
after a  decrease in the level of blood Ca2+. It was reported that removal of the
parathyroid glands in rats results in decreased serum PTH levels and hypocalcemia,
which is accompanied by decreased levels of TRPV5, calbindin-D28K and NCX1
(44). Furthermore, serum Ca2+ concentrations and abundance of these Ca2+
transporters in kidney are restored by supplementation with PTH (44). Vitamin D
levels are not significantly altered in these conditions. Together, this suggests that
PTH affects renal Ca2+ handling through the regulation of the expression of the
Ca2+ transport proteins, including TRPV5.
Chapter 1
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INFLUENCE OF DIETARY CA2+ ON TRPV5 AND TRPV6 EXPRESSION
Rickets and hyperparathyroidism caused by a defective vitamin D receptor can be
prevented in humans and animals by high Ca2+ intake, suggesting a VDR-inde-
pendent regulation of the Ca2+ balance (35). Rescue of the hypocalcemic state of
the VDR knockout mice is accompanied by a slight increase in renal TRPV6
expression (35). However, in duodenum, different effects were reported. In wild-
type animals, high dietary Ca2+ content decreases the expression of both TRPV5
and TRPV6 in duodenum and TRPV5 in kidney. This effect is accompanied by a
large decrease in serum 1,25(OH)2D3 concentration (35, 43). VDR-independent
effects of 1,25(OH)2D3 have been described in several cell tissues including intes-
tine and kidney (45, 46) and are accompanied by increases in cytosolic Ca2+, pH
and cyclic nucleotides and protein kinase C activation (47). It is conceivable that
some of these pathways will influence the expression of TRPV5 or TRPV6 (40).
Therefore, 1α-OHase knockout mice are an ideal model to study the role of
dietary Ca2+ in the regulation of TRPV5 or TRPV6 independent of 1,25(OH)2D3.
High dietary Ca2+ treatment results in the rescue of the 1α-OHase knockout mice
from several aspects of the VDDR-I like phenotype, including hypocalcemia (40).
Interestingly, high dietary Ca2+ intake, which down-regulated renal TRPV5 expres-
sion in wild-type mice, results in an upregulation of renal TRPV5 and the proteins
involved in active Ca2+ transport in 1α-OHase knockout mice (40). Furthermore,
in duodenum, TRPV6, calbindin-D9K and PMCA1b are increased upon high
dietary Ca2+ treatment in the 1α-OHase knockout mice (42). Together, this
demonstrates the vitamin D-independent regulation of Ca2+ transport proteins by
dietary Ca2+. The molecular signaling mechanism of this vitamin D-independent
Ca2+-sensitive pathway remains elusive.
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High Ca2+ diet
OVX + estrogen
AR antagonist
Androgen
CaSR agonist
PTX
PTX + PTH
up
down
up
=/down
down
up
ND
ND
down
down
up
K,D
K,D
K,D
K/D
K,D
K,D
K
K
K
up
down
up
=/down
down
up
up
down
=/down
=
=
K,D
D
D
K/D
D
D
P
P
K/D
K
K
(33, 35)
(40, 42)
(40, 42)
(15, 35)
(35, 40)
(41, 42)
(19)
(19)
(44)
VA
VA
up: upregulation; down: downregulation; ND: not determined; =: not changed, K: kid-
ney; D: duodenum; P: prostate; VA: Van Abel, unpublished results; WT: wild type mice;
1aOHase -/-: 1aOHase knockout mice; VDR: vitamin D receptor; OVX: ovarioec-
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tomized; PTH: parathyroid hormone
TRPV5 tissue(s) TRPV6 tissue(s) References
CHANNEL ACTIVITY AT THE PLASMA MEMBRANE
In addition to hormonal regulation, the biological activity of TRPV5 and TRPV6
is subject to regulation of channel activity at the plasma membrane.
Electrophysiological studies in human embryonic kidney (HEK293) cells, heterol-
ogously expressing TRPV5 or TRPV6, show that these channels are constitutive-
ly open at physiological membrane potentials. Unlike several other members of the
TRP superfamily, there are no indications that TRPV5 and TRPV6 requires a stim-
ulus or ligand to become active. However, the activity of these channels is regu-
lated by various means. First, TRPV5 and TRPV6 are rapidly inactivated upon an
increase in the intracellular Ca2+ concentration, although the initial inactivation is
faster in TRPV6 than in TRPV5 (31). The intracellular region between transmem-
brane domain 2 and 3 was identified as a crucial domain in the fast inactivation of
TRPV6 (31). In addition, two domains in the carboxyl-terminus of TRPV5 con-
tribute to the Ca2+-dependent inactivation (48). Deletion of the last 30 amino
acids of the carboxyl-terminus of TRPV5 (G701X), significantly decreased the
Ca2+ sensitivity (48). Detailed mutation analysis revealed that a region upstream in
the carboxyl-terminus (between E649 and C653) forms another critical stretch for
Ca2+-dependent inactivation of TRPV5 (48).
A second factor involved in the regulation of TRPV5/6 is the extracellular pH.
Early studies in excitable tissues indicated that acidification inhibits voltage-gated
Na+ channel function (49). Similar findings were observed by Prod’hom and col-
laborators for L-type Ca2+ channels (50). Changes in pH have been found to reg-
ulate a number TRP channels. External acidic pH increases TRPV1 (51) currents
and decreases the activity of TRPP2 (52), a distant TRP family member of
TRPV5/6. Importantly, it was previously demonstrated that 45Ca2+ uptake in
Xenopus laevis oocytes expressing TRPV5 is inhibited by acidification of the incu-
bation medium (9). Indeed, extracellular acidification reduces currents through
TRPV5 carried by either monovalent or divalent cations (53), which was con-
firmed by Peng and colleagues (54). Mutation of the glutamate at position 522,
preceding the pore region, to glutamine (E522Q) decreases the inhibition of
TRPV5 by extracellular protons (55). Therefore, this residue may act as the “pH
sensor” for TRPV5. It is well know that acidification of the apical medium inhibits
transcellular Ca2+ absorption across primary cultures of rabbit CNT and CCD
cells (56). Extrapolating the pH influence of TRPV5 to the in vivo situation sug-
gests that inhibition of TRPV5 by low extracellular pH may at least in part pro-
vide the molecular basis of acidosis-induced calciuresis.
A third level of control of the channel activity is the recovery from the Ca2+-
dependent inactivation. This intriguing phenomenon seems to be mediated by a
mechanism distinct from Ca2+-dependent inactivation. Recovery from inhibition
occurs both upon washout of extracellular Ca2+ (whole-cell configuration) or by
removal of Ca2+ from the inner side of the channel (inside-out patches) (57). This
process does not correlate with the removal of intracellular Ca2+, since full recov-
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ery occurs much later than restoration of the basal Ca2+ level in non Ca2+-
buffered cells, or after removing Ca2+ from the inner side of excised membrane
patches. It is currently unknown whether the recovery reflects re-opening of chan-
nels present at the plasma membrane or insertion of channels into the plasma
membrane.
TRAFFICKING OF TRVP5 AND TRPV6 
Plasma membrane trafficking plays a major role in the regulation of several ion
channels. For instance, when the antidiuretic hormone vasopressin binds to its
receptor in the collecting duct of the kidney, an intracellular signaling cascade
results in the insertion of aquaporin 2 water channels into the apical plasma mem-
brane (58). This process links channel trafficking to the hormonal regulation of
water transport. Likewise, a significant subset of TRPV5 channels is located sub-
apically in DCT and CNT of the kidney, hinting at a shuttling mechanism of these
channels to the plasma membrane (20). Because TRPV5 and TRPV6 are constitu-
tively active at physiological membrane potentials, control of the number of chan-
nels at the cell surface is essential for efficient and balanced Ca2+ transport.
Furthermore, endocytosis of TRPV5/6 might provide Ca2+ transporting cells
with a powerful protecting tool to prevent Ca2+ overload. Currently, there is little
information about the subcellular localization of TRPV5/6 and the mechanisms
underlying their trafficking to and from the plasma membrane. In general, our
understanding of regulated TRP channel trafficking is still in its infancy. To date,
regulated TRP channel translocation to the plasma membrane has only been
observed for TRPL (59), TRPV2 (60), TRPC5 (61) and TRPC3 (62).
TRPV5 AND TRPV6 MOLECULES: FROM SYNTHESIS TO DEGRADATION
TRPV5/6 regulation can be divided in three main aspects: (i) the number of chan-
nels present at the plasma membrane, (ii) their open probability and (iii) their sin-
gle channel conductance. The availability at the cell surface can be regulated at dif-
ferent locations within the cell. The amount of protein synthesised in the endo-
plasmic reticulum (ER) is largely controlled by gene transcription. In addition, the
ER quality control system regulates the exit of proteins from the ER (63). After
translational modification and tetramer assembly in the ER-Golgi (63), the chan-
nel has to be properly targeted to the apical membrane. At the plasma membrane,
the endocytic machinery can select proteins for internalization via clathrin-coated
pits, caveolin-containing structures or other pathways (64, 65). In endosomes,
internalised proteins are either recycled back to the plasma membrane or targeted
to the lysosome for degradation (66).
The open probability and single channel conductance of TRPV5/6 channels
depends on a number of factors, not only including membrane voltage, pH and
Ca2+ (as decribed above), but possibly also a number of signalling processes (7,
15
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Protein-protein interactions could play a key role in the regulation of these discrete
steps of ion channel regulation. For example, the targeting to the plasma mem-
brane and subsequent insertion into specific domains of the membrane has been
demonstrated for several ion channels to depend on interaction with so-called
PDZ (postsynaptic density-95/Discs large/ zona occludens-1) proteins (68-71).
For TRPC1 it has been shown that the retention in the plasma membrane depends
on the interaction of the PDZ domain containing protein InaD (72). Similar
mechanisms might exist for TRPV5 and TRPV6. Furthermore, the activity of sev-
eral members of the TRP superfamily has been demonstrated to be regulated by
an interaction with the IP3 receptor (73, 74). This provides an attractive model for
the Ca2+ depletion-induced activation of these channels. However, store-depend-
ent activation is not a hallmark of TRPV5 or TRPV6, despite recent controversy
on this issue (75, 76). In contrast, Ca2+ does play an essential role in the activity of
both TRPV5 and TRPV6, as increases in intracellular Ca2+ levels largely inhibits
TRPV5- and TRPV6-mediated currents. For several Ca2+ channels, including L-
type channels and TRP family members, protein-protein interactions have been
shown to be essential for this Ca2+-dependent inactivation (77, 78).
Finally, degradation of TRPV5 and TRPV6, could be subjective to regulation by
protein-protein interaction, as has been shown for the epithelial Na+ channel
(ENaC). ENaC interacts with the ubiquitin-ligase Nedd4 via its PY domains in a
phosphorylation-dependent fashion (79). Ubiquitinated ENaC is removed from
the plasma membrane and targeted for degradation (80). This “regulation through
degradation” process is tightly regulated by aldosterone (81). Mutations in ENaC’s
Nedd4-binding domains results in an excess of channels in the plasma membrane,
which underlies the phenotype of patients with Liddle’s syndrome (79).
AIM OF THIS THESIS
Active transcellular Ca2+ transport involves a chain of Ca2+ transport proteins
mediating apical Ca2+ influx, transport to the basolateral membrane and extrusion
into the bloodstream. Regulation of the two channels that mediate the rate-limit-
ing Ca2+ entry step, TRPV5 and TRPV6, is pivotal to control the Ca2+ transport
rate. In this respect, elucidation of the mechanisms underlying the activity of
TRPV5 and TRPV6 is instrumental for our understanding of the molecular nature
of Ca2+ homeostasis. Despite progress in the research of these channels, many
aspects of TRPV5 and TRPV6 regulation remain elusive. As outlined above, sev-
eral lines of evidence suggest that the activity of TRPV5 and TRPV6 could be reg-
ulated by interacting proteins. The aim of this thesis, therefore, was to identify
TRPV5/6-associated proteins to further elucidate the molecular regulation of
these channels. To this end, we used a yeast two-hybrid approach using the car-
boxyl-termini of TRPV5 and TRPV6 to isolate channel-associated proteins from
a pool of kidney proteins. A disadvantage of this technique is the large number of
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false-positives that are identified. Therefore, we confirmed the binding using GST
pull-down assays. These assays were also used to determine whether the interac-
tion is dependent  on certain cofactors (i.e. Ca2+ or guanine nucleotides) and to
elucidate the binding site for associated proteins in the TRPV5/6 carboxyl-termi-
nus. Furthermore, co-immunoprecipitation, immunohistological and immunocyto-
chemical analyses were performed to investigate whether the identified proteins
can associate with TRPV5/6 under physiological conditions. Finally, the function
of the auxiliary proteins in the regulation of TRPV5/6 was investigated using var-
ious approaches. First, the association of auxiliary proteins was abolished by dis-
turbing the binding site for the identified proteins in TRPV5/6. Second, the
expression level of TRPV5/6 auxiliary proteins was manipulated either by over-
expression or by RNA interference-mediated downregulation. Third, we generat-
ed mutants of the associated proteins, deficient in specific properties, i.e.
nucleotide or Ca2+ binding. The functional consequences of these manipulations
were determined using patch-clamp analysis and 45Ca2+ uptake experiments.
In Chapter 2, the association of the S100A10-annexin 2 complex with TRPV5 and
TRPV6 is described and a role for this interaction in the targeting of these chan-
nels to the plasma membrane is discussed. This study describes the first example
of a TRPV5/6-associated protein that is involved in the trafficking of these chan-
nels. A second example of channel trafficking that is mediated by direct protein-
protein interaction is described in Chapter 3. In this chapter, a novel direct associ-
ation of Rab11a with TRPV5 and TRPV6 is demonstrated. This study shows a
unique mode of operation for Rab11 via direct interaction with these channels
while in the GDP-bound configuration. Chapter 4 shows results of the identifica-
tion and characterization of the interaction of TRPV5 and TRPV6 with BSPRY.
BSPRY is a novel protein containing a B-box and SPRY domain, is co-localized
with TRPV5 in renal tubules and inhibits TRPV5-mediated Ca2+ influx in conflu-
ent Madine Darby Canine Kidney cells. Chapter 5 reports of the specific interac-
tion of NHERF2, a PDZ protein with TRPV5. The interaction was localized to
the last three amino acids in the carboxyl-terminus of TRPV5, which are absent in
TRPV6. Co-expression of TRPV5 with NHERF2 and the serum and glucocorti-
coid inducible kinase SGK resulted in a significant increase in TRPV5 channel
activity. A distinct interaction of TRPV6 with the PDZ protein IKEPP is
described in Chapter 6. This chapter illustrates the identification of IKEPP using
two independent yeast two-hybrid screens with the TRPV5 and TRPV6 carboxyl-
termini as bait. Furthermore, the interaction results are substantiated by GST pull-
down, co-immunoprecipitation and co-localization assays. Finally, a general dis-
cussion and summary on these subjects is presented in Chapter 7.
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ABSTRACT
TRPV5 and TRPV6 constitute the Ca2+ influx pathway in a variety of epithelial
cells. Here, we identified S100A10 as the first auxiliary protein of these epithelial
Ca2+ channels using yeast two-hybrid and GST pull-down assays. This S100 pro-
tein forms a heterotetrameric complex with annexin 2 and associates specifically
with the conserved sequence VATTV located in the C-terminal tail of TRPV5 and
TRPV6. Of these five amino acids, the first threonine plays a crucial role since the
corresponding mutants (TRPV5 T599A and TRPV6 T600A) exhibited a dimin-
ished capacity to bind S100A10, were re-distributed to a subplasma membrane area
and did not display channel activity. Using GST pull-down and co-immunoprecip-
itation assays we demonstrated that annexin 2 is part of the TRPV5-S100A10
complex. Furthermore, the S100A10-annexin 2 pair co-localizes with the Ca2+
channels in TRPV5-expressing renal tubules and TRPV6-expressing duodenal
cells. Importantly, downregulation of annexin 2 using annexin 2-specific siRNA
inhibited TRPV5 and TRPV6-mediated currents in transfected HEK293 cells. In
conclusion, the S100A10-annexin 2 complex plays a crucial role in routing of
TRPV5 and TRPV6 to plasma membrane.
INTRODUCTION
The epithelial Ca2+ channels TRPV5 and TRPV6 (recently renamed after ECaC1
and ECaC2, respectively) belong to the superfamily of transient receptor potential
(TRP) channels (1, 2). The physiological function of this group of non-selective
cation channels is diverse and ranges from involvement in phototransduction,
olfaction, nociception, sexual behavior, heat and cold sensation, to epithelial Ca2+
transport (1). Moreover, these channels display a plurality in ion selectivities and
activation mechanisms, some of which represent previously unrecognized modes
of channel regulation (1).
TRPV5 and TRPV6 are by far the most Ca2+ selective channels of the TRP super-
family and constitute the rate-limiting influx step in active Ca2+ (re)absorption that
takes place in kidney, proximal intestine and placenta (3, 4). A delicate regulation
of their activity is of utmost importance to maintain the extracellular Ca2+ bal-
ance. Several lines of evidence demonstrate that these Ca2+ channels are, indeed,
controlled by various mechanisms (3). First, TRPV5 and TRPV6 display a Ca2+-
dependent feedback regulation of channel activity. The intracellular Ca2+ concen-
tration in close vicinity to the channel mouth exerts an inhibitory effect on chan-
nel activity. Several domains in the channel protein sequence have been implicated
in this inhibitory mechanism (5). Second, the recovery from the Ca2+-dependent
inactivation renders another plausible site of regulation. This recovery is a rela-
tively slow process that may reflect an intrinsic property of TRPV5 and TRPV6 or
could result from (re)insertion of channels from an intracellular pool (6, 7). A sig-
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nificant subset of TRPV5 channels is localized subapically in distal tubules of the
kidney, hinting at a shuttling mechanism of these channels to the plasma mem-
brane (8). Third, vitamin D, estrogen and dietary Ca2+ content have been shown
to regulate the abundance of these Ca2+ channels resulting in normalization of
hypocalcemia in 25-hydroxyvitamin D3-1α-hydroxylase (1α-OHase) knockout
mice (9-12). Fourth, the amino acid sequence of TRPV5 and TRPV6 contains
conserved motifs for putative regulatory activities including protein kinase C phos-
phorylation sites, ankyrin repeats and PDZ motifs (4). To date, little information
is available concerning the molecular players responsible for these processes regu-
lating the activity of TRPV5 and TRPV6. A number of regulatory proteins have
recently been described that modify the biophysical, pharmacological and expres-
sion properties of ion channels and transporters by direct interactions (13, 14).
These newly identified associated proteins have facilitated the elucidation of
important molecular pathways modulating transport activity.
The aim of the present study was, therefore, to identify auxiliary proteins interact-
ing specifically with TRPV5 and TRPV6. To this end, we have used a yeast two-
hybrid screen to identify proteins associated with the epithelial Ca2+ channels. The
functional interaction between TRPV5 and TRPV6 and the identified interacting
protein was further substantiated by pull-down assays, immunohistological studies,
RNA interference (RNAi) and electrophysiological analysis of the regulatory effect
of the newly identified protein ligands on TRPV5 and TRPV6 activity.
MATERIALS AND METHODS
DNA constructs and cRNA synthesis
The C-terminal tail of mouse TRPV5 was amplified using PCR (forward primer
5’-cccctgggatccggcgacactcactggcgagtggcc-3’ and reverse primer 5’-acagaag-
tcgactcagaaatggtagatctcctc-3’) on mouse kidney cDNA and cloned in the pAS-1
yeast cloning and expression vector, which was kindly provided by Dr. Steve
Elledge (Baylor College of Medicine, Houston, TX). The product was sequenced
and compared with three independent mouse cDNAs to confirm the sequence.
The C-terminal tail of mouse TRPV5 and TRPV6 was subcloned into pGEX6p-
2 (Amersham Pharmacia Biotech AB, Uppsala, Sweden). Deletion mutants of
TRPV5 were obtained by PCR and cloned into pGEX6p-2. Full-length mouse
S100A10 cDNA was subcloned into pGEX6p-2 by PCR (forward primer 5’-
cgcgggatccatgccatcccaaatggagcac-3’ and reverse primer 5’- gctccagatatcctacttcttcc-
ccttctgctt-3’) using the S100A10 pACT2 construct as a template. Annexin 2 was
obtained using PCR (forward primer 5’-gctctagatgtctactgtccacgaaatcc-3’ and
reverse primer 5’-cgaagtctctagaacgccagg-3’) on mouse kidney cDNA and cloned
into pT7Ts (15). A VSV epitope tag was fused to the N-terminal tail of S100A10
by PCR (forward primer 5’-gaagatctatggagatttatacagacatagagatgaaccgacttgg aaagct-
tatgccatcccaaatggag-3’ and reverse primer 5’-gctccagatatcctacttcttccccttctgctt-3’)
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using the pACT2 construct as a template and the obtained product was subcloned
into pT7Ts. Wildtype TRPV5 and TRPV6 were tagged at the N-terminal tail with
a HA and Flag tag, respectively. The N-terminally tagged fragments were amplified
by PCR using for TRPV5 (forward primer 5’-cagatcgcgagccaccatgtacccatacgacgt-
gccagactacgcaggggcctgtccacccaaggca-3’ and reverse primer 5’-cccagggagtcctgggc-
ccgg-3’) and for TRPV6 (forward primer 5’-cagatcgcgagccaccatggactacaaggatgac-
gatgacaaggggtggtccctgcccaaggagaag-3’ and reverse primer 5’-ggacaaagggtgctctcca-
ta-3’) with the wildtype TRPV5 and TRPV6 pTLN-constructs as templates. The
obtained fragments were subsequently cloned into the pTLN vector (16). Oocyte
expression constructs were linearized and TRPV5, TRPV6, annexin 2 and
S100A10 cRNA was synthesized in vitro using SP6 RNA polymerase for TRPV5
and TRPV6 and T7 RNA polymerase for annexin 2 and S100A10 as described
(17). All constructs were verified by sequence analysis.
Yeast two-hybrid system 
The Y153 yeast strain (18) was first transformed to Trp prototrophy with pAS-1
containing the TRPV5 C-terminal tail. Expression of the Gal4-TRPV5 hybrid pro-
tein was confirmed by immunoblotting using monoclonal antibodies against the
HA epitope (Sigma, St. Louis, MO). Yeast was transformed with a mouse kidney
cDNA library (Clontech, Palo Alto, CA) present in the pACT2 vector, containing
a leucine selection marker. Subsequently, yeast cells were plated onto Trp-Leu-His
selective medium supplemented with 25 mM 3-aminotriazole. Positive colonies
were assayed for β-galactosidase activity as described (19). Yeast DNA of positive
colonies was isolated (20), and prey plasmids were rescued by transformation into
KC8 cells, which carries trpC, leuB, and hisB mutations (Clontech). Yeast two-
hybrid results were confirmed using purified library plasmids and negative controls
were performed by replacing a binding partner with either a pAS-1 construct con-
taining the N-terminal tail (amino acids 1-53) of rat γENaC (21) or the empty
pACT2 vector.
GST-TRPV5 fusion protein and interaction assays
pGEX6p-2 constructs were transformed in Escherichia coli BL21 and glutathion-
S-transferase (GST) fusion proteins were expressed and purified according to the
manufacturer’s protocol (Amersham Pharmacia Biotech AB). Xenopus laevis
oocytes were injected with 20 ng S100A10 cRNA, 20 ng annexin 2 cRNA, or co-
injected with 10 ng S100A10 cRNA and 10 ng annexin 2 cRNA as described else-
where (22). After 48-72 h oocytes were homogenized in pull-down buffer (20 mM
Tris-HCl pH 7.4, 140 mM NaCl, 1 mM CaCl2, 0.2% (v/v) Triton X-100 and 0.2%
(v/v) NP-40) and centrifuged twice for 10 minutes at 16,000 x g. Oocyte super-
natants were added to GST or GST-TRPV5 fusion proteins immobilized on glu-
tahione-Sepharose 4B beads (Amersham Pharmacia Biotech AB). [35S]Methionine
labeled full-length TRPV5 protein was prepared using a reticulocyte lysate system
in the presence of canine microsomal membranes (Promega Madison, WI) and
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added to GST or GST-S100A10 immobilized on glutahione-Sepharose 4B beads.
After 2 h incubation at room temperature, the beads were washed extensively with
pull-down buffer. Bound proteins were eluted with SDS-PAGE loading buffer,
separated on SDS-PAGE gels and visualized either by autoradiography (for
TRPV5 and TRPV6) or immunoblotting using monoclonal anti-VSV (1:10,000
clone P5D4, Sigma, St Louis, MO) (for S100A10) or monoclonal anti-annexin 2
(1:5,000; BD Transduction Laboratories, Lexington, USA).
Co-immunoprecipitation
For chemical cross-linking experiments, 20 ng S100A10 cRNA injected oocytes
were lysed in 20 mM Hepes pH 7.2, 5 mM KCl, 130 mM NaCl, 5 mM EDTA and
10% (v/v) glycerol containing 2 mM dimethyl-3’-3’-dithiobispropionimidate.2HCl
(DTBP) (Pierce, Rockford, IL) incubated on ice for 30 min and 100 mM Tris-HCl
pH 7.4 was added. The lysates were centrifuged for 30 min 16,000x g and super-
natant was analyzed by immunoblot as described above. For co-immunoprecipita-
tion experiments, S100A10 and annexin 2 cRNA co-injected oocytes were labeled
with [35S]methionine for 48 h and homogenized in pull-down buffer containing 2
mM EDTA instead of 1 mM CaCl2 to allow for annexin 2 solubilization. Oocyte
homogenates were centrifuged twice for 10 min at 16,000 x g. Supernatants were
incubated with anti-VSV antibodies immobilized on protein A-agarose beads
(Kem-En-Tec A/S, Kopenhagen, Denmark) for 2 h at room temperature. After
three washing steps with pull-down buffer, immunoprecipitated proteins were
eluted with SDS-PAGE loading buffer, separated on SDS-PAGE gel and visual-
ized by autoradiography.
RT- PCR analysis
Total RNA from mouse kidney, mouse duodenum, HEK293 and Xenopus laevis
oocytes was isolated using Trizol (Gibco, BRL, Grand Island NY). Total RNA (2
µg) was reverse transcribed and PCR reactions for S100A10 and annexin 2 were
performed (S100A10 forward primer 5’-gccatggaaaccatgatg-3’ and reverse primer
5’-aaatagtcattgcatgcaatg-3’; annexin 2 forward primer 5’atgtctactgttcacgaaatc-3’ and
reverse primer 5’-ccccttcatggaagcttttag-3’). For PCR analysis of oocyte mRNA dif-
ferent primers were used (S100A10 forward 5’-gatggtggccccctctga-3’ and reverse
primer 5’-ccacaagtttagagttta-3’; annexin 2 forward primer 5’-gctgcacctacagctgct-3’
and reverse primer 5’-ctttatttgtcctggagc-3’).
Realtime quantitative PCR
1α-OHase knockout mice were supplemented with 1,25(OH)2D3 as described pre-
viously (10). S100A10 mRNA expression levels in kidney were quantified by real-
time quantitative PCR using the ABI Prism 7700 Sequence Detection System (PE
Biosystems, Rotkreuz, Switzerland) as described (10) (forward primer 5’-tgccatcc-
caaatggagc-3’ and reverse primer 5’-tcgcctgcaaacctgtgaa-3’ and probe: 5’-cgccatg-
gaaaccatgatgcttacg-3’). The expression level of mouse hypoxanthine-guanine
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phosphoribosyl transferase (HPRT) was detected with the forward primer 5’-
ttatcagactgaagagctactgtaatgatc-3’, reverse primer 5’-ttaccagtgtcaattatatcttcaacaatc-
3’ and probe 5’-tgagagatcatctccaccaataacttttatgtccc-3’ and used as an endogenous
control to normalize variations in RNA extractions, the degree of RNA degrada-
tion, and variabilities in RT efficiencies.
Immunohistochemistry
Immunohistochemistry was performed as described (12). Briefly, rat and rabbit
duodenum sections were incubated for 16 h at 4 ºC with rabbit antiserum against
TRPV6 (1:100) kindly provided by Dr. M. Suzuki, monoclonal anti-S100A10 (1:50;
Swant, Bellinzona, Switzerland) or monoclonal anti-annexin 2 (1: 50; BD
Transduction Laboratories). Rabbit kidney sections were incubated for 16 h at 4 ºC
with affinity purified guinea pig antiserum against TRPV5 (1:50) (23) and mono-
clonal anti-S100A10 (1:100) or monoclonal anti-annexin 2 (1: 50). To visualize
TRPV5 and TRPV6, a goat anti-guinea pig Alexa 488 conjugated antibody (1:300)
or a goat anti-rabbit Alexa 488 conjugated antibody (1:300) (Molecular Probes,
Eugene, USA) was used. To visualize S100A10 and annexin 2, sections were incu-
bated with a goat anti-mouse Alexa 594 conjugated antibody (1:300; Molecular
Probes). Xenopus laevis oocytes were injected with 5 ng HA-tagged TRPV5 (wild-
type or T600A) or Flag-tagged TRPV6 (wildtype or T599A) cRNA. Three days
after injection immunocytochemistry was performed as described (17) using mon-
oclonal anti-HA (1: 400; Sigma, St. Louis, MO) or monoclonal anti-Flag (1:400;
Sigma, St Louis, MO). Images were taken with a Biorad MRC 100 confocal laser
scanning microscope. All negative controls, including sections incubated with
preimmune serum or conjugated antibodies alone, were devoid of any staining.
Electrophysiology
The full-length cDNA encoding TRPV5 and TRPV6 was cloned into the pIRES
vector and transfected in HEK293 as described previously (4, 7). Currents using
the whole-cell configuration were measured with an EPC-9 (HEKA Elektronik,
Lambrecht, Germany, 8-Pole Bessel filter 10 kHz). Electrode resistances were
between 2 and 5 M(, and capacitance and series resistance were compensated, and
access resistance was monitored continuously. Current-voltage relationships were
measured from linear 400 ms voltage ramps which were applied every 5 s from a
holding potential of +20 mV or +70 mV with a sampling interval of 0.8 msec.
The step protocol consisted of 3 s voltage steps to -100 mV form a holding poten-
tial of +70 mV. The standard extracellular solution contained (in mM) 150 NaCl,
1 CaCl2, 6 CsCl, 1 MgCl2, 10 glucose and 10 HEPES/CsOH, pH 7.4. Monovalent
cation currents were measured in nominally Ca2+ and Mg2+ free solution (free
Ca2+ concentration is 10 nM) and Ca2+ currents in 1 mM CaCl2 but Mg2+ free
solutions. Monovalent cation currents were inhibited by replacing 150 mM NaCl
with an equimolar amount of NMDG-Cl. The standard internal (pipette) solution
contained (in mM): 20 CsCl, 100 Cs-aspartate, 1 MgCl2, 10 BAPTA, 4 Na2ATP,
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10 HEPES/CsOH, pH 7.2. Cells were kept in a nominally Ca2+-free medium to
prevent Ca2+ overload and exposed for maximal 5 min to a Krebs solution con-
taining 1.5 mM Ca2+ before sealing the patch pipette to the cell. In the siRNA
experiments, 0.5 mM EGTA was used for intracellular Ca2+ buffering. All experi-
ments were performed at room temperature (20-22 (C).
RNA interference
RNAi employed a 21 nucleotide RNA duplex corresponding in sequence to
nucleotides 94 to 113 of the human annexin 2 mRNA with a two nucleotide dT 3’
overhang. Cells grown on coverslips were transfected with 100 nM of the annealed
RNA duplex using oligofectamine according to the manufacturer’s instructions
(Invitrogen, Carlsbad, CA). After 24 h these siRNA transfected HEK293 cells
were transfected with pIRES-TRPV5 or pIRES-TRPV6 vector and analyzed in a
patch-clamp setup 24 h following the last transfection. Expression of TRPV5 and
TRPV6 was determined using immunoblotting with affinity purified guinea pig
(TRPV5) or rabbit (TRPV6) antibodies as described elsewhere (24).
Statistical analysis
In all experiments, the data are expressed as mean ± SEM. Overall statistical sig-
nificance was determined by analysis of variance (ANOVA). In case of signifi-
cance (P<0.05), individual groups were compared by Student’s t-test.
RESULTS
Identification of S100A10 as TRPV5-associated protein
To identify proteins that interact with TRPV5, the C-terminal tail of TRPV5 was
used to screen a mouse kidney cDNA library using the yeast two-hybrid technique.
One of the positive clones encoded S100A10, a distinct member of the EF-hand
containing S100 protein family. S100A10 is also known as calpactin light chain, p11
or annexin 2 light chain (25). To confirm this interaction, the full-length S100A10
coding sequence was analyzed with the C-terminal tail of TRPV5 as bait using the
yeast two-hybrid system (Figure 1A). As a negative control the γ subunit of the
epithelial Na+ channel, γENaC, was used. S100A10 strongly interacted with
TRPV5, whereas no binding was observed with γENaC, indicating the specificity
of the S100A10-TRPV5 interaction (Figure 1B). In addition, β-galactosidase activ-
ity was not detectable in the absence of prey, or after co-transformation of the bait
with the empty pACT2 (prey) vector (data not shown).
S100A10 interacts with TRPV5 and TRPV6
To further establish the interaction between TRPV5 and S100A10 GST pull-down
binding assays were performed. Xenopus laevis oocytes were injected with
S100A10 cRNA and homogenized after three days. The S100A10 containing
homogenate was incubated with GST or GST-TRPV5 fusion proteins immobi-
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lized on glutathione-Sepharose 4B beads. S100A10 bound specifically to the C-ter-
minal tail of TRPV5, since no interaction was observed with GST alone (Figure
1C). Subsequently, this binding was investigated in the presence of 1 mM Ca2+ or
2 mM EDTA as shown in Figure 1D. S100A10 interacted with the C-terminal tail
of TRPV5 in a Ca2+-independent manner. In addition, [35S]methionine-labeled
full-length TRPV5 protein bound to GST-S100A10, whereas GST alone was neg-
ative (Figure 1E). Interestingly, the interaction with S100A10 was not restricted to
TRPV5, since S100A10 also interacted with the C-terminal tail of TRPV6 (Figure
1C). Likewise, [35S]methionine labeled full-length TRPV6 bound to S100A10
immobilized on glutathione-Sepharose 4B beads, confirming the TRPV6-S100A10
interaction (Figure 1E).
TRPV5 interacts with the S100A10-annexin 2 complex
S100A10 forms a heterotetramer with annexin 2, which is a member of the Ca2+
and phospholipid binding proteins (26). This heterotetramer consists of a
S100A10 dimer binding to two annexin 2 molecules in a highly symmetrical man-
ner (25). In Xenopus laevis oocytes S100A10 also forms a dimer, as was demon-
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Figure 1.
Interaction of TRPV5 and S100A10 as
shown by yeast two-hybrid and GST pull-
down analyses. (A) The C-terminal tail of
TRPV5 or γENaC and full-length S100A10
were co-transformed into the Y153 yeast
strain and grown on media without tryp-
tophan and leucine. (B) β-galactosidase
activity was demonstrated in TRPV5 and
S100A10 co-transformed yeast, whereas
no activity was observed in γENaC and
S100A10 co-transformed yeast. Two rep-
resentative colonies are depicted. (C)
Lysates of Xenopus laevis oocytes inject-
ed with 20 ng of VSV-tagged S100A10
cRNA were incubated with GST or GST
fused to the C-terminal tail of TRPV5 or
TRPV6 immobilized on glutahione-
Sepharose 4B beads. S100A10 interacted
specifically with TRPV5 and TRPV6, but
not with GST alone. (D) The experiment
was performed as outlined under C.
Binding of S100A10 to TRPV5 was
demonstrated in the presence of 1 mM Ca2+ or 2 mM EDTA. (E) [35S]Methionine labeled
full-length TRPV5 or TRPV6 was incubated with GST or GST-S100A10 immobilized on
glutathione-Sepharose 4B beads. Both TRPV5 and TRPV6 interacted with S100A10,
whereas no binding to GST alone was observed.
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strated by chemical cross-linking using DTBP in S100A10 cRNA injected oocytes
(Figure 2A). To demonstrate the presence of annexin 2 in the S100A10-TRPV5
complex, GST pull-down assays and co-immunoprecipitations of these proteins in
their native form were performed. To this end, annexin 2 and a vesicular stomati-
tis virus glycoprotein (VSV)-tagged S100A10 cRNA were co-injected in Xenopus
laevis oocytes. These oocytes were subsequently metabolically labeled with
[35S]methionine and homogenized in pull-down buffer containing 2 mM EDTA.
Solubilized proteins were immunoprecipitated using anti-VSV antibodies. Annexin
2 could be co-immunoprecipitated with S100A10, demonstrating the presence of
a S100A10-annexin 2 complex in these oocytes (Figure 2A). In addition, annexin
2 was precipitated from homogenates of S100A10-annexin 2 cRNA co-injected
oocytes using GST-TRPV5 C-terminal tail-loaded glutathion-Sepharose 4B beads
(Figure 2B), demonstrating a physical interaction between TRPV5, S100A10 and
annexin 2. However, the TRPV5-annexin 2 interaction could only be observed
when S100A10 was co-expressed with annexin 2, indicating that S100A10 bridges
annexin 2 to TRPV5. Finally, co-immunoprecipitations were performed using in
vitro translated TRPV5, S100A10 and annexin 2. S100A10 and annexin 2 co-
31
Chapter 2
Figure 2.
Annexin 2 interacts with TRPV5 via
S100A10. Xenopus laevis oocytes were
injected with S100A10 or co-injected with
annexin 2 and VSV-tagged S100A10
cRNAs. (A) Lysates of S100A10 cRNA
injected oocytes were treated with DTBP
and analyzed by immunoblot. The chem-
ically cross-linked S100A10 band runs at
23 kDa, exactly the expected size of a
VSV-tagged S100A10 dimer.
Homogenates of non-injected and oocytes
co-injected with S100A10 and annexin 2
cRNAs were subjected to immunoprecip-
itation using monoclonal anti-VSV anti-
bodies. Annexin 2 co-immunoprecipitat-
ed with S100A10 as was visualized by
autoradiography of the metabolically
labeled proteins. As a control the expres-
sion of S100A10 and annexin 2 in the co-
injected oocytes was demonstrated by
immunoblot analysis to demonstrate that the precipitated proteins were of the correct
size. (B) Homogenates of annexin 2 cRNA injected or S100A10 and annexin 2 cRNA co-
injected oocytes were incubated with GST alone or GST-fusion protein containing the
TRPV5 C-terminal tail immobilized on glutathione-Sepharose 4B beads. The association
of annexin 2 with TRPV5 in the presence of S100A10 was demonstrated by immunoblot
using a monoclonal anti-annexin 2 antibody. (C) full length annexin 2, S100A10 and
TRPV5 were in vitro translated using a reticulocyte lysate system in the presence of
canine microsomal membranes. S100A10 and annexin 2 were co-immunoprecipitated
with TRPV5 confirming the formation of a TRPV5-S100A10-annexin2 complex.
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immunoprecipitated with TRPV5, but not in a control reaction carried out with an
unrelated antibody, confirming the specificity of the procedure (Figure 2C).
Co-localization of TRPV5, S100A10 and annexin 2 in Ca2+ transporting
epithelia 
Co-expression of S100A10 and annexin 2 in kidney and small intestine, which
express TRPV5 and TRPV6 (22, 27), was first investigated by reverse transcrip-
tase-PCR (RT-PCR). Using two specific primer sets a 239 and 360 bp product was
amplified in kidney and duodenum, corresponding to the expected sizes of the
S100A10 and annexin 2 fragments amplified. Subsequently, the cellular localization
of these proteins was studied in kidney and duodenal sections by immunohisto-
chemistry. In kidney, immunopositive staining for TRPV5 was predominantly pres-
ent at the apical membrane of distal convoluted and connecting tubules (Figure
3A). S100A10 and annexin 2 co-localized with TRPV5, since an immunopositive
staining for these proteins was observed along the apical domain of the TRPV5-
expressing distal tubular cells. Importantly, the same observations were made for
the localization of these proteins in duodenum, where TRPV6, S100A10 and
annexin 2 were observed along the brush-border membrane (Figure 3B).
Mapping of the S100A10 binding site in TRPV5
To identify the S100A10 binding site in TRPV5, a series of deletion mutants of the
C-terminal tail of TRPV5 was constructed as shown in Figure 4. Truncated forms
of TRPV5 were expressed as GST-fusion proteins and pull-down experiments
were performed as described above. The interaction between S100A10 and
TRPV5 was lost when TRPV5 was truncated at position 598, whereas truncations
at positions 673 up to 596 had no effect on the interaction with S100A10.
Subsequently, the identified S100A10 binding region between amino acids 591-596
(VATTV) was mutated into glycines and the binding of S100A10 was analyzed by
a GST pull-down assay. The binding between S100A10 and TRPV5 was virtually
abolished when this putative binding region was mutated. Mutation of the first
threonine in this motif into an alanine (TRPV5 T593A) also prevented the associ-
ation of this protein, indicating the crucial role of this amino acid for binding of
S100A10. Further studies were performed using the full lenght rabbit TRPV5,
containing 7 additional amino acids at the amino terminus. Therefore, the T593A
mutation in mouse corresponds with T600A in rabbit TRPV5.
S100A10 binding to TRPV5 or TRPV6 is critical for channel activity
The effect of S100A10 on TRPV5 and TRPV6 activity was determined by whole
cell patch-clamp analysis in transiently transfected human embryonic kidney
(HEK293) cells, as shown in figure 5A,B. HEK293 cells heterologously expressing
wildtype TRPV5 displayed Ca2+ and Na+ currents in line with our previous stud-
ies including a high Ca2+ selectivity over Na+, the presence of large Na+ currents
in the absence of extracellular divalent ions and strong inward rectification (7).
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The T600A mutant of TRPV5 failed to produce significant Na+ and Ca2+ currents
in HEK293 cells in the absence and presence of extracellular Ca2+, respectively,
while the channel was readily detectable by immunoblotting. Likewise, the corre-
sponding mutant in TRPV6 (T599A) expressed in HEK293 cells was functionally
inactive. Notably, HEK293 cells endogenously expressed S100A10 and annexin 2
as confirmed by RT-PCR analysis (data not shown). Thus, these findings suggest-
ed that the binding of S100A10 to TRPV5 and TRPV6 is crucial to obtain chan-
nel activity.
S100A10 is essential for trafficking of TRPV5 and TRPV6
The role of S100A10 in the routing of TRPV5 and TRPV6 was investigated using
Xenopus laevis oocytes, as shown in Figure 5C. Immunocytochemical analysis of
TRPV5 or TRPV6 cRNA-injected oocytes demonstrated a strong immunopositive
labeling of the plasma membrane for both channels, whereas the cytoplasm was
only faintly stained. This finding suggests that wildtype TRPV5 and TRPV6 are
targeted efficiently to the plasma membrane. In contrast, the subcellular localiza-
tion of the TRPV5 T600A and TRPV6 T599A mutants was seriously disturbed.
The plasma membrane was virtually devoid of immunopositive staining for these
mutant channels, but instead a strong immunopositive signal accumulated in an
area just below the plasma membrane. Notably, Xenopus laevis oocytes endoge-
nously express S100A10 and annexin 2 as demonstrated by RT-PCR analysis.
Taken together, these results imply that the association of S100A10 is necessary
for correct trafficking (i.e. targeting or retention) of TRPV5 and TRPV6 to the
plasma membrane.
Gene silencing of annexin 2 using RNA interference
The use of small interfering RNAs (siRNAs) has become a powerful tool to
knockdown specific gene expression in mammalian cell lines including HEK293
cells (28, 29). We have applied this novel technique to further substantiate the role
of annexin 2 in the regulation of Ca2+ channel activity. First, HEK293 cells were
transfected with annexin 2-specific siRNAs, subsequently with the pIRES-TRPV5
or pIRES-TRPV6 vector and finally analyzed by immunoblotting, immunofluo-
rescence and patch-clamp as shown in figure 6. Annexin 2 expression was signifi-
cantly downregulated by annexin 2-specific siRNA transfection (Figure 6A), while
the expression of TRPV5 and TRPV6 was not affected in these cells (Figure 6C),
demonstrating the specificity of the RNAi. In addition, we observed a decrease in
S100A10 expression (Figure 6B), most likely due to a decreased stability of the
S100A10 protein in the absence of annexin 2 (30).In line with these immunoblot
results, the number of annexin 2-immunopositive cells significantly decreased fol-
lowing siRNA transfection as determined by fluorescence microscopy (Figure
6D,E). In these experiments the Na+ currents were determined by patch-clamp
analysis as a direct measure of channel activity. Control HEK293 cells heterolo-
gously expressing TRPV5 exhibited a normal distribution of the Na+ current with
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Figure 3.
Co-localization of TRPV5 and TRPV6 with S100A10 and annexin 2. (A) Kidney sections
were co-stained with antibodies against TRPV5 and S100A10 or TRPV5 and annexin 2.
(B) Duodenum sections were stained with antibodies against TRPV6, S100A10 and
annexin 2. Immunopositive staining for TRPV5 and TRPV6 is depicted in green and for
S100A10 and annexin 2 in red. 
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Figure 4.
Mapping of the S100A10 binding site in
TRPV5. GST fusion proteins containing
different portions of the C-terminal tail of
TRPV5 were constructed according to the
schematic drawing. These proteins were
immobilized on glutathione-Sepharose
4B beads and then incubated with lysates
from Xenopus laevis oocytes injected
with 20 ng S100A10 cRNA. Interaction of
S100A10 with the GST fusion proteins
was determined by immunoblotting. The
binding site was localized between amino
acids 591 and 596. Virtually all interaction
with S100A10 was abolished when this
region (VATTV) was mutated into
glycines. A similar effect was observed
with the single point mutant TRPV5
T593A.
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a peak around 800 pA/pF (Figure 6H). Interestingly, HEK293 cells co-transfect-
ed with annexin 2-specific siRNAs and TRPV5 demonstrated a shift in the distri-
bution of the Na+ current possibly resulting from two different populations of
cells (Figure 6H). The minority of cells exhibited a normal Na+ current reflecting
annexin 2 expressing cells, while in the majority of cells only a small current was
measured (Figure 6FG), reflecting annexin 2 downregulated cells. Identical results
were obtained for TRPV6 in the annexin 2 siRNA treated cells. Also when the cur-
rent was averaged over the total population of cells a significant decrease in the
Na+ current was apparent for both TRPV5 and TRPV6 (Figure 6I).
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Figure 5.
Activity and subcellular localization
of TRPV5 and TRPV6 with a mutated
S100A10 binding site. HEK293 cells
were transiently transfected with
TRPV5 (wildtype or T600A) or TRPV6
(wildtype or T599A) and analyzed
using the whole-cell patch-clamp configuration and immunoblotting. (A) Currents
were measured during voltage ramps from -150 to +100 mV (400 ms) in the absence of
permeable cations (all substituted by N-methyl-D-glucamine+, NMDG+), in the absence
of divalent cations only, and in the presence of 1 mM Ca2+. The I/V curves showed
inward rectification typical for TRPV5 and TRPV6. In the TRPV5 T600A and TRPV6
T599A mutants Na+ and Ca2+ currents were virtually abolished, while the channel was
readily detectable. (B) The average currents measured in the absence of divalent cations
and in the presence of 1 mM Ca2+ of three independent transfections for wildtype and
mutant TRPV5 and TRPV6 are depicted. (C) Immunocytochemistry was performed on
Xenopus laevis oocytes injected with 5 ng HA-tagged TRPV5 (wildtype or T600A) or
Flag-tagged TRPV6 (wildtype or T599A) cRNA. Oocytes injected with wildtype chan-
nels showed predominant immunopositive staining at the plasma membrane, whereas
the channels containing a mutation in the S100A10 binding site accumulated in an area
just below the plasma membrane. Representative images of three independent experi-
ments are shown.
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Hormonal regulation of S100A10
Recently, we have shown that the TRPV5 and TRPV6 expression level in kidney
and dudodenum are positively regulated by 1,25-dihydroxyvitamin D3
(1,25(OH)2D3) in vitamin D receptor and 1α-OHase knockout mice, animal mod-
els for pseudovitamin D-deficiency rickets (10, 11). The renal expression level of
S100A10 was, therefore, analyzed under identical circumstances. 1,25(OH)2D3
treatment significantly upregulated the mRNA abundance of S100A10 (158 ± 16
% compared to control levels, P<0.05). Thus, in kidney S100A10 is, like TRPV5,
upregulated by 1,25(OH)2D3.
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Figure 6
Small interfering RNA mediated annexin 2 gene silencing inhibits channel activity in
HEK293 cells heterologously expressing TRPV5. Immunoblot showing annexin 2 (A),
S100A10 (B), TRPV5 and TRPV6 (C) protein levels in control (CT) and annexin 2-spe-
cific siRNA treated HEK293 cells. Images (E) and corresponding histogram (D) of
annexin 2 immunofluorescence staining of control and annexin 2-specific siRNA trans-
fected HEK293 cells. Ca2+ currents in response to a voltage step from +20 to -100 mV in
control  and annexin 2-specific siRNA transfected  HEK293 cells (F). Current response
to a voltage ramp from -150 to 100 mV measured in N-methyl-D-glucamine+ (NMDG+)
and divalent free solution in control and annexin 2-specific siRNA transfected HEK293
cells (G). Distribution of Na+ currents as a measure of channel activity analyzed in con-
trol (open bars) and annexin 2-specific siRNA transfected (closed bars) HEK293 cells at
-80 mV (H) and the corresponding averaged data (I). N is more than 25 cells of two
independent transfections. *, P<0.001 significantly different from control. CT, control.
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DISCUSSION
The present study identified the S100A10-annexin 2 pair as the first auxiliary pro-
tein complex for the newly identified epithelial Ca2+ channels, TRPV5 and
TRPV6. S100A10 forms a well-defined heteromeric complex with annexin 2 and
associates specifically with the conserved sequence VATTV located in the C-ter-
minal tail of TRPV5 and TRPV6. Of these five amino acids, the first threonine
residue plays a crucial role since the corresponding channel mutants preclude
S100A10 binding and accumulate below the plasma membrane preventing the
facilitation of Ca2+ inward currents.
S100A10-annexin 2 complex associates with TRPV5 and TRPV6
S100A10 was initially identified as a TRPV5-interacting protein by a yeast two-
hybrid screening and the binding between both proteins was subsequently con-
firmed by GST pull-down assays. The binding was not restricted to TRPV5 since
TRPV6 was also shown to bind S100A10, indicating a mutual mechanism in the
regulation of these Ca2+ channels. Considering the high degree of homology and
the similarities in electrophysiological behavior between both channels (4), it is
indeed likely that TRPV5 and TRPV6 have common regulatory factors such as
associated regulatory proteins. S100A10 is a distinct member of the S100 family,
since its two EF hands carry mutations that render it Ca2+ insensitive (31), explain-
ing the Ca2+-independent association with TRPV5. Furthermore, we could show
by co-immunoprecipitations and GST pull-down experiments that the membrane-
associated and microfilament-binding protein, annexin 2, is part of the channel-
S100A10 complex. Employing lysates from cells coexpressing TRPV5 and
S100A10/annexin 2, we were not able to immunoprecipitate S100A10 and annex-
in 2 together with TRPV5 using anti-TRPV5 antibodies (not shown). The physi-
cal association of the S100A10-annexin 2 complex with TRPV5 could be too weak
to resist detergent solubilization, or could be spatially restricted to the plasma
membrane, only locally regulating TRPV5 and TRPV6. Both scenarios would pre-
clude an efficient co-immunoprecipitation. Interestingly, an association of annex-
in 2 with TRPV5 could be shown only in the presence of S100A10, demonstrat-
ing that annexin binds indirectly to the TRPV5 C-terminal tail, with S100A10 most
likely operating as a bridge between TRPV5 and annexin 2. Annexin 2 forms a het-
erotetrameric complex with S100A10, consisting of a S100A10 dimer associated
with the N-terminal tails of two annexin 2 molecules in a highly symmetric man-
ner (25). Furthermore, we have recently demonstrated that TRPV5 and TRPV6
form homo- and heterotetramic channel complexes, which possibly create four
S100A10 binding sites per functional channel (Hoenderop et al., EMBO J, in press,
17-02-2003). Taken together, TRPV5 and TRPV6 interact with the S100A10-
annexin 2 heteromultimer with possibly four available interaction sites.
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Co-localization of S100A10-annexin 2 complex and the epithelial Ca2+
channels in kidney and duodenum
In kidney, TRPV5 is primarily expressed along the apical membrane of distal con-
voluted and connecting tubules (8, 23). Importantly, S100A10 and annexin 2 were
consistently detected in these TRPV5-expressing tubules, where they concentrated
along the apical membrane. Furthermore, the S100A10-annexin 2 complex was
present along the brush-border membrane of duodenum, which is in agreement
with the TRPV6 localization. S100A10 and annexin 2 were previously identified in
placenta and pancreas, sites with a prominent TRPV5 and TRPV6 expression (22,
32-36). Generally, the S100A10-annexin 2 complex is localized to the cytoskeleton
underlying the plasma membrane (37, 38) and it has been proposed to participate
in membrane trafficking and/or organization in this area of the cell (26). Thus, the
observed apical localization of the S100A10-annexin 2 complex in TRPV5 and
TRPV6 expressing epithelia is in line with a regulatory role in the plasma mem-
brane localization of the Ca2+ channels and thus their function in the process of
Ca2+ (re)absorption.
S100A10 interaction with TRPV5 and TRPV6 is essential for trafficking
The association of S100A10 with TRPV5 and TRPV6 was restricted to a short
peptide sequence VATTV located in the C-terminal tail of these channels. This
stretch is completely conserved among all identified species of TRPV5 and
TRPV6 (4). Interestingly, the TTV sequence in the S100A10 binding motif resem-
bles an internal type I PDZ consensus binding sequence, which is S/TXV (39).
However, S100A10 does not contain PDZ domains, indicating that the TRPV5-
S100A10 interaction has a different nature. The first threonine of the S100A10
interaction motif was identified as a crucial determinant for binding. Furthermore,
the activity of TRPV5 and TRPV6 was abolished when this particular threonine
was mutated, demonstrating that this motif is essential for channel function.
Malfunctioning of these mutant channels was accompanied by a major disturbance
in their subcellular localization. These findings suggest a role for the S100A10-
annexin 2 heterotetramer in the trafficking process of TRPV5 and TRPV6 to the
plasma membrane. Whether this involves facilitated translocation of TRPV5 and
TRPV6 channels to the plasma membrane or enhancement of channel retention
remains to be elucidated.
Recently, S100A10 was demonstrated to interact with the background K+ channel
TASK-1, controlling the membrane trafficking and, therefore, the functionality of
this K+ channel (40). TASK-1 associated with S100A10 via its carboxyl terminal
sequence SSV. This sequence resembles the binding motif in TRPV5 and TRPV6
identified in the present study, suggesting a shared structural S100A10 binding
pocket. However, this motif is absent in the tetrodotoxin (TTX)-insensitive volt-
age-gated Na+ channel (Nav1.8), which has been shown to bind S100A10 via its
N-terminal tail (41). This S100A10 interaction promoted the translocating of
Nav1.8 to the plasma membrane producing functional Na+ channels.
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Role of annexin 2 in Ca2+ channel activity
S100A10 is predominantly present as a heterotetrameric complex with annexin 2,
which has been implicated in numerous biological processes including endocyto-
sis, exocytosis and membrane-cytoskeleton interactions (26, 42). Annexin 2 is pos-
tulated to bind to the cytoplasmic face of membrane rafts to stabilize these
domains, thereby providing a link to the actin cytoskeleton. The present study
demonstrated the presence of annexin 2 in the S100A10-channel complex, indi-
cating a possible function in regulating channel localization and/or activity.
Importantly, downregulation of annexin 2 using annexin 2-specific siRNAs signif-
icantly inhibited the currents through TRPV5, indicating that annexin 2 in con-
junction with S100A10 is crucial for TRPV5 activity. In line with the cortical local-
ization of annexin 2 and its postulated function in organizing certain plasma
membrane domains, our findings provided the first functional evidence for a reg-
ulatory role of annexin 2 controlling Ca2+ channel trafficking. For neither TASK-
1 nor Nav1.8 a role of annexin 2 was assessed (40, 41). It remains, therefore, to be
determined whether annexin 2 also mediates the regulatory role of S100A10 for
these ion channels. Importantly, annexin 2 has been shown to modulate the activ-
ity of volume-activated Cl- channels in vascular endothelial cells (43). Disruption
of the S100A10-annexin 2 complex resulted in a gradual decrease of Cl- current,
possibly indicating a decrease of functional channels at the plasma membrane.
These findings together with our data clearly show that the S100A10-annexin 2
complex is a significant component for the trafficking of different ion channels to
the plasma membrane and is thus a major regulator of ion homeostasis.
Regulation of S100A10
Vitamin D is an important calciotropic hormone determining the Ca2+ balance in
the body. An increase in functional expression of TRPV5 and TRPV6 has been
implicated as one of the major determinants of long-term vitamin D efficacy (10-
12). Here, we indicated that S100A10 abundance, analogous to TRPV5 and
TRPV6, is regulated by 1,25(OH)2D3. In addition, annexin 2 expression levels
have been shown to increase upon prolonged incubation with 1,25(OH)2D3 (44).
Together, our observations imply that 1,25(OH)2D3 exerts a major calciotropic
effect by concomitantly increasing the S100A10, annexin 2 and epithelial Ca2+
channel expression and thus efficiently stimulating Ca2+ channel recruitment dur-
ing Ca2+ demand.
In conclusion, our data provided the first evidence of a regulatory role for the
S100A10-annexin 2 heterotetramer in vitamin D-mediated Ca2+ (re)absorption in
general and in particular in TRPV5 and TRPV6 routing. The elucidated molecular
mechanism involves tethering of the S100A10-annexin 2 complex to the Ca2+
channel resulting in functional plasma membrane localization. This mechanism is
likely applicable to other ion transporters given the wide tissue distribution of
S100A10 and the associated annexin 2 protein.
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ABSTRACT
TRPV5 and TRPV6 are the most Ca2+-selective members of the transient recep-
tor potential (TRP) family of cation channels and play a pivotal role in the main-
tenance of body Ca2+ balance. However, little is known about the mechanisms
underlying the targeting to the plasma membrane of these channels to facilitate
epithelial Ca2+ transport. In this study, we identified Rab11a as a novel TRPV5-
and TRPV6-associated protein. The interaction was direct, specific for GDP-
bound Rab11a and contributed to the recruitment of Rab11a to the membranous
fraction. In addition, Rab11a co-localized with TRPV5 and TRPV6 in vesicular
structures underlying the apical plasma membrane of Ca2+-transporting epithelial
cells. In addition, co-expression of GDP-locked Rab11a S25N with TRPV5 and
TRPV6 resulted in decreased Ca2+ uptake, caused by diminished channel cell sur-
face expression. Furthermore, disturbance of Rab11a binding by mutagenesis of a
conserved stretch of 5 amino acids between position 595 and 601 in the carboxyl-
terminus of TRPV5 resulted in impaired channel targeting to the plasma mem-
brane and consequently inhibited cellular Ca2+ influx. Together, our data demon-
strate the role of Rab11a in the targeting of TRPV5 and TRPV6 towards the plas-
ma membrane. The Rab GTPase exerts this function in a novel fashion, operat-
ing via direct cargo interaction while in the GDP-bound configuration.
INTRODUCTION
TRPV5 and TRPV6 form a distinct group of highly Ca2+ selective channels
belonging to the transient receptor potential (TRP) channel superfamily. This fam-
ily fulfills a plurality of physiological functions, which vary from phototransduc-
tion, nociception, olfaction, heat and cold sensation to epithelial Ca2+ transport
(1). TRPV5 and TRPV6 mediate the rate-limiting luminal influx step of transcel-
lular Ca2+ transport (2, 3). Therefore, understanding the regulation of these chan-
nels is of utmost importance for our insight in the Ca2+ homeostasis. TRPV5 and
TRPV6 display constitutive activity (4), suggesting that channel abundance at the
cell surface is of crucial importance for regulation of the Ca2+ influx via these
channels. It is becoming increasingly evident that channel trafficking is essential in
determining the activity of TRP proteins (5-9). For instance, inducible vesicular
translocation and plasma membrane insertion has been described for several TRP
channels, i.e. TRPV2, TRPC5, TRPC3, TRPL. This trafficking process stimulated
the Ca2+ influx from the extracellular compartment essential to growth factor- (6,
8), carbachol- (5) or light-induced signalling (7). However, little is known about the
molecular mechanisms involved in trafficking to the plasma membrane of TRP
channels in general and in particular of TRPV5 and TRPV6.
Several protein families have been described to play key roles in cargo trafficking
to and from specific cellular compartments, including the plasma membrane. One
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of these families consists of the Rab GTPases. The ability to act as molecular
switches that cycle between GTP- and GDP-bound states, underlies the function-
ality of this family. Many Rab proteins show a distinct subcellular localization,
making them ideal candidates to govern the specificity of vesicle trafficking, most
likely cooperatively operating with other proteins (10, 11). Further characterization
of the largely elusive mechanism underlying the function of Rab proteins in ion
channel trafficking could further contribute to the already enigmatic Rab-depend-
ent regulation of cargo trafficking in the highly organized cellular transport
machinery.
The aim of this study was to identify regulatory proteins directly interacting with
TRPV5 or TRPV6. Using biochemical, histological and functional analyses we
demonstrate a novel operation mode for Rab11a in the regulation of TRPV5 and
TRPV6 trafficking to the plasma membrane requiring direct interaction with these
cargo molecules.
EXPERIMENTAL PROCEDURES
DNA constructs and cRNA synthesis
The carboxyl termini of mouse TRPV5 and TRPV6 and deletion mutants of
TRPV5 in pGEX6p-2 were obtained as described previously (12). A VSV tag-
encoding oligo duplex (sense 5’-CATGGCATACACTGATATCGAAAT GAAC-
CGCCTGGGTAAGGCGCGCCTT-3’ and antisense 5’-CTAGAAG GCGCGC-
CTTACCCAGGCGGTTCATTTCGATATCAGTGTATGC-3’) was inserted into
the NcoI/XbaI restriction sites of the pTLN oocyte expression vector. Rab11a was
cloned into this construct by PCR (forward primer 5’- GGCGCGCCTTGGCAC-
CCGCGACGACGAGTAC-3’ and reverse primer (5’-
GTGAACTTGCGGGGTTTTTCAGTATCTACGA-3’) using the pACT2 con-
struct as a template and subsequently subcloned into pGEX6p2 (Amersham
Biosciences, Uppsala, Sweden) and pCB7 (13). TRPV5 was cloned into eGFP-C1
(Clontech Palo Alto, CA) by PCR (forward primer 5’- TCCG-
GACGGGGGGGGATGGGGGCCTGTCCACCC-3’ and reverse primer 5’-
CCGGTGGATCCTGATCAG-3’). All constructs were verified by sequence
analysis. Oocyte expression constructs were linearized and TRPV5, TRPV6 and
Rab11a cRNA was synthesized in vitro using SP6 RNA polymerase as described
previously (14).
Yeast two-hybrid system 
Yeast was subsequently transformed with pAS-1 containing the TRPV6 carboxyl-
terminus, and a mouse kidney cDNA library (Clontech, Palo Alto, CA) present in
the pACT2 vector. Screening of the library was performed as described previous-
ly (12). Yeast two-hybrid results were confirmed using purified library plasmids and
negative controls were performed by replacing a binding partner with either a
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pAS-1 construct containing the amino-terminus (amino acids 1-53) of rat γENaC
or the empty pACT2 vector.
GST-TRPV5 fusion protein and interaction assays
pGEX6p-2 constructs were transformed in Escherichia coli BL21 and GST fusion
proteins were expressed and purified according to the manufacturer’s protocol
(Amersham Biosciences, Piscataway, NJ). GST-Rab proteins were prepared in
GTP or GDP bound conformation as described (15). Rab11a S25N was cleaved
from GST using Precission Protease (Amersham Biosciences), concentrated using
Centriprep YM10 (Millipore, Amsterdam, The Netherlands) and checked by SDS-
PAGE. [35S]Methionine-labeled full-length Rab11a or TRPV5/TRPV6 protein was
prepared using a reticulocyte lysate system (Promega, Madison, WI). HEK293
cells were transfected with Rab11a, Rab22b or Rab7 constructs and lysed in pull-
down buffer (20 mM HEPES, 100 mM NaCl, 5 mM MgCl2, 1 mM DTT, 100 µM
GTP or GDP and 0.4% (v/v) Triton X-100 [pH 7.5]). Rab proteins, TRPV5 or
TRPV6 were added to GST or GST-fusion proteins immobilized on glutathione-
Sepharose 4B beads (Amersham Biosciences) in pull-down buffer and incubated
for 2h at room temperature. After extensive washings, bound proteins were eluted
with SDS-PAGE loading buffer and visualized by autoradiography or
immunoblotting using rabbit anti-Rab11 (Zymed, San Fransisco, CA), monoclon-
al anti-VSV (Sigma, St Louis, MO, for Rab11 and Rab22b) or anti-myc (Santa Cruz
Biotechnology, Santa Cruz, CA, for Rab7). The quality and quantity of GST or
GST- fused proteins was routinely analyzed by Coomassie staining.
Co-immunoprecipitation
Xenopus laevis oocytes were co-injected with 10 ng TRPV5 and 10 ng Rab11a S25N
cRNA as described (14). After 48 h injected oocytes were lysed in sucrose buffer
containing 20 mM Tris pH 7.4, 5 mM EDTA, 135 mM NaCl, 0.1 % (v/v) NP-40,
0.5 % (w/v) sodium desoxycholate and 10 % (w/v) sucrose, centrifuged at 100 g
for 5 min and subsequently incubated on ice for 60 min. The lysates were cen-
trifuged for 30 min at 16,000 g and supernatants were incubated with monoclonal
anti-HA antibodies (Sigma, St Louis, MO) immobilized on protein A-agarose
beads (Kem-En-Tec A/S, Kopenhagen, Denmark) for 16 h at 4 (C.
Immunoprecipitated proteins were analyzed by immunoblot analysis using rabbit
anti-Rab11a antibodies.
Cell fractionation
Xenopus laevis oocytes were homogenated in HBA (in mM: 20 Tris, 5 MgCl2, 5
Na2HPO4, 1 EDTA, 80 sucrose, pH 7.4), centrifuged twice at 400 g for 10 min
to remove plasma membranes and yolk proteins and incubated with in vitro trans-
lated [35S]methionine-labeled Rab11a S25N protein for 16 h at 4 (C. Subsequently,
the microsomal fraction was separated from the cytosol by centrifugation at
100,000 g for 1 h, washed once with HBA buffer and analyzed by autoradiography.
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CNT and CCD primary cell culture and transepithelial Ca2+ transport
Rabbit kidney CNT/CCD tubules were immunodissected from the kidney cortex
of New Zealand White rabbits (± 0.5 kg), placed in primary culture on permeable
filters (0.33 cm2; Costar) and transepithelial Ca2+ transport was measured as
described previously (16) in the presence or absence of 1 µM ruthenium red
(Sigma, St Louis, MO). Cells were subsequently fixed in 3% (w/v) paraformalde-
hyde in PBS for 30 min at 4 (C.
Immunofluorescence microscopy
Immunohistochemistry on mouse kidney sections was performed as described
previously (17) using affinity purified guinea pig antiserum against TRPV5 and
rabbit anti-Rab11 antibodies. Serial sections were incubated with rabbit anti-
TRPV6 or rabbit anti-Rab11a antibodies. Xenopus laevis oocytes were injected with
5 ng HA-tagged TRPV5 cRNA with or without 10 ng Rab11a cRNA. Two days
after injection immunocytochemistry was performed as described (14) using mon-
oclonal anti-HA (dilution 1: 400; Sigma, St. Louis, MO). Cell fixed on permeable
filter supports were stained with guinea pig anti-TRPV5 and rabbit anti-Rab11 and
appropriate secondary antibodies coupled to Alexa 488 or 596 and mounted in
Mowiol. The cell surface was visualized by biotinylation, followed by incubation
with streptavidin-Oregon green 488, essentially as described (18). Images were
taken sequentially with a Biorad MRC 1024 confocal microscope with a 60x objec-
tive. XZ scans were constructed from 35 confocal optical sections (0.2 µm apart).
All negative controls, including non-injected cells or sections incubated with
preimmune serum or conjugated antibodies alone, were devoid of staining.
45Ca2+ uptake assay
Xenopus laevis oocytes were co-injected with TRPV5 or TRPV6 and Rab11a cRNA.
Ca2+ uptake was determined 2 days after injection as described previously (19).
Plasma membrane isolation
Xenopus laevis oocytes were injected with 5 ng TRPV5 cRNA only or co-injected
with 5 ng TRPV5 and 10 ng Rab11a cRNA. After 48 h follicle membranes were
manually removed and plasma membranes were isolated from 12 oocytes as
described before (20).
Statistical analysis
In all experiments, the data are expressed as mean ± SEM. Overall statistical sig-
nificance was determined by analysis of variance (ANOVA). P values below 0.05
were considered significant.
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Figure 1
Direct and specific interaction of TRPV5 and TRPV6 with Rab11a. The carboxyl-termi-
nus of TRPV6 or γENaC and full-length Rab11a were co-transformed into the Y153
yeast strain and grown on media without tryptophan and leucine. β-Galactosidase
activity was determined in TRPV6 and Rab11a co-transformed yeast, γENaC and
Rab11a co-transformed yeast were used as negative control. Two representative
colonies are depicted (A). [35S]Methionine labeled TRPV5 (left) or TRPV6 (right) was
incubated with GST-Rab11a WT, GTP-locked mutant Rab11a (S20V) or GDP-locked
Rab11a (S25N) or GST alone immobilized on glutathione-Sepharose 4B beads (B).
[35S]Methionine labeled Rab11a S20V or Rab11a S25N was incubated with GST-TRPV5, 
GST-TRPV6 or GST immobilized on glutathione-Sepharose 4B beads. Both TRPV5 and
TRPV6 strongly interacted with Rab11a S25N, whereas no binding to Rab11a S20V was
observed (C). Rab11a S25N was purified from bacteria as a GST fusion protein, GST
was cleaved of using Precission protease and Rab11a S25N was incubated with immo-
bilized and purified GST-TRPV5 (D). VSV tagged Rab11a S25N or Rab22b S19N and
myc-tagged Rab7 T22N were transiently expressed in HEK293 cells and incubated with
GST or GST-TRPV5 and interaction was analyzed using immunoblot analysis using
monoclonal anti-VSV or anti-Myc (E). Xenopus laevis oocytes were injected with
Rab11a S25N or co-injected with HA-tagged TRPV5 and Rab11a S25N cRNAs. Oocytes
lysates were subjected to immunoprecipitation using monoclonal anti-HA antibodies.
The precipitated sample was immunoblotted for the presence of TRPV5 (F) or co-pre-
cipitated Rab11a (G). Follicle membranes of non-injected or TRPV5 cRNA injected
Xenopus laevis oocytes were removed. Subsequently, oocytes were homogenized, plas-
ma membranes and yolk proteins were pelleted. Supernatant was incubated with
radioactively labeled Rab11a S25N for 16 h at 4 °C and microsomal membranes were
isolated at 100,000 g and analyzed for the presence of Rab11a S25N (* p<0.05, n=6, 3 sep-
arate experiments) (H).
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RESULTS
Identification of Rab11a as a TRPV5- and TRPV6-associated protein
Using the carboxyl-terminus of TRPV6 as bait to screen a mouse kidney cDNA
library with the yeast two-hybrid technique, we isolated full length Rab11a, a mem-
ber of the Rab family of small GTPases, as a TRPV6-interacting protein. Rab11a
strongly interacted with TRPV6 (figure 1A), whereas β-galactosidase activity was
not observed with the negative control, in the absence of prey or after co-trans-
formation of the bait with the empty pACT2 (prey) vector.
The interaction between TRPV6 and Rab11a was further substantiated using GST
pull-down assays. In vitro translated [35S]methionine-labeled TRPV6 strongly inter-
acted with Rab11a S25N, a mutant deficient in GTP binding. Binding to wild type
(WT) Rab11a was moderate and only minor binding to Rab11a S20V, a GTPase-
deficient Rab11a mutant (21), was observed (figure 1B). Identical results were
obtained with [35S]methionine-labeled TRPV5 (figure 1B). The reverse binding
reaction, using GST, GST-TRPV5 carboxyl-terminus or GST-TRPV6 carboxyl-
terminus incubated with in vitro translated [35S]methionine-labeled Rab11a S20V
or Rab11a S25N mutants, confirmed the TRPV5- and TRPV6-binding specificity
for Rab11a S25N (figure 1C). Similar binding efficiencies were observed using
recombinant, purified GST fused TRPV5 carboxyl-terminus and Rab11a S25N
(figure 1D), demonstrating that the interaction is direct and does not require addi-
tional proteins. In contrast, Rab22b S19N and Rab7 T22N, both GTP binding-
deficient Rabs, did not bind TRPV5, indicating the specificity of the interaction of
TRPV5/6 with Rab11a (figure 1E). GST alone failed to show any binding in all
conditions.
In order to further assess the Rab11a interaction, HA-tagged TRPV5 and Rab11a
S25N were co-expressed in Xenopus laevis oocytes and subjected to immunoprecip-
itation using monoclonal anti-HA antibodies. HA-tagged TRPV5 was specifically
precipitated using these monoclonal antibodies, as indicated by the specific bands
at ~70 kDa for the core-glycosylated TRPV5 and ~90 kDa for complex glycosy-
lated TRPV5 (figure 1F). Rab11a S25N could be co-precipitated with TRPV5 from
these oocytes, as represented by an immunopositive band of ~25 kDa (figure 1G).
TRPV5 and TRPV6 interacted specifically with Rab11a S25N, mimicking the
GDP-bound configuration of Rab11a. Therefore, it was investigated whether the
expression of TRPV5 or TRPV6, both intrinsic membrane proteins, could stimu-
late membrane association of this particular Rab11a configuration. To this end,
TRPV5 cRNA- and non-injected Xenopus laevis oocytes were homogenized, plasma
membranes and yolk proteins were removed by low speed centrifugation. The
supernatant containing cytosol and microsomes was incubated with soluble in
vitro translated Rab11a S25N and analyzed by ultracentrifugation and SDS-PAGE
followed by autoradiography. Rab11a S25N was detected in the microsomal frac-
tion of non-injected oocytes. Co-expression of TRPV5 resulted in a significant
increase in the membrane-bound fraction of Rab11a S25N (figure 1H).
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Co-localization of Rab11a with TRPV5 and TRPV6
To determine whether the interaction can occur in physiological situations the co-
localization of endogenous TRPV5 and TRPV6 with endogenous Rab11a was
investigated. Immunopositive staining for Rab11a was co-localized with TRPV5
along the luminal domain of kidney tubules, previously identified as distal convo-
luted (DCT) and connecting tubules (CNT) (17) (figure 2A). Furthermore, serial
sections were stained for the presence of Rab11a and TRPV6, revealing co-local-
ization of both proteins along the luminal domain of connecting tubule and cor-
tical collecting ducts (CCD) (22) (figure 2B). More detailed localization studies
were subsequently performed on primary cultures of CNT and CCD cells,
immunodissected from rabbit kidney. These cells exhibited net apical-to-basolater-
al Ca2+ transport, indicating the intactness and functionality of the preparation.
Ca2+-transport was blocked (from 63 ( 3 to 5 ( 2 nmol/cm2/h) by ruthenium red,
a polycationic dye that blocks TRPV5 activity with an IC50 of 111 nM (23) (fig-
ure 2F). TRPV5-staining localized predominantly to the apical side of the cell and
was absent from the basolateral membrane that is in line with its physiological
function as apical Ca2+ influx channel (figure 2E). Importantly, TRPV5
immunopositive staining overlapped with that of Rab11a in vesicular structures
(figure 2C), present in a subapical region (figure 2D). Thus, these findings further
substantiate the physiological relevance of the interaction between the epithelial
Ca2+ channels and Rab11a.
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Figure 2
Co-localization of TRPV5 and TRPV6
with Rab11a. Mouse kidney sections were
co-stained with antibodies against TRPV5
(green) and Rab11a (red) (A). Serial kid-
ney sections were stained with antibodies
against TRPV6 (green) or Rab11a (red)
(B). immunodissected CNT and CCD cells
were grown on permeable filter supports
and double-labeled with anti-TRPV5
(red) and anti-Rab11 (green) (C,D) or
steptavidin-Oregon green to visualize the
cell surface (E).  Arrowheads indicate the
positions utilized to render XZ projec-
tions from 35 confocal optical sections (0.2
µm apart).  Ruthenium red-sensitive
transcellular Ca2+ transport was meas-
ured prior to fixation to ensure monolay-
er integrity and cell viability (F). Bar
denotes 100 µm (A,B) or 5 µm (C-E). 
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Rab11a S25N inhibited TRPV5- and TRPV6-mediated Ca2+ influx
The effect of Rab11a expression on TRPV5 and TRPV6 activity at the plasma
membrane was determined in Xenopus laevis oocytes, using a 45Ca2+ uptake assay.
Expression of TRPV5 and TRPV6 resulted in a ~5-fold increase of Ca2+ influx
compared to non-injected oocytes (figure 3A,B). Co-expression of Rab11a S25N
significantly decreased the TRPV5- and TRPV6-mediated Ca2+ influx to a level
that was indistinguishable from non-injected oocytes (figure 3A,B). Co-expression
of Rab11a S20V had no significant effect on TRPV5 and TRPV6 activity. Ca2+
uptake in oocytes expressing only Rab11a S20V or Rab11a S25N was not differ-
ent from non-injected oocytes (0.49 ± 0.07, 0.42 ± 0.05 versus 0.44 ± 0.04 pmol
Ca2+/oocyte/h, respectively). The effect of Rab11a S25N is consistent with a role
for Rab11a in TRPV5- and TRPV6- targeting to the plasma membrane. Therefore,
we investigated the trafficking of TRPV5 in Xenopus laevis oocytes. A distinct band
at the size of complex glycosylated TRPV5 (24) was observed by immunoblot
analysis in plasma membrane preparations of TRPV5-injected oocytes (figure 3C).
The core-glycosylated form of TRPV5 was not detectable, indicating the purity of
the plasma membrane preparation obtained by using this method (20).
Importantly, TRPV5 could not be detected in the plasma membrane of oocytes
co-expressing TRPV5 and Rab11a S25N, whereas co-injection of Rab11a S20V
resulted in normal plasma membrane localization of TRPV5 (figure 3C). In all
conditions, TRPV5 was produced and glycosylated to a similar extent as in the
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Figure 3
Role of Rab11a in TRPV5 and TRPV6 traf-
ficking towards the plasma membrane.
45Ca2+ uptake was measured in oocytes
injected with TRPV5 cRNA (A) or TRPV6
cRNA (B) only or co-injected with Rab11a
S20V or Rab11a S25N cRNA.  Asterix
denotes significantly (P<0.05) different
from non-injected oocytes. HA-TRPV5
and Rab11a cRNA was co-injected in
Xenopus laevis oocytes. Plasma mem-
branes (C) or total membranes (D) were
isolated and blotted for TRPV5 using
monoclonal anti-HA. Oocytes were inject-
ed with HA-tagged TRPV5 cRNA with or
without Rab11a cRNA and TRPV5 local-
ization was determined by immunocyto-
chemistry using monoclonal anti-HA (E).
Rab11a S25N expression decreased the
TRPV5 plasma membrane localization.
Representative images of three independ-
ent experiments are shown. Bar denotes
10 µm.
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absence of mutant Rab11a protein (figure 3D). These results were verified by
immunocytochemical analysis of TRPV5- and Rab11a-expressing oocytes.
Immunopositive staining for TRPV5 was predominantly localized along the plas-
ma membrane (figure 3E). Co-injection of TRPV5 with Rab11a S25N resulted in
largely dispersed intracellular immunopositive staining with virtually no staining of
TRPV5 at the plasma membrane, while expression of Rab11 S20V had no effect
(figure 3E).
Characterization of the Rab11a binding site in TRPV5
In order to distinguish a possible general effect of Rab11a S25N expression on
protein trafficking (21, 25, 26) from direct consequences of Rab11a association
with the epithelial Ca2+ channels, we mutated the Rab11a binding site in TRPV5.
To map the Rab11a binding site, a series of deletion mutants of the carboxyl-ter-
minus of TRPV5 was constructed as depicted in figure 4A. These mutants were
expressed and purified as GST-fusion proteins and incubated with in vitro trans-
lated Rab11a S25N. Rab11a interacted with TRPV5 truncates up to position 601,
narrowing the binding site to a helical region of 29 amino acids. Two truncated
TRPV5 mutants, containing stop codons at position 596 or 591, failed to co-pre-
cipitate Rab11a (figure 4B). Therefore, the region between amino acids 595 and
601 of TRPV5 is essential for Rab11a binding. Subsequently, this region, corre-
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Figure 4
The Rab11a binding site in TRPV5. GST
fusion proteins containing different por-
tions of the carboxyl-terminus of mouse
TRPV5 were constructed according to the
schematic drawing (A). These proteins
were immobilized on glutathione-
Sepharose 4B beads and then incubated
with in vitro translated Rab11a S25N.
Interaction of Rab11a with the GST fusion
proteins was determined by autoradio-
graphy. The region between amino acids
595 and 601 was essential for binding (B).
Mutation of this region diminished the
interaction with Rab11a (B) and resulted
in significantly disturbed TRPV5 traffick-
ing, resulting in a low number of channels
at the cell surface (C). Accordingly,
TRPV5-mediated 45Ca2+ uptake was sig-
nificantly decreased in Xenopus laevis
oocytes, injected with TRPV5 595-5G-601
compared to oocytes injected with wild-
type TRPV5 (D). TRPV5 and TRPV6 sequences, varying from human to zebrafish, were
aligned using the Clustal method, demonstrating complete conservation of the Rab11a
binding-site during evolution (E). Bar denotes 25 µm.
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sponding to the amino acid sequence MLERK, was mutated into glycines (595-
5G-601) and the binding of Rab11a was re-analyzed by GST pull-down. The inter-
action between Rab11a and the mutant 595-5G-601 TRPV5 was significantly
decreased, further indicating the relevance of this MLERK domain for Rab11a
interaction (figure 4B). Of note, the binding region for the previously identified
TRPV5-interacting protein S100A10 is located upstream of this Rab11a binding
region (12) and the T593A (numbering according to the mouse sequence) muta-
tion in TRPV5, which is crucial for S100A10 binding, had no effect on the bind-
ing of Rab11a (data not shown), indicating the specificity of the identified region.
Importantly, the diminished binding of Rab11a to the TRPV5 596-5G-601 mutant
was accompanied by an impaired trafficking of TRPV5, as was demonstrated by
immunocytochemical analysis of Xenopus laevis oocytes injected with TRPV5 wild
type or 596-5G-601 mutant cRNA. Wild-type channels showed robust plasma
membrane localization, whereas the binding-deficient mutant is mainly localized to
the cytoplasm (figure 4C).
The functional role of Rab11a binding was subsequently investigated by 45Ca2+
uptake in oocytes. Expression of wild-type TRPV5 resulted in a ~5-fold increase
in the Ca2+ uptake compared to non-injected oocytes, whereas expression of the
TRPV5 596-5G-601 mutant resulted in a Ca2+ uptake that was indistinguishable
from non-injected oocytes (figure 4D). The functional significance of the identi-
fied Rab11a-binding site is further underscored by sequence conservation among
all members of the epithelial Ca2+ channels TRPV5 and TRPV6 identified so far
(figure 4E), ranging from human to zebrafish (Danio rerio).
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DISCUSSION
The present study demonstrates a novel function of Rab11a mediating trafficking
of TRPV5 and TRPV6 towards the plasma membrane by direct cargo interaction.
First, GDP-bound Rab11a directly and specifically binds to a conserved stretch in
the carboxyl-terminus of TRPV5 and TRPV6, demonstrating a unique interaction
between a TRP channel and a GDP-bound Rab. Second, the epithelial Ca2+ chan-
nels colocalize with Rab11a in subapical vesicles present in Ca2+ transporting cells
of the kidney. Third, functional data indicates that cargo interaction (in the GDP
status) and subsequent GTP binding are required for Rab11a-mediated TRPV5
and TRPV6 targeting towards the plasma membrane.
GDP-bound Rab11a as a novel TRPV5- and TRPV6-interacting protein
Our study describes for the first time cargo proteins that interact directly with
Rab11a. Although Rab proteins are known to interact with a large variety of effec-
tors (10, 27, 28), only a few studies have demonstrated direct interaction between
a Rab GTPase and a cargo molecule (29). Recently, it was reported that the poly-
meric IgA receptor (pIgR) interacts directly with Rab3b, controlling IgA-stimulat-
ed transcytosis (30). The second example is the interaction between Rab5a and the
angiotensin II type 1A receptor (31). Finally, Pfeffer and coworkers have recently
demonstrated a mechanism in which Rab proteins interact indirectly with cargo.
They showed that a ternairy complex of Rab9, mannose-6-phosphate receptor and
the adaptor protein TIP47 plays a role in the vesicular transport of the mannose-
6-phosphate receptor (32). Direct interaction of Rabs with cargo could provide
further insight into the mechanisms of Rab localization and function. The recruit-
ment of Rabs to specific membranes is mediated by the Rab carboxyl-terminus
(33). This suggests the involvement of Rab-interacting proteins in the membrane
localization of Rab proteins. An intriguing possibility is that certain Rab-accesso-
ry proteins are cargo themselves, contributing to the membrane localization of
specific Rab proteins. TRPV5 and TRPV6 preferentially interacted with Rab11a in
its inactive configuration, which stimulated the Rab11a membrane association.
Therefore, TRPV5 and TRPV6 may support the recruitment of Rab11a to specif-
ic membrane compartments in Ca2+-transporting epithelia. Similarly, it was sug-
gested that the direct interaction between Rab3b and pIgR provides a partial expla-
nation for the specificity of binding of Rab3b to pIgR-containing vesicles (30).
Furthermore, direct interaction of Rabs with cargo could contribute to the target-
ing of proteins to their proper destination. For TRPV5 and TRPV6, the direct
association with Rab11a constitutes the “delivery machinery” destined to transport
these channels to the apical plasma membrane. Identification of additional novel
cargo that interacts with Rab proteins could provide means to further dissect the
mechanism of Rab activity and thus a novel insight into the molecular machinery
of membrane traffic.
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Co-localization of Rab11a and TRPV5 and TRPV6
Further evidence for a role of Rab11a in TRPV5 and TRPV6 regulation is the pre-
dominant co-localization of Rab11a with TRPV5 or TRPV6 along the apical
domain of DCT, CNT and CCD, corroborating previous Rab11 localization data
from Goldenring et al. (34). Furthermore, Rab11a is present along the luminal
membrane of enterocytes, where TRPV6 expression is prominent (34, 35). The
specific expression pattern in kidney and intestine supports a role for Rab11a in
the regulation of TRPV5 and TRPV6. Also at the subcellular level, Rab11a shows
significant co-localization with TRPV5 in subapical vesicular structures. Previous
functional and histological studies have identified Rab11-positive structures as api-
cal recycling endosomes, which are specialized compartments involved in polar
sorting of endocytosed membrane proteins (21, 36-39). Despite the multiple
examples of proteins that are present in Rab11-containing endosomes, TRPV5 is
the first TRP channel identified in this compartment. Furthermore, our study is
the first to indicate that cargo molecules that travel via these structures can be
directly bound to Rab11a.
Rab11a binding targets TRPV5 and TRPV6 towards the plasma mem-
brane
The unique role of Rab11a in targeting of TRPV5 and TRPV6 towards the plas-
ma membrane by direct interaction to the channel was further established using
combined biochemical, functional and immunocytochemical analyses. The interac-
tion between Rab11a and TRPV5 is localized to a helical stretch in the carboxyl-
terminus. A stretch of five amino acids at position 595-601 within the Rab11a
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Figure 5
Schematic model depicting the
role of Rab11a in TRPV5 and
TRPV6 trafficking. Rab11a-GDP
interacts directly with TRPV5 or
TRPV6 in intracellular vesicles.
Subsequently, Rab11a is docked
at the vesicle, and GDP is
exchanged for GTP. Several Rab-
effectors stabilize Rab11a in the
membrane in the GTP-bound
state. At this state, Rab11a does
no longer interact with TRPV5
or TRPV6. The vesicle is subse-
quently targeted to the plasma
membrane, where its fusion
enables TRPV5- and TRPV6-
mediated Ca2+-influx.
TRPV5
or
TRPV6
Rab11a -GDP Rab11a -GTP
Lumen
Tight junction
binding site of TRPV5 was demonstrated to be required for Rab11a binding.
Moreover, this region is conserved among all identified species of TRPV5 and
TRPV6. Mutations in this stretch resulted in a lack of TRPV5-mediated Ca2+
uptake, based on defective trafficking of TRPV5. Recently, we demonstrated that
the interaction of TRPV5 with 80K-H, a Ca2+ binding protein, was localized to
the same region (40), suggesting a possible common binding site in TRPV5/6 for
these two distinct proteins. Importantly, 80K-H operates as a Ca2+ sensor for
TRPV5 at the plasma membrane instead of modulating TRPV5 trafficking (40).
Therefore, the impaired trafficking of this TRPV5 mutant observed in this study
suggests an essential role for Rab11a in targeting TRPV5 towards the plasma
membrane. In addition, we further substantiated the functional role of Rab11a in
the trafficking of TRPV5 and TRPV6 using Rab11a mutants. GDP-locked Rab11a
expression strongly reduced the TRPV5- and TRPV6-mediated Ca2+ influx, result-
ing from a significantly decreased number of Ca2+ channels at the plasma mem-
brane. Together, these data indicate that cargo interaction (in the GDP status) as
well as subsequent GTP binding is required for Rab11a-mediated TRPV5/6 traf-
ficking. Our findings show a novel interaction between a Rab GTPase and TRP
channels and point to a unique role for Rab11a in the regulation of TRPV5/6
channel trafficking.
Concluding remarks
We propose the following model for the role of Rab11a in trafficking of TRPV5
and TRPV6 (figure 5). Initially, cytosolic GDP-bound Rab11a specifically interacts
with TRPV5 and TRPV6 in a subapical compartment. Subsequently, Rab11a is
docked to this compartment, while GDP is exchanged with GTP. At this state,
Rab11a effectors will associate and Rab11a does no longer interact with TRPV5
and TRPV6. Finally, active GTP-bound Rab11a mediates transport of TRPV5 and
TRPV6 containing structures to the plasma membrane, where membrane fusion
allows Ca2+ influx.
In conclusion, our data provide new insight into the molecular machinery of TRP
channel trafficking via direct interaction between a Rab GTPase and apically tar-
geted cargo. This association is involved in the physiological regulation of TRPV5
and TRPV6 cell surface abundance, a critical component in Ca2+ homeostasis. The
future challenge is to find the signals that modulate the interaction of TRPV5/6
and Rab11a to fine-tune cell surface expression of these epithelial channels.
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ABSTRACT
The epithelial Ca2+ channels TRPV5 and TRPV6 are the most Ca2+-selective
members of the superfamily of Transient Receptor Potential (TRP) channels. The
TRP superfamily consists of a diverse group of cation channels that play an
important role in various processes ranging from pain, heat and cold perception to
active Ca2+ (re)absorption in epithelia. The Ca2+ influx through TRPV5 and
TRPV6 is tightly controlled to modulate the Ca2+ balance and prevent cellular
Ca2+ overload. However, little is known about intracellular proteins that interact
with TRPV5 and TRPV6, and regulate the activity of these channels. Using a yeast
two-hybrid approach to screen a kidney cDNA library, the present study identified
BSPRY (B-box and SPRY-domain containing protein) as a novel factor involved in
the control of TRPV5. BSPRY was initially identified as a zyxin and 14-3-3 inter-
acting protein, but its biological function remains to be established. We demon-
strated the specific Ca2+-independent interaction between BSPRY and TRPV5 by
GST pull-down and co-immunoprecipitation assays. Importantly, a significant co-
localization of BSPRY with TRPV5 was observed in the apical domain of distal
convoluted and connecting tubules of mouse kidney. Co-expression of TRPV5
and BSPRY resulted in a significant reduction of the TRPV5-induced Ca2+ influx
in confluent monolayers of Madine Darby Canine Kidney cells. Together, these
results demonstrate the role of BSPRY in the regulation of epithelial Ca2+ trans-
port via modulation of TRPV5 activity and reveal the first physiological function
of this novel protein.
INTRODUCTION
The Transient Receptor Potential (TRP) superfamily of cation channels plays a
pivotal role as the initial signal transduction molecules in a wide variety of senso-
ry processes, including vision (TRPC1), hearing (TRPA1) (1), tasting (TRPM5),
heat (TRPV1-4), cold (TRPM8) and osmosensation (TRPV4, TRPM3) (2).
Furthermore, these channels have been implicated in several other processes
including vasoregulation (TRPC6) and ion homeostasis (TRPV5-6, TRPM6-7) (2).
TRPV5 and TRPV6 form homo- or heterotetrameric channels that possess unique
functional characteristics among the highly heterogeneous group of TRP channels
(3, 4). They exhibit a constitutively activated Ca2+ permeability, a high Ca2+ selec-
tivity, and a Ca2+-dependent feedback mechanism regulating channel activity (5).
Recent studies using TRPV5 knockout mice have demonstrated the pivotal gate-
keeper role of TRPV5 in active Ca2+ reabsorption (6). These mice show a robust
renal Ca2+ loss and display considerable bone abnormalities. Furthermore, these
mice exhibit polyuria and urinary acidification. In addition, TRPV5 knockout mice
exhibit a significant Ca2+ hyperabsorption, associated with an increased duodenal
TRPV6 expression level. The characteristics of TRPV6 knockout mice, including
decreased intestinal Ca2+ absorption and bone mineral density further substanti-
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ates the role of this channel in intestinal Ca2+ absorption (7). Together, TRPV5
and TRPV6 form the gatekeepers of transcellular Ca2+ transport and understand-
ing their regulation is pivotal for our insight into the (patho)physiology of Ca2+
homeostasis (for review see (8)).
TRPV5 and TRPV6 are regulated at various levels. The expression of these chan-
nels in kidney and intestine is subject to strict regulation by steroid hormones, i.e.
vitamin D, estrogen, androgen, and by the parathyroid hormone (PTH) (8).
Furthermore, the activity of TRPV5 and TRPV6 at the plasma membrane is reg-
ulated by a negative feedback mechanism, inhibiting the channels upon increases
in the intracellular Ca2+ concentration (5). The latter mechanism inhibits pro-
longed Ca2+ influx, driven by the steep electrochemical inward gradient for Ca2+.
Because this  regulatory mechanism is mainly operational at increased intracellular
Ca2+ concentrations (228 nM in inside-out patches (9)), additional channel activi-
ty-restricting mechanisms seem essential for TRPV5/6 expressing cells to prevent
cytotoxic intracellular Ca2+ concentrations. Furthermore, calbindin-D28K and cal-
bindin-D9K, specialized Ca
2+-binding proteins that completely colocalize with
TRPV5/6 at the cellular level, provide additional Ca2+ buffering capacity to Ca2+
transporting cells. In addition, regulated endo- and exocytosis of TRPV5 and
TRPV6 could contribute to the fine-tuning of the number of channels at the cell
surface. A significant fraction of TRPV5 channels is localized intracellularly, sug-
gesting a shuttling mechanism controlling the function of this channel at the api-
cal plasma membrane (10).
These regulatory processes are fundamental in the maintenance of the extracellu-
lar Ca2+ balance. Furthermore, TRPV5/6-inhibitory processes might protect cells
from a deleterious Ca2+ influx mediated by these constitutively active channels.
The molecular mechanisms underlying channel trafficking and regulation of its
activity at the plasma membrane are not well understood.
The aim of the present study was, therefore, to identify proteins that modulate the
activity of TRPV5 or TRPV6 to regulate transcellular Ca2+ transport. To this end,
we performed a yeast two-hybrid screen to identify channel-associated regulatory
proteins. Here, we describe the identification of BSPRY, a novel protein with pre-
viously unknown function, as a channel-associated regulatory protein of the
epithelial Ca2+ channel TRPV5.
MATERIALS AND METHODS
DNA constructs and cRNA synthesis
Full-length and carboxyl-termini of TRPV5 and TRPV6 were obtained as
described previously (11). Full-length BSPRY was obtained from mouse EST
I.M.A.G.E. 5116439, cloned from the pCMVsport6.0 vector into the pTLN
oocyte expression vector in frame with an amino-terminal VSV tag by PCR (for-
ward 5’-GGCGCGCCTTTCCGCGGATGTCTCCGGGACG-3’, reverse 5’-
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AATACGACTCAC TATAGGG-3’) and into pGEX6p2 (Amersham Biosciences,
Uppsala, Sweden) (forward 5’-CGGAATTCCCATGTCCGCGGATGTCTCC-3’;
reverse 5’-AATACGACTCACTATAGGG-3’) using AscI/XhoI and EcoRI/XhoI,
respectively. Subsequently, VSV-BSPRY was subcloned into the BamHI/KpnI sites
of pCB7 by PCR using the pTLN construct as a template (forward 5’-
GGGGTACCGCCACCATGGCATA CACTGATATC-3’ and reverse 5’-AGAT-
ACGAATGGCTACATTTT-3’) followed by digestion with BglII and KpnI. All
constructs were verified by sequence analysis. pTLN constructs were linearized
and TRPV5, TRPV6 and BSPRY cRNA was synthesized in vitro using SP6 RNA
polymerase as described previously (11).
Yeast two-hybrid system 
The Y153 yeast strain was first transformed to Trp prototrophy with pAS-1 con-
taining the TRPV6 carboxyl-terminus. Yeast was subsequently transformed with a
mouse kidney cDNA library (Clontech, Palo Alto, USA) present in the pACT2
vector, and screening of the library was performed as described previously (11).
Yeast two-hybrid results were confirmed using purified library plasmids and nega-
tive controls were performed by replacing a binding partner with either a pAS-1
construct containing the amino-terminus (amino acids 1-53) of the gamma sub-
unit of the rat epithelial Na+ channel (ENaC) or the empty pACT2 vector.
GST-TRPV5 fusion protein and interaction assays
pGEX6p-2 constructs were transformed in Escherichia coli BL21 and GST fusion
proteins were expressed and purified according to the manufacturer’s protocol
(Amersham Biosciences). BSPRY cRNA was injected in Xenopus laevis oocytes.
After 2 days oocytes were lysed in PBS containing 0.4 % (v/v) Triton X-100.
[35S]Methionine-labeled full-length BSPRY or TRPV5/TRPV6 protein was pre-
pared using a reticulocyte lysate system Xenopus oocyte lysates or in vitro translated
proteins were added to GST or GST-fusion proteins immobilized on glutathione-
Sepharose 4B beads (Amersham Biosciences) in PBS containing 0.4 % (v/v)
Triton X-100. After 2 h incubation at room temperature, the beads were washed
extensively and bound proteins were eluted with SDS-PAGE loading buffer, sub-
sequently separated on SDS-PAGE gels and visualized by autoradiography or
immunoblotting using a monoclonal anti-VSV antibody (Sigma, St Louis, USA).
RT-PCR analysis
Total RNA was isolated using TRIzol (GIBCO/BRL, Life Technologies, Breda,
The Netherlands). Total RNA (2 µg) was subjected to reverse transcription using
Moloney murine leukemia virus reverse transcriptase, and a PCR for BSPRY was
performed using the primers 5’-GATTCGGAGAAATTAAGC-3’ and 5’-GGCT-
GCAGTTACAGAGTGC-3’. The primers used to amplify β-actin were 5’-
ACCATTTCCCTCTCAGCTGTG-3’ and 5’-GTATGCCTCTGGTCGTACCAC-
3’.
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MDCK transfection and propagation
MDCK cells were maintained in Dulbecco’s modified eagle’s medium (DMEM)
(Biowhittaker, Verviers, Belgium) supplemented with 5 % (v/v) fetal calf serum.
Cells were stably transfected using the Amaxa Nucleofector (Amaxa, Cologne,
Germany) according to the manufacturers’ instructions. Clones were selected by
culture in the presence of 800 µg/ml G418 and 400 µg/ml hygromycin.
Expression of BSPRY and GFP-TRPV5 was confirmed by immunoblot analysis
using anti-VSV and anti-GFP antibodies. Five clones were pooled to eliminate
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Figure 1
BSPRY sequences from different species were identified using BLAST
(http://www.ncbi.nlm.nih.gov/BLAST/) and alligned using AllignX (VectorNTI
Suite, Invitrogen, Breda, The Netherlands). Significant evolutionary sequence conser-
vation was observed ranging from 38% between fish and mouse to 90% between human
and chimpanzee. The following accession numbers were used: CAC09324 (human),
XP528397 (chimpanzee), CAC09325 (mouse), NP071597 (rat), XP415546 (chicken),
CAF99179 (tetraodon nigroviridis). Indicated in boxed areas are the B-box (position 66-
107 in the mouse protein) and the SPRY domain (position 332-454 in the mouse pro-
tein). 
1                                                               70
human  ------------------------------------------MSAEGAEPGPGSGSGPGP------GPLC
chimpanzee  ------------------------------------------MSAEGSEPGPGSGSGPGP------GPLC
mouse  MSADVSGTESGSESGPEPEPGPEPGPESRPESRPKPGPGPEPRPESGPEPGPRSGLRRGPKQGSERSQLC
chicken  ----------------------------------------------------------------------
rat  ----------------------------------------------------------------------
fish  ---------------------MELEGPGFSPPGGDGKRRQQVSEAAATPTDTESGIFPGE------GELC
71                                                              140
human  PEHGQALSWFCGSERRPVCAACAGLGGRCRGHRIRRAEERAEELR-------------------------
chimpanzee  PEHGQALSWFCGSERRPVCAACAGLGGRCRGHRIRRAEERAEELRVSGCGRRKARAPETPGAPGGTRQGL
mouse  PEHFEPLSWFCLSERRPVCATCAGFGGRCHRHRIRRAEEHAEELR-------------------------
rat  ----------------------------------------------------------------------
chicken  ---------------MPADAVCFPQPNPAAQPDVREAPPRTHRGR-------------------------
fish  VEHEAELDWFCGTEQKVVCSLCTVAG-PCQGHAVTPLADRVTAVR-------------------------
141                                                             210
human  ----------------------NKIVDQCERLQLQSAAITKYVADVLPGKNQRAVSMASAARELVIQRLS
chimpanzee  GSLGLGGLDSRPRSLGSSVALANKIVDQCERLQLQSAAITKYVADVLPGKNQRAVSMASAARELVIQRLS
mouse  ----------------------NKIVDQCERLQLQSAGISKYMAEVLQGKNQKAVVMASAARDLIIQRLS
rat  ------------------------------------------------------MIMANATREVIIQRLS
chicken  ---------------------------SVSPLRVPAPCGSMLFLLFLPFP---WQSAANSARELVIQRLI
fish  ----------------------------AR-MEVDADGNGAKIFAYAFDIGKGRCFAANRKRQQVFARIS
211                                                             280
human  LVRSLCESEEQRLLEQVHGEEERAHQSILTQRVHWAEALQKLDTIRTGLVGMLTHLDDLQLIQKEQEIFE
chimpanzee  LVRSLCESEEQRLLEQVHGEEERAHQSILTQRVHWAEALQKLDTIRTGLVGMLTHLDDLQLIQKEQEIFE
mouse  LVRSLCESEEQRLLEQVHGEEERAHQSILTQRAHWVDAVQKLDTLRTNMVDMITHLDDLQLIQREQEIFE
rat  LVRCLCESEEQRLLEQVHSEEERAHQCILTQRAHWDDKLRKLDSLRTSMVDMLTHLNDLQLIQMEQEILE
chicken  FVGKVCENEEQRLLEEVHAEEERAQHSILTQRAHWTEALQKLSALRTYLVDTITNLDDQDLVNAEQEIFE
fish  AAREALEEEEQRLLEEVQREEERVEQCLLTHRAHWSQALENLSQTRSSLVHMLTHAADTHLATSSQEIAE
281                                                             350
human  RTEEAEGILDPQESEMLNFNEKCTRSPLLTQLWATAVLGSLSGT--EDIRIDERTVSPFLQLSDDRKTLT
chimpanzee  RTEEAEGILDPQESEMLNFNEKCTRSPLLTQLWATAVLGSLSGT--EDIRIDERTVSPFLQLSDDRKTLT
mouse  RAEEAEGILDPQDSEKLSFNEKCAWSPLLTQLWAASVLGSLSGV--EEVLIDERTVSPLLHLSEDRRTLT
rat  RAEEAEGILEPQESEKLSFNEKCAWSPLLTQLWATSVLGSLSGM--EDVLIDERTVGPLLNLSEDRKTLT
chicken  RTEVAEGILEPRESAKLNFNQQRVQSPLLHRLWASAVLCCVAGS--QEISIDEKTVSPYLSLSEDKKTLT
fish  RVEETEGVGEPCDTDKLNLNPNCGDSRLLRGLWAAAVLLGPNGYGSPHLKFDERTVSPLLSLSDDFCTVT
351                                                             420
human  FSTKKSK-ACADGPERFDHWPNALAATSFQNGLHAWMVNVQNSCAYKVGVASGHLPRKGSGSDCRLGHNA
chimpanzee  FSTKKSK-ACADGPERFDHWPNALAATSFQNGLHAWMVNVQNSCAYKVGVASGHLPRKGSGSDCRLGHNA
mouse  FIAKKSK-VCSDEPERFDHWPNALAATAFQTGLHAWIVNVKHSCAYKVGVASDQLPRKGSGNDCRLGHNA
rat  FNAKKSK-VCSVTQQRFDHWPNALAVNAFQTGLHAWAVNVKHSCAYKVGVASAQLPRKGSGSDCRLGHNA
chicken  FSPKKAK-LDLDGPERFDHWPNALATAAFHTGLHAWKVSVEKSCAYKLGVCYGSLPRKGPGNEVRLGFNA
fish  FLHKKPRQAVRYDPARFDCWPNVLGSLSLSSGTHSWVVDVGQSDAFKVGVCYASLERKGSGNEARLGHNS
421                                                             490
human  FSWVFSRYDQEFRFSHNGQHEPLGLLRGPAQLGVVLDLQVQELLFYEPASGIVLCAHHVSFPGPLFPVFA
chimpanzee  FSWVFSRYDQEFRFSHNGQHEPLGLLRGPAQLGVVLDLQAQELLFYEPASGTVLCAHHGSFPGPLFPVFA
mouse  FSWVFSRYDQEFCFSHNGYHEPLPLLRCPAQLGMLLDLQAGELVFYEPASGTVLHIHRASFPQVLFPVFA
rat  FSWVFSRYDQEFCFSHNGNHEPLALLRCPTQLGLLLDLQAGELIFYEPASGTVLHIHRESFPHRLFPVFA
chicken  ASWVFSRYDKEFRFLHAGQPQPVELLRAPAEIGVLVDFAGGEVLFYDPDSCTILFSHREAFAAPLYPVFA
fish  QSWVLSRFAGDYSFFHAGQKVPLQVVKGPQRIGVLLDWPSQTLLFYEADSGAVLYTLTHPFSSPLLPACA
491                                        536
human  VADQTISIVR------------------------------------
chimpanzee  VADQTISIVR------------------------------------
mouse  VADQLISIVRGPLATVRLDSPPHHPCSIRRTTCQDTVGQNVVVGVW
rat  VADQVISIVC------------------------------------
chicken  VAHQSISLSQ------------------------------------
fish  VSDCSVTIL-------------------------------------
clonal differences. For flow cytometry analysis of GFP-TRPV5 expression,
MDCK cells were harvested by trypsinization and the relative fluorescence inten-
sity was measured on a FACSCaliburTM (BD Biosciences, Oxnard, USA).
Co-immunoprecipitation
Madine Darby canine kidney (MDCK) cells stably transfected with GFP-TRPV5
and VSV-BSPRY were lysed in sucrose buffer containing 20 mM Tris pH 7.4, 5
mM EDTA, 135 mM NaCl, 0.5 % (v/v) NP-40, 0.2 % (v/v) Triton X-100 and 10
% (w/v) sucrose, incubated on ice for 60 min and centrifuged for 30 min at 16,000
g. Supernatants were incubated with guinea pig anti-TRPV5 or monoclonal anti-
VSV antibodies (Sigma, St Louis, MO) immobilized on protein A-agarose beads
(Kem-En-Tec A/S, Kopenhagen, Denmark) for 16 h at 4 (C. Immunoprecipitated
proteins were analyzed by immunoblot analysis using rabbit anti-GFP or mono-
clonal anti-VSV antibodies.
Preparation of antibodies and immunohistochemistry
Antibodies were raised against the peptide H2N-LFPVFAVADQLISIV-COOH of
mouse BSPRY and used for immunohistochemistry as described (3). Briefy, mouse
kidney sections were incubated for 16 h at 4 ºC with affinity purified guinea pig
antiserum against TRPV5 and rabbit anti-BSPRY. To visualize TRPV5 and BSPRY,
a goat anti-guinea pig Alexa 488 conjugated antibody (1:300) or a goat anti-rabbit
Alexa 594 conjugated antibody (1:300) (Molecular Probes, Eugene, USA) was
used. Images were taken with a Biorad MRC 1024 confocal microscope. All nega-
tive controls, including sections incubated with preimmune serum or conjugated
antibodies alone, were devoid of any staining.
Preparation and analysis of cell fractions
HeLa cells were stably transfected with pCB7-VSV-BSPRY or the empty pCB7
vector using Lipofectamine 2000 (Invitrogen, Breda, The Netherlands) DMEM
supplemented with 10 % (v/v) fetal calf serum. Clones were selected by culture in
the presence of 400 µg/ml hygromycin. Subsequently, cell were grown to conflu-
ency in a T75 flask (Greiner Bio-One GmbH, Frickenhausen, Germany) and
homogenized by brief sonication in homogenization buffer (250 mM sucrose, 10
mM Tris, pH 7.4). After a 10 min spin at 400 g (input fraction), the particulate or
membrane fraction was obtained by centrifugation at 100,000 g for 30 min. The
supernatant was collected (cytosol fraction) and the pellet was resuspended in
homogenization buffer and recentrifuged at 100,000 g for 30 min to wash away
cytosolic contaminants of the membrane fraction. The expression of VSV-BSPRY
in the membrane and cytosol fraction was analyzed by immunoblot analysis.
45Ca2+ uptake assay
Ca2+ uptake was determined using confluent MDCK cells by incubation in uptake
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medium (in mM: 110 NaCl, 5 KCl, 1.2 MgCl2, 1 CaCl2, 10 Na-acetate, 2
NaH2PO4, 20 HEPES-Tris, pH 7.4 supplemented with 10 µM felodipine, 10 µM
methoxyverapamil, 1 mM BaCl2 and 1 µCi/ml 45CaCl2) for 5 min at room tem-
perature. After extensive washing in stop buffer (in mM: 110 NaCl, 5 KCl, 1.2
MgCl2, 0.5 CaCl2, 1.5 mM LaCl3, 10 Na-acetate, 20 HEPES-Tris, pH 7.4) at 4 °C
cells were lysed with 0.05 % (w/v) SDS, and counted for radioactivity.
Statistical analysis
In all experiments, the data are expressed as mean ± SEM. Overall statistical sig-
nificance was determined by analysis of variance (ANOVA). p values below 0.05
were considered significant.
RESULTS
Identification of BSPRY as a novel TRPV5 and TRPV6-associated protein
In order to find novel TRPV5 and TRPV6-associated proteins a yeast two-hybrid
screen was performed on a mouse kidney cDNA library. Using the mouse TRPV6
carboxyl-terminus as a bait 5 clones were isolated that were identified as BSPRY.
Four of the clones contained different fractions of full-length BSPRY.
Furthermore, the yeast two-hybrid results indicated that the first 50 amino acids of
mouse BSPRY are not required for TRPV6 binding, as these were missing in one
of BSPRY clones. BSPRY contains 486 amino acids, a B-box (12) and SPRY
domain. The SPRY domain was originally identified in the splA kinase of
Dictyostelium and the ryanodine receptor (13). The function of these domains is
currently unknown, although they have been postulated to play a role in protein-
protein interaction (13, 14). The BSPRY amino acid sequence has been determined
for several species, ranging from mammals to bird and fish. Comparison of these
sequences showed considerable sequence conservation during evolution, with pro-
tein similarities ranging from ~40% between fish and mouse to ~90% between
human and chimpanzee. The most prominent discrepancy is located in the amino-
terminus, which varies considerably in length among the investigated species (fig-
ure 1).
Full-length BSPRY was obtained from a mouse Expressed Sequence Tag (EST)
library and used to further establish the yeast two-hybrid binding results. BSPRY
was expressed in Xenopus laevis oocytes and incubated with GST-TRPV5 or TRPV6
carboxyl-termini, immobilized on sepharose 4B beads. BSPRY interacted with the
carboxyl-terminus of TRPV6 in a GST pull-down assay, confirming the interac-
tion (figure 2A). TRPV5, which is closely related to TRPV6, also interacted with
BSPRY (figure 2A). No interaction was observed with GST alone, indicating the
specificity of the binding. Furthermore, also the reverse approach, where full-
length, GST-fused BSPRY was immobilized on sepharose beads and incubated
with in vitro translated full-length TRPV5 or TRPV6 resulted in significant binding
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of both Ca2+ channels to BSPRY (figure 2B). GST did not co-precipitate TRPV5
or TRPV6. Subsequently, the binding of BSPRY was investigated in the presence
of 1 mM Ca2+ or in Ca2+-free (2 mM EDTA) conditions, as shown in figure 2C.
BSPRY interacted with the carboxyl-terminus of TRPV5 in a Ca2+-independent
manner.
Co-immunoprecipitation of BSPRY and TRPV5 in mammalian cells
In order to further substantiate the BSPRY-interaction, we generated MDCK cell
lines, stably transfected with GFP-fused TRPV5 and subsequently with VSV-
BSPRY or the empty pCB7 vector (figure 3A,B). These cell lines allowed the inves-
tigation of TRPV5 in a polarized epithelium, whereas endogenous expression lev-
els of these channels in native tissues including kidney were below detection limit
of our immunoblot analysis. Using these stably transfected cells, TRPV5 could be
co-immunoprecipitated with anti-VSV antibodies upon expression of VSV-
BSPRY, as indicated by the specific bands at ~95 kDa for the core-glycosylated
GFP-TRPV5 and ~115 kDa for complex glycosylated GFP-TRPV5 (figure 3B).
Importantly, TRPV5 was not detected in the immunoprecipitated sample in the
absence of VSV-BSPRY, confirming the specificity of the procedure. Similarly,
BSPRY was co-immunoprecipitated with TRPV5 in the reverse reaction using
anti-TRPV5 antibodies immobilized on sepharose beads, as represented by an
immunopositive band of ~65 kDa (figure 3A). Here, actin was used as a control
to demonstrate equal input of the samples. β-Actin was absent in the immuno-
precipitated sample, indicating the specificity of the interaction.
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Figure 2
Interaction of TRPV5 or TRPV6 with
BSPRY as shown by GST pull-down
analyses. (A) Lysates of Xenopus laevis
oocytes injected with 10 ng of VSV-tagged
BSPRY cRNA were incubated with GST
or GST fused to the carboxyl-terminus of
TRPV5 or TRPV6 immobilized on glu-
tahione-Sepharose 4B beads. BSPRY inter-
acted specifically with TRPV5 and
TRPV6, but not with GST alone. (B)
[35S]Methionine labeled full-length TRPV5
or TRPV6 was incubated with GST or
GST-BSPRY immobilized on glutathione-
Sepharose 4B beads. (C) Binding of
BSPRY to TRPV5 and TRPV6 was demon-
strated in the presence (+) or absence (-)
of Ca2+. Both TRPV5 and TRPV6 interact-
ed with BSPRY, whereas no binding to
GST alone was observed. Input lane
reflects 20 % (A, C) or 35 % (B) of the
material.
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Co-localization of BSPRY and TRPV5 
The expression of BSPRY in mouse tissues was analyzed by RT-PCR. BSPRY was
detected in several tissues including kidney, small intestine, prostate, lung and
uterus. BSPRY was less abundantly present in heart, whereas skeletal muscle and
liver were negative (figure 4A, upper panel). All samples expressed β-actin, which
was used as a positive control to confirm cDNA integrity (figure 4A, lower panel).
The cellular localization of BSPRY was determined by immunocytochemistry on
mouse kidneys using affinity purified antiserum from rabbits and guinea pigs
immunized with a 15 amino acids containing peptide of BSPRY. BSPRY was main-
ly detected in a subset of renal tubules, whereas proximal tubules and glomeruli
were negative (figure 4B). Pre-immune serum did not show any staining.
Subsequently, the identity of the BSPRY-containing tubules was investigated by
co-immunostaining with anti-TRPV5, present in principal cells of the second part
of the distal convoluted tubule (DCT2) and connecting tubule (CNT) (10, 15).
BSPRY showed complete cellular co-localization with TRPV5 (figure 4B), in line
with a physiological role in the regulation of this Ca2+ channel. Moreover, BSPRY
staining was dispersed throughout the cell and concentrated in the apical domain
of these cells (figure 4C). Because we observed a strong colocalization of BSPRY
with TRPV5, we focused on the latter channel in this study.
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Figure 3
Co-immunoprecipitation of BSPRY with
TRPV5 in MDCK cells. MDCK cells stably
expressing GFP-TRPV5 were transfected
with pCB7-VSV-BSPRY of the empty
pCB7 vector and 5 clones with equal
growth rate and TRPV5 expression of
both conditions were pooled to eliminate
clonal variation.  (A) Expression of VSV-
BSPRY was determined by immunoblot
analysis using monoclonal anti-VSV.
Expression of β-actin was used to show
equal loading. Lysates were subjected to
immunoprecipiation using anti-TRPV5
antibodies. Co-immunoprecipitated
BSPRY was demonstrated by
immunoblot analysis using anti-VSV anti-
bodies. Actin was not co-immunoprecipi-
ated, showing the specificity of the inter-
action. (B) The reverse co-immoprecipia-
tion was performed in which MDCK
lysates were incubated with anti-VSV
antibodies. Co-immunoprecipitated
TRPV5 was demonstrated using anti-GFP antibodies. TRPV5 could not be precipitated
in the absence of BSPRY, although TRPV5 expression was similar in both conditions,
demonstrating the specificity of the interaction. None-transfected MDCK cells (NT)
were used to demonstrate the specificity of the antibodies.
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Figure 4
Localization and tissue distribution of
BSPRY. (A) RNA was extracted from sev-
eral mouse tissues and BSPRY expression
was determined by RT-PCR. The BSPRY
specific band was amplified in brain lung,
duodenum, ileum, kidney, prostate and
uterus (top). A faint signal was detected
in heart, whereas skeletal muscle and
liver were negative (top). β-Actin was
used as a control to ensure cDNA integri-
ty and was positive in all tested tissues
(bottom). (B) Immunohistochemical
analysis of BSPRY and TRPV5 in mouse
kidney sections. Kidney sections were co-
stained with antibodies against BSPRY
and TRPV5. BSPRY and TRPV5 have a
remarkable similarity in localization and
show significant overlap in the apical
region of the cell. No signal was detected
with pre-immune serum or with fluo-
rophore-conjugated antibodies only.
Br
ain
Lu
ng
He
art
Sk
ele
tal
 M
us
cle
Du
od
en
um
Ile
um
Kid
ne
y
Ut
eru
s
Liv
er
Pr
os
tat
e
bp
339
247
339
247
B
A
TRPV5 BSPRY
Figure 5
The subcellular localization of BSPRY was
determined in transiently (A,B) or stably
(C,D) transfected HeLa cells. BSPRY
showed a predominantly cytoplasmic
localization, with a signal that was diffuse
cytosolic or punctate. In HeLa cells stably
expressing BSPRY, the localization was
more uniform with a punctate distribu-
tion in all cells. (D) HeLa cell
homogenates were centrifuged at 400 g
(input) and subsequently at 100,000 g.
The cytosolic (supernatant) and membra-
nous (pellet) pools of BSPRY were quanti-
fied using two clones of HeLa cells (1 &
2), stably expressing VSV-BSPRY. None-
transfected (NT) cells showed no signal,
demonstrating the specificity of the sig-
nal. The distribution of β-actin (cytosolic)
and Na+, K+-ATPase (intrinsic membrane
protein) was used to verify the cell frac-
tionation procedure.
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Subcellular distribution of BSPRY
The subcellular distribution of BSPRY was further investigated in HeLa cells by
immunofluorescence and immunoblot analysis using the monoclonal anti-VSV
antibody. Upon transient transfection, BSPRY showed predominant cytosolic
staining (figure 5A) and a punctate staining pattern throughout the cell, although
absent from intranuclear regions (figure 5B). The large variation between individ-
ual cells was abolished when BSPRY was stably transfected in HeLa cells. Here, a
punctate staining on a diffuse background was observed in all clonal cell lines test-
ed (figure 5C). Subsequently, we investigated whether BSPRY was present in the
particulate fraction by cell fractionation and immunoblot analysis. The different
subcellular fractions obtained from HeLa cells stably expressing VSV-BSPRY were
analyzed by SDS-PAGE and immunoblot analysis using the anti-VSV antibody.
BSPRY protein was detected in the post-nuclear fraction (figure 5D). After high-
speed centrifugation of the post-nuclear fraction, a large fraction (80-90%) of the
protein was present in the soluble cytosolic fraction (figure 5D) whereas a signifi-
cant amount of the protein (10-20%) localized in the membrane/particulate frac-
tion (figure 5D). Analysis of Na,K-ATPase or actin as markers for intrinsic mem-
brane proteins or cytosolic proteins, respectively, indicated the purity of the
cytosol and membrane fraction.
BSPRY-mediated TRPV5 inhibition of Ca2+ influx
To elucidate the physiological role of BSPRY on the regulation of TRPV5 activi-
ty, the effect of BSPRY co-expression on Ca2+ influx was measured using conflu-
ent monolayers of MDCK cells stably expressing GFP-TRPV5. TRPV5 expres-
sion in these cells resulted in a ~2.5 fold increased Ca2+ influx compared to non-
transfected cells. Upon co-expression with BSPRY, Ca2+ influx was inhibited by 41
± 13 % (figure 6D, p<0.01), compared to cells stably co-transfected with the
empty pCB7 vector. Next we assessed the expression levels of GFP-TRPV5 in
these stably transfected cells. TRPV5 expression levels were identical in the
MDCK cells transfected with pCB7 containing VSV-BSPRY or the empty pCB7
vector, as was demonstrated by immunoblot analysis using anti-GFP antibodies
(figure 6A). Furthermore, the correct size of the bands at ~95-110 kDa demon-
strated the integrity of the GFP-TRPV5-fusion protein. The expression of
BSPRY in these cells was determined by immunoblotting using anti-VSV antibod-
ies and showed a single band at ~65 kDa (figure 6B). In addition, flow cytometry
analysis of the GFP signal demonstrated that >98% of the cells expressed
TRPV5, demonstrating that all cells that form the confluent monolayer of MDCK
cells contributed to the TRPV5-dependent Ca2+ influx, both in the presence and
absence of BSPRY (figure 6C). Together, this shows that BSPRY-mediated
TRPV5-inhibition occurs independently of changes in the GFP-TRPV5 expres-
sion level and suggests a major effect of BSPRY on TRPV5 trafficking to the plas-
ma membrane or modulation of TRPV5 channel characteristics.
69
Chapter 4
DISCUSSION
The present study provides the first evidence of the physiological role of BSPRY
as a novel regulatory protein for the epithelial Ca2+ channel TRPV5. This conclu-
sion is based on three independent observations. First, the specific interaction
between this channel and BSPRY was demonstrated by yeast two-hybrid, GST
pull-down and co-immunoprecipitation assays. Second, BSPRY showed complete
co-localization with TRPV5 in Ca2+-transporting tubular segments of the kidney.
Third, stable expression of BSPRY significantly inhibited Ca2+ influx in confluent
layers of MDCK cells expressing TRPV5.
In this study we identified BSPRY by a yeast two-hybrid screening of a kidney
cDNA library and subsequently confirmed the association of full-length BSPRY
with TRPV5 and TRPV6 by GST pull-down assays. Importantly, the association
of BSPRY and TRPV5 was demonstrated by co-immunoprecipitation assays using
confluent MDCK cells. These polarized cells exhibit apical uptake of Ca2+ and
provide a valuable model for a Ca2+ (re)absorbing epithelium (16). BSPRY was
orgininally identified in a yeast two-hybrid screen using zyxin as bait (17). Zyxin is
a cytoskeletal protein present in focal adhesions (18). BSPRY contains a B-box and
SPRY domain, whose tentative functions are protein-protein interaction modules
(13, 14). The majority of the BSPRY protein is highly conserved from human to
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Figure 6
Functional consequence of BSPRY
expression on TRPV5 activity. (A) The
expression level of GFP-tagged TRPV5
was determined by immunoblot using
anti-GFP antibodies and shows equal
expression levels in the presence or
absence of BSPRY. (B) BSPRY expres-
sion was verified using monoclonal
anti-VSV antibodies. (C) Flow cytome-
try analysis of the GFP signal demon-
strated similar GFP-TRPV5 expression
levels and confirmed the presence of a
single TRPV5-positive cellpopulation,
independent of the presence of BSPRY.
The dashed peak of the two panels indi-
cates the background fluorescence,
measured in non-transfected cells. (D)
TRPV5 activity was determined by
radioactive Ca2+ uptake in MDCK cells
grown to confluency. Expression of
TRPV5 resulted in a 2.5 fold increase in
Ca2+ influx. Co-expression of BSPRY
with TRPV5 resulted in a ~40% decrease in Ca2+ influx. 
* p<0.05 versus all.
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fish. However, the first 150 amino acids present in mouse BSPRY, that contain the
B-box element, are missing in the rat orthologue of BSPRY (19), suggesting that
this part is functionally less relevant.
Using antibodies raised against a conserved epitope present in the carboxyl-termi-
nus of mouse BSPRY, we demonstrated that the localization of BSPRY in kidney
is strikingly similar to the localization TRPV5. BSPRY was present in the apical
domain of all TRPV5-immunopositive tubules. Similar colocalization with TRPV5
in CNT/DCT has previously been observed for calbindin-D28K and the
Na+/Ca2+ exchanger (15, 20). These proteins play an essential role in renal trans-
cellular Ca2+ transport as they respectively facilitate the diffusion of Ca2+ from the
apical to the basolateral side and the extrusion into the blood. Similarly, the robust
colocalization between BSPRY and TRPV5 strongly supports a physiological and
specific function of BSPRY in the regulation of epithelial Ca2+ transport by direct
association with TRPV5 in the kidney.
This study provides the first evidence of a functional role for BSPRY as TRPV5
activity was significantly decreased upon co-expression with BSPRY in MDCK
cells. So far, only 2 studies provide information about BSPRY. First, BSPRY was
recently identified in a yeast two-hybrid screen using zyxin as bait. In epithelial cells
zyxin is involved in the formation of cell-cell contacts, which require actin
cytoskeleton rearrangement (21). Schenker and coworkers provided no informa-
tion about the localization and function of BSPRY. However, the association with
zyxin might hint at a role of the cytoskeleton in the BSPRY-mediated regulation
of TRPV5.
Second, it was shown that BSPRY interacts with 14-3-3 proteins (19). Although the
exact role of 14-3-3 proteins remains to be fully elucidated, their role in the recog-
nition of phosphorylated proteins is well established (22). It has been demon-
strated that 14-3-3 proteins bind to specific motifs containing a phosphorylated
serine residue and have been implicated in the binding to and activation of signal-
ing proteins (22, 23). Furthermore, serine phosphorylation-dependent interaction
of the tandem pore background K+ (KCNK) channels with 14-3-3 proteins over-
comes the ER retention of these K+ channels. Since cell surface biotinylation did
not provide evidence for TRPV5 trafficking as an explanation for the observed
inhibitory function of BSPRY (data not shown), it is tempting to speculate that
BSPRY is involved inhibitory signaling cascades controlling the activity of the
epithelial Ca2+ channels or their targeting to the plasma membrane. Indeed,
TRPV5 activity might also be subject to phosphorylation-dependent regulation
(25, 26).
An analogous inhibitory mechanism has been found for the epithelial Na+ chan-
nel ENaC. The underlying mechanism involved in the restriction of ENaC activi-
ty involve a channel-associated protein Nedd4 (27) that is regulated through phos-
phorylation by the serum- and glucocorticoid-responsive kinase SGK (28).
Furthermore, it has been described that increased channel activity, due to muta-
tions in the Nedd4-binding site of ENaC, is the cause of Liddle syndrome, char-
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acterized by a seriously disturbed Na+ balance (27).
Similarly, unbalanced transcellular Ca2+ transport seems a key feature in certain
pathophysiological conditions including hyperparathyroidism and familial hypocal-
ciuric hypercalcemia. The latter is mostly caused by loss-of-function mutations in
the Ca2+-sensing receptor (CASR) gene (29). Restraining TRPV5/6 activity might
provide novel means to treat hypercalcemia in these patients. In this aspect, it is
first important to gain more insight in the factors that inhibit TRPV5/6, including
BSPRY, to elucidate possible new drug targets.
Likely, TRPV6 is also subject to regulation by BSPRY. First, BSPRY associates to
both TRPV5 and TRPV6. This is in line with  the significant homology between
these channels and their similar functional characteristics (8). Second, the co-local-
ization of BSPRY with TRPV6 in several tissues (other than kidney) is expected
given the broad expression of both BSPRY and TRPV6. Of the investigated tis-
sues especially prostate, brain, lung and duodenum of special interest in this
respect, as they express relatively abundant levels of TRPV6 (30, 31). Finally, the
comparable physiological function of the epithelial Ca2+ channels in kidney
(TRPV5) and small intestine (TRPV6) (8), suggests the presence of regulatory pro-
teins, operating on both proteins.
In conclusion, we have identified BSPRY as a novel auxiliary protein of the epithe-
lial Ca2+ channels TRPV5 and TRPV6. The association, co-localization and func-
tional analyses described in this study demonstrate the first functional role of the
novel protein BSPRY in the direct regulation of TRPV5.
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ABSTRACT
The epithelial Ca2+ channel TRPV5 plays a key role in Ca2+ (re)absorption and is
regulated by vitamin D. The present study aims to explore whether TRPV5 is reg-
ulated by the serum and glucocorticoid inducible kinase SGK1, a kinase transcrip-
tionally upregulated by vitamin D. To this end, cRNA encoding TRPV5 was inject-
ed into Xenopus laevis oocytes with or without additional injection of SGK1, relat-
ed kinases SGK2 and SGK3, constitutively active SGK1 (S422DSGK1), inactive
SGK1 (K127NSGK1), constitutively active protein kinase B (T308D,S473DPKB)
and/or the Na+/H+ exchanger regulating factor NHERF2. Expression of TRPV5
increases uptake of tracer Ca2+ and induces a Ca2+ current (ICa) in the oocytes. In
the presence of Cl- , TRPV5 mediated entry leads to secondary activation of Ca2+-
sensitive Cl- channels (ICl(Ca)). Coexpression of TRPV5 with both 
S422DSGK1 and
NHERF2 stimulates tracer Ca2+ entry, ICa and ICl(Ca). The effect of
S422DSGK1 on
TRPV5 and NHERF2 expressing oocytes is mimicked by SGK1 and SGK3, but
not SGK2, constitutively active protein kinase B or inactive SGK1. Further exper-
iments disclosed the requirement for the second PDZ domain within the
NHERF2 protein. Pull-down experiments and overlay assays revealed that the
TRPV5 carboxyl tail interacts in a Ca2+-independent manner with NHERF2.
These experiments reveal the importance of SGK and NHERF as regulators of
TRPV5 that are likely to participate in the regulation of Ca2+ homeostasis.
INTRODUCTION
The serum- and glucocorticoid-dependent kinase SGK1 is a 49 kDa serine/threo-
nine kinase. SGK1 has originally been cloned as a glucocorticoid-sensitive gene
from rat mammary tumor cells (1). The human isoform has been identified as a
cell volume regulated gene (2). Subsequent studies revealed the genomic regulation
of SGK1 by aldosterone (3-7), tumor growth factor ( (8), fibroblast growth factor
and a variety of further cytokines (9). The catalytic domain of SGK1 is ~55 %
homologous to the catalytic domain of other serine/threonine kinases including
protein kinase A and protein kinase C (10). Furthermore, SGK1 is related to two
isoforms SGK2 and SGK3 (11) and to protein kinase B  (PKB) (12). All three iso-
forms SGK1-3 and PKB (13) are activated via a signaling cascade involving phos-
phatidylinositol 3-kinase and phosphoinositide-dependent kinase PDK1 (11-14).
Activation of SGK1 requires phosphorylation at Ser422, the activation of PKB
phosphorylation at Thr308 and Ser473. Replacement of those amino acids by
aspartate leads to the respective constitutively active kinases S422DSGK1 (13) and
T308D,S473DPKB (12). The inactive mutant of SGK1 is formed upon destruction of
the catalytic subunit by replacement of the Lys127 with asparagine (K127NSGK1)
(13).
Co-expression studies in Xenopus laevis oocytes revealed that the kinase is capable
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of stimulating a wide variety of channels including Cl- channels (volume-regulat-
ed Cl- channel ClC2 and the cystic fibrosis transmembrane conductance regulator
CFTR), K+ channels (renal outer medullary K+ channel ROMK1 and voltage-
gated K+ channels KCNE1/KCNQ1 and Kv1.3), and Na+ channels (epithelial
Na+ channel ENaC and the voltage-gated cardiac Na+ channel SCN5A).
Moreover, SGK1 up-regulates the activity of several transporters including the
Na+/H+ exchanger NHE3, the Na+, K+, 2Cl- co-transporter NKCC2, the intes-
tinal phosphate transporter NaPiIIb, the glucose transporter SGLT1, the gluta-
mine transporter SN1, the glutamate transporters EAAT1 and EAAT3 and the
Na+/ K+-ATPase (reviewed in (10, 15)).
The expression of SGK1 is  positively regulated by the calciotropic hormone 1,25-
dihydroxyvitamin D3 (16), suggesting a possible role in Ca
2+ homeostasis. SGK1
(2), SGK2, SGK3 (11) and protein kinase B (17-20) are expressed in a wide vari-
ety of human tissues including kidney. Thus, they may participate in the regulation
of Ca2+ transport in this epithelial tissue. The epithelial Ca2+ channel TRPV5 (21,
22) plays a key role in renal reabsorption of Ca2+. The channel accomplishes Ca2+
uptake across the apical membrane of epithelial cells. Subsequently, Ca2+ moves to
the basolateral plasma membrane while it is bound to calbindin-D28K, where it is
extruded to the blood compartment via the Ca2+ ATPase and Na+/Ca2+ exchang-
er (23). As entry via TRPV5 is the initial step in transcellular transport of Ca2+,
TRPV5 activity is decisive for transepithelial transport regulation (24).
The present study has been performed to test for a role of the SGK isoforms and
PKB in the regulation of TRPV5 activity. Previously, it was demonstrated that the
stimulating effect of SGK1 on NHE3 (25) and ROMK (26) requires the presence
of the NHE regulatory factor 2 (NHERF2). The carboxyl terminal tail of TRPV5
contains a PDZ motif which may bind NHERF2 (24). NHERF2 and the homol-
ogous NHERF1 modulate the targeting and trafficking of several proteins includ-
ing TRPC4 into the plasma membrane (27-29). Thus, the possibility was investi-
gated that NHERF2 participates in the SGK-dependent regulation of TRPV5
activity. To this end, cRNA encoding TRPV5 has been injected with or without
NHERF2 and/or wild-type SGK1, SGK2, SGK3, constitutively active
S422DSGK1, inactive K127NSGK1, or constitutively active T308D,S473DPKB into
Xenopus laevis oocytes.
MATERIALS AND METHODS
Expression in Xenopus laevis oocytes 
cRNA encoding rabbit TRPV5 (30), human NHERF2 (25), NHERF2 lacking the
first PDZ domain (NHERF2∆P1) (25) or NHERF2 lacking the second PDZ
domain (NHERF2∆P2) (25), human SGK1 (2), human SGK2 (11), human SGK3
(11), constitutively active human S422DSGK1 (11), inactive human K127NSGK1
(11), and constitutively active human T308D,S473DPKB (12) have been synthesized
as described (31). Oocytes were injected with 2.5 ng TRPV5, 7.5 ng S422DSGK1
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and/or 5 ng NHERF2 or NHERF2∆P1 or NHERF2∆P2 cRNA or H2O. All
experiments were performed at room temperature 3 days after injection of the
respective cRNAs.
Tracer Ca2+ uptake 
Ca2+ uptake was measured similar to what has been described earlier (32-34) with
slight modifications. In detail, uptake of 45Ca2+ (ICN Biomedicals GmbH,
Eschwege, Germany), delivered as CaCl2 in aqueous solution (specific activity:
0.185-1.11 TBq/g Ca) was determined 3 days after injection of oocytes with the
respective cRNAs by incubating 10 - 15 oocytes at 20 °C in uptake solution con-
taining 96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 0.1 mM CaCl2, 1 mM BaCl2, 10
µM methoxyverapamil, 5 mM HEPES-Tris, pH 7.4. Radioactive 45Ca2+ was added
to give a final concentration of 7 µCi per ml. After different incubation times, the
oocytes were washed three times in stop buffer containing 96 mM NaCl, 1 mM
MgCl2, 0.5 mM CaCl2, 1.5 mM LaCl3, 5 mM HEPES-Tris, pH 7.4. Single oocytes
were then placed separately in scintillation vials and solubilized in 200 µl 10 %
(w/v) sodium dodecyl sulfate. After addition of 3 ml scintillation fluid (Ultima
Gold, Packard, Groningen, The Netherlands), radioactivity in the samples was
measured in a liquid scintillation counter (Wallac, Freiburg, Germany).
Voltage-clamp analysis
In two-electrode voltage-clamp experiments currents were recorded during a 4 s
linear voltage ramp from -150 mV to +50 mV. The intermediate holding potential
between the voltage ramps was -50 mV. Data were filtered at 10 Hz and recorded
with MacLab digital to analog converter and software for data acquisition and
analysis (ADInstruments, Castle Hill, Australia). The bath solution contained 96
mM NaCl, 2 mM KCl, 1 mM MgCl2, 1 mM BaCl2,10 µM methoxyverapamil, 5 mM
HEPES, pH 7.4 with or without 10 mM CaCl2. Oocytes were kept in modified
Barth´s solution containing 88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 0.8 mM
MgSO4, 0.3 mM Ca(NO3)2, 0.4 mM CaCl2 and 5 mM HEPES, pH 7.4 supple-
mented with 25 µg/ml gentamycin. The flow rate of the superfusion was 20
ml/min and a complete exchange of the bath solution was reached within about
10 s. For direct determination of Ca2+ currents (ICa), the experiments were per-
formed with Cl- depleted oocytes (bathed for 24 h in Cl- free medium) in the
absence of extracellular Cl- in the bath. Under those experimental conditions, the
currents were insensitive to the Cl- channel blocker (5-nitro-1-(3-phenylpropy-
lamino)benzoic acid (NPPB) (100 µM). In the presence of Cl- and absence of Cl-
channel inhibitors, the addition of 10 mM CaCl2 induced an inward current
(ICl(Ca)) which was created by entry of Ca
2+ and subsequent activation of Ca2+
sensitive Cl- channels (30). The peak inward current was taken as a measure for
TRPV5 activity. ICl(Ca) activity is synchronously triggered by the intracellular Ca
2+
concentration close to the membrane determined by the epithelial Ca2+ channel
TRPV5. Thus, ICl(Ca) activity mirrors activation and inactivation kinetics of
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TRPV5 (36). These Cl- channels were inhibited by NPPB. Where indicated, ruthe-
nium red was added at a concentration of 5 µM to inhibit TRPV5. Ruthenium red
further inhibits voltage-sensitive Ca2+ channels (35), which in our experiments are
already suppressed by 10 µM methoxyverapamil. Comparisons were always made
within batches of oocytes.
GST-TRPV5 fusion protein and pull-down assays 
The amino and carboxyl tails of mouse TRPV5 were amplified by PCR using
mouse kidney cDNA (amino terminus: forward 5’-ccgaattcggatgggggctaaaac
tccttggatc-3’; reverse 5’-cgcgctcgagctcaaggctgtccatatttcttccactt-3’; carboxyl termi-
nus: forward 5’-cccctgggatccggcgacactcactggcgagtggcc-3’; reverse: 5’-acagaagtc-
gactcagaaatggtagatctcctc-3’), digested with EcoRI and XhoI (N tail) or BamHI and
SalI  (C tail) and cloned into pGEX6p-2 (Amersham Pharmacia Biotech AB,
Uppsala, Sweden). PGEX6p-2 construct containing full-length mouse NHERF2
was generously provided by Dr. J. Biber (University of Zürich, Switserland).
pGEX6p-2 constructs were transformed in Escherichia coli BL21 and glutathione
S-transferase (GST) fusion proteins were expressed and purified according to the
manufacturer’s protocol (Amersham Pharmacia Biotech AB). [35S]Methionine-
labeled full-length TRPV5 and NHERF2 were prepared using a reticulocyte lysate
system in the presence of canine microsomal membranes (Promega Madison, WI)
and added to GST or GST-fusion proteins immobilized on glutahione-sepharose
4B beads. The binding buffer contained 20 mM Tris-HCl pH 7.4, 140 mM NaCl,
0.2 % (v/v) Triton-X-100 and 0.2 % (v/v) NP-40, supplemented with 1 mM CaCl2
or 2 mM EDTA. After 2 h incubation at room temperature, the beads were washed
extensively with binding buffer. Bound proteins were eluted with SDS-PAGE load-
ing buffer, separated on SDS-PAGE gels and visualized by autoradiography.
Overlay assay
Approximately 10 µg GST, GST-TRPV5 carboxyl tail, GST-TRPV6 carboxyl tail,
GST-NHERF2 or bovine serum albumin were separated on SDS/PAGE gels and
blotted onto PVDF. Blots were blocked for 1 h in binding buffer containing 20
mM Tris-HCl pH 7.4, 140 mM NaCl, 1 mM CaCl2, 0.2 % (v/v) Triton-X-100 and
3 % (w/v) BSA. Subsequently, blots were incubated with in vitro translated
[35S]methionine-labeled NHERF2 or TRPV5 for 2 h at room temperature in bind-
ing buffer containing 0.3 % (w/v) bovine serum albumin (BSA), washed exten-
sively and bound proteins were visualized by autoradiography.
Statistics
Data are provided as means ± SEM, n represents the number of oocytes investi-
gated. All experiments were repeated with at least 3 batches of oocytes from dif-
ferent frogs. All data were analyzed using ANOVA, and only results with p < 0.05
were considered statistically significant.
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RESULTS
To explore whether TRPV5 is regulated by SGK and/or NHERF2, Ca2+ uptake
was measured in Xenopus laevis oocytes. As evident from figure 1A, uptake of Ca2+
into Xenopus laevis oocytes was increased ~5-fold by expression of TRPV5. The
increase of Ca2+ uptake reflects the Ca2+ permeating capacity of TRPV5.
Additional expression of either NHERF2, SGK1, SGK2, SGK3 or constitutively
active T308D,S473DPKB alone did not further stimulate 45Ca2+ entry. However,
expression of TRPV5 together with both, SGK1 and NHERF2 resulted in signif-
icant further stimulation of Ca2+ uptake (figure 1A). In the absence of TRPV5,
expression of SGK1 and NHERF2 did not significantly increase Ca2+ uptake (fig-
ure 3D). Thus, coexpression of SGK1 and NHERF2 increased Ca2+ uptake by
stimulation of TRPV5. Similarly, the coexpression of TRPV5 together with SGK3
and NHERF2 increased Ca2+ uptake. In contrast, the coexpression of neither
SGK2 nor T308D,S473DPKB significantly modified the Ca2+ uptake of oocytes
expressing TRPV5 and NHERF2.
As reported earlier, the entry of Ca2+ triggers Ca2+-sensitive Cl- channels (36).
Therefore, the Ca2+-activated Cl- current (ICl(Ca)) was determined by the two-elec-
trode voltage-clamp technique in these oocytes as a measure for Ca2+ influx activ-
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Figure 1
Stimulation of Ca2+ entry by the com-
bined expression of TRPV5, NHERF2 and
SGK1 or SGK3 but not SGK2 or protein
kinase B. Xenopus laevis oocytes were
injected with either water or cRNA
encoding TRPV5 with or without co-injec-
tion of cRNA encoding wild type
NHERF2, SGK1, SGK2, SGK3 or constitu-
tively active T308D,S473DPKB. (A) 45Ca2+
uptake was measured after 30 minutes of
incubation. n = 8 - 46. (B) Measurement of
Ca2+ influx activated Cl- currents indicate
stimulation of TRPV5 activity upon coex-
pression with NHERF2 and SGK1 or
SGK3. Coexpresion of TRPV5 with
NHERF2, SGK1 or SGK3 alone or
NHERF2 together with SGK2 and PKB
did not stimulate Ca2+ influx. * denotes
significant difference (p < 0.05) between
Xenopus laevis oocytes expressing
TRPV5 alone and oocytes expressing
TRPV5 together with NHERF2 and the
respective kinase.
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ity, as described by Hoenderop and coworkers (30). Similar to tracer Ca2+ uptake,
ICl(Ca) was stimulated by coexpression of TRPV5 together with NHERF2 and
either SGK1 or SGK3 (figure 1B). Coexpression of TRPV5 with either NHERF2,
SGK1 or SGK3 alone did not significantly enhance ICl(Ca). Moreover, neither
SGK2 nor T308D,S473DPKB stimulated ICl(Ca), even if NHERF2 was coexpressed
(figure 1B). Thus, SGK1 and SGK3, but not SGK2 or T308D,S473DPKB stimulate
TRPV5 in the presence of NHERF2.
Previously, TRPV5 has been shown to be inhibited by ruthenium red (33), a poly-
cationic dye. Thus, the effect of ruthenium red on Ca2+ uptake and Ca2+-induced
Cl- currents was tested. Here, constitutively active S422DSGK1 was used which
stimulated Ca2+ entry similarly to wild-type SGK1 when coexpressed with TRPV5
and NHERF2, as illustrated in figure 2. Five µM ruthenium red completely
reversed the increase of Ca2+ uptake (figure 2A) and currents (figure 2B) in
TRPV5 expressing oocytes with or without additional expression of S422DSGK1
and NHERF2.
Further studies were performed to determine the influence of SGK1/NHERF2
on TRPV5 induced currents. In the presence of Cl- the Ca2+ entry through
TRPV5 stimulated Ca2+-sensitive Cl- channels leading to the appearance of a large
Cl- current (ICl(Ca)). In TRPV5-expressing oocytes, hyperpolarization from -50 mV
to -110 mV in the presence of 10 mM Ca2+ triggered a rapidly activating, slowly
and partially inactivating inward current (figure 3B). The transiently activating cur-
rent was only present in Xenopus oocytes expressing TRPV5. In water-injected
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Figure 2
Inhibitory effect of ruthenium red on
TRPV5 activity. Xenopus laevis oocytes
were injected with water alone or TRPV5
with or without cRNA encoding
S422DSGK1 and NHERF2. (A) Ca2+ uptake
or (B) Ca2+-induced Cl- current via
TRPV5 with or without S422DSGK1 and
NHERF2 was inhibited by addition of 5
(M ruthenium red. n = 6 - 10.  
* denotes significant difference (p < 0.05)
between oocytes expressing TRPV5 and
oocytes injected with water. + denotes sig-
nificant difference (p < 0.05) between
oocytes expressing TRPV5 together with
S422DSGK1 and NHERF2 and oocytes
expressing TRPV5 alone.
0
0.5
1.0
1.5
2.0
control
ruthenium red [5 µM]
*
+
A
B
0
1
2
3
4
5
control
ruthenium red [5 µM] +
*
*
*
C
a2
+  
up
ta
ke
 (p
m
ol
/3
0m
in
/o
oc
yt
e)
C
ur
re
nt
 (µ
A
)
H 2
O
TR
PV
5 +
 H 2
O
TR
PV
5 +
 S
42
2D S
GK
1 
+ N
HE
RF
2
H 2
O
TR
PV
5 +
 H 2
O
TR
PV
5 +
 S
42
2D S
GK
1 
+ N
HE
RF
2
oocytes increase of cytosolic Ca2+ activity by addition of Ca2+ ionophore iono-
mycin (10 µM) led to the stimulation of a non inactivating current (figure 3C).
Figure 3A depicts a recording from a non-injected oocyte. In oocytes not express-
ing TRPV5, the Ca2+-sensitive Cl- current could be activated by Ca2+ ionophore
ionomycin (10 µM). As shown in figure 3D, the ionomycin induced Cl- current was
not significantly enhanced by expression of S422DSGK1, NHERF2 or both. In
addition, to determine the Ca2+ current directly, the contribution of Cl- channels
was suppressed by incubating the oocytes in Cl- free extracellular solution for 24
hours. As shown in figure 4, coexpression of TRPV5 together with S422DSGK1
and NHERF led to a significant increase of the current induced by addition of 10
mM CaCl2 compared to TRPV5 expression only. The current was not increased by
coexpression of TRPV5 with either NHERF2 or SGK1 alone (figure 4A). The Cl-
channel blocker NPPB completely inhibited these currents, in line with a TRPV5-
mediated activation of Cl- channels. However, currents measured in Cl--depleted
oocytes were insensitive to the Cl- channel inhibitor NPPB (figure 3B).
Importantly, co-expression with NHERF2 and S422DSGK1 still resulted in a sig-
nificant increase in TRPV5-dependent currents. Therefore, the increase of ICl(Ca)
following coexpression of S422DSGK1 and NHERF2 was not due to upregulation
of the endogenous Cl- channels in these oocytes but due to increased of TRPV5
activity.
To investigate whether the regulatory effect of NHERF2 and S422DSGK1 on
TRPV5 activity is mediated by protein-protein interaction of NHERF2 and
TRPV5, pull-down and overlay assays were performed. To this end, full-length
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Figure 3
Characterization of Ca2+-
induced Cl- currents by the
combined expression of
TRPV5, NHERF2 and the
S422DSGK1. Xenopus oocytes
were injected with water or
TRPV5 cRNA and analyzed by
two-electrode voltage-clamp. 
Hyperpolarization from -50 to -110
mV in the presence of 10 mM Ca2+ to
the bath  induced a rapidly activating
and inactivating  inward current in
TRPV5 expressing oocytes (B) but not
water injected oocytes (A). Elevation of
cytosolic Ca2+ by addition of the Ca2+
ionophore ionomycin (10 µM) led to the stimulation of a non-inactivating current (C),
which could easily be discriminated from TRPV5-induced currents. (D) The ionomycin-
induced endogenous Cl- currents were not significantly enhanced by expression of
S422DSGK1, NHERF2 or both (n = 6).
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TRPV5 protein was labeled with [35S]methionine by in vitro transcription/transla-
tion and its interaction with NHERF2 was tested. As shown in figure 5A, TRPV5
interacted with GST-NHERF2 fusion protein, whereas no binding to GST alone
was observed, indicating the specificity of the interaction. The binding was identi-
cal in the presence of 2 mM EDTA or 1 mM Ca2+ (figure 5A), demonstrating the
Ca2+-independence of the binding. Results obtained were corroborated by overlay
assays. in vitro translated [35S]methionine-labeled TRPV5 bound GST-NHERF2,
whereas GST alone and BSA showed no interaction (figure 5B).
To identify the interaction site of NHERF2 in TRPV5, we amplified the amino
and carboxyl tails of mouse TRPV5 by PCR using mouse kidney cDNA. GST
fusion proteins encompassing either the amino or carboxyl tail of TRPV5 were
incubated with [35S]methionine-labeled NHERF2. NHERF2 interacted specifical-
ly with the carboxyl tail, while the amino tail of TRPV5 was unable to bind
NHERF2. The binding was again Ca2+-independent (figure 5C). To investigate the
specificity of the NHERF2 interaction we performed experiments with the
TRPV5 isoform TRPV6. Figure 5D/E shows that neither the amino nor the car-
boxyl tail of TRPV6 interacted with [35S]methionine-labeled NHERF2 in GST
pull-down (figure 5D) and overlay assays (figure 5E), demonstrating the specifici-
ty of the interaction.
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Figure 4
Inhibition of the TRPV5 induced Cl-, but
not Ca2+ current by NPPB. Xenopus laevis
oocytes were injected with water alone or
TRPV5 with or without cRNA encoding
S422DSGK1 and NHERF2. (A) Inhibition of
ICl(Ca) by application of 100 (M NPPB. (B)
To decrease the contribution of Ca2+-acti-
vated Cl- channels to the currents to
measure TRPV5 currents directly, oocytes
were incubated in Cl- free medium for 24
hours. In this condition,TRPV5-mediated
currents were not sensitive to NPPB (100
(M). In addition, the NPPB-insensitive
current was significantly increased upon
coexpression of TRPV5 with NHERF2
and S422DSGK1 (n= 5-8). * denotes signifi-
cant difference (p < 0.05) between
Xenopus oocytes expressing TRPV5 and
oocytes injected with water. + denotes sig-
nificant difference (p < 0.05) between
Xenopus oocytes expressing TRPV5
together with S422DSGK1 and NHERF2
and oocytes expressing TRPV5 alone.
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Further studies were performed to elucidate the role of SGK kinase-activity and
to identify the PDZ binding domain of NHERF2 required for the stimulating
effect of SGK1 and NHERF2 on TRPV5 activity. Inactivation of SGK1 by
replacement of the lysine at position 127 with asparagine (25) (K127NSGK1), abol-
ished the stimulating effect of SGK1 on oocytes coexpressing TRPV5 and
NHERF2 (figure 6A). Furthermore, TRPV5 channel activity was enhanced with
both, S422DSGK1 and wild-type NHERF2, but not by coexpression of TRPV5
together with S422DSGK1 and NHERF2 lacking the second PDZ domain
(NHERF2∆P2), as shown in figure 6B. In contrast, coexpression of S422DSGK1
together with a NHERF2 mutant deficient of the first PDZ domain
(NHERF2D∆P1) increased TRPV5 activity similar to coexpression of S422DSGK1
together with wild type NHERF2. Thus, the second, but not the first, PDZ
domain is essential for upregulation of TRPV5 activity. This requirement for the
second PDZ domain is consistent with the interaction of SGK1 with the second,
but not first, PDZ domain of NHERF2.
DISCUSSION
The present observations demonstrate a novel mechanism regulating TRPV5
activity, i.e. the control by two members of the serum and glucocorticoid inducible
kinase family and the NHE regulating factor NHERF2.
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Figure 5
NHERF2 interacts with the carboxyl tail
of TRPV5, but not TRPV6 as demonstrat-
ed by GST pull-down and overlay assays.
Full length NHERF2 expressed as GST
fusion protein was purified from E.coli
and immobilized on glutathione-
sepharose 4B beads (A) or blotted onto
PVDF membranes (B) and incubated with
in vitro translated [35S]methionine-labeled
TRPV5. In the reverse binding experi-
ments (C-E) GST fusion proteins encom-
passing either the amino or carboxyl tails
of TRPV5 or TRPV6, immobilized on glu-
tathione-sepharose 4B beads were incu-
bated with in vitro translated [35S]methio-
nine-labeled NHERF2. Bound proteins
were analyzed by autoradiography.
NHERF2 interacted in a Ca2+-independ-
ent manner with the carboxyl tail of
TRPV5, whereas no binding to TRPV6,
the amino tail of TRPV5, GST or BSA was
observed.
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NHERF2 and SGK1 modulate TRPV5, but not the Ca2+-activated Cl- channels,
since intrinsic NPPB-sensitive Cl- current remains unaffected upon SGK1 and/or
NHERF2 coexpression. The effect of SGK1 depends on an intact catalytic sub-
unit, as the inactive mutant K127NSGK1 did not influence TRPV5 even in the pres-
ence of NHERF2. Thus, the kinase is obviously effective through phosphoryla-
tion of a target protein. SGK1 has been reported to bind NHERF2 (37). However,
SGK1 cannot phosphorylate NHERF2 (Lang et al., unpublished observations).
TRPV5 possesses a putative SGK1 phosphorylation site in its sequence. Hence,
SGK1 might phosphorylate and thereby stimulate TRPV5 activity. Nevertheless
this stimulatory effect requires NHERF2 which, similar to what has been
described for the modulation of NHE3 by PKA (37), might bind SGK1 to bring
the kinase in close proximity to TRPV5 or an associated protein. The stimulating
effect of SGK1 is shared by SGK3, but not by SGK2 or PKB. The TRPV5-stim-
ulating capacity correlates with the ability of the two kinases to bind NHERF2
(37). In contrast to SGK1 and SGK3, SGK2 does not bind NHERF2 (37) and is,
according to the present study, not able to stimulate TRPV5.
A well-known function of SGK1 is its participation in the regulation of the epithe-
lial Na+ channel ENaC (4, 6, 7, 38-42). It was demonstrated that co-expression of
SGK1 significantly increases the activity of the epithelial Na+ channel (ENaC) (4,
7, 43). Debonneville and coworkers demonstrated that SGK1 binds and phospho-
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Figure 6
Requirement of SGK1 kinase activity and
the second PDZ domain of NHERF2 for
the stimulation of TRPV5 activity. (A)
Xenopus laevis oocytes were injected with
water or cRNA encoding TRPV5 alone or
with S422DSGK1, K127NSGK1, NHERF2 or
coinjected with cRNA encoding TRPV5,
NHERF2 and S422DSGK1, K127NSGK1.
Stimulation of TRPV5 activity required
SGK1 kinase activity and was not
observed with kinase-dead K127NSGK1.
(B) Xenopus laevis oocytes were injected
with water or cRNA encoding TRPV5
alone or with S422DSGK1 and either wild-
type NHERF2, NHERF2 lacking the sec-
ond PDZ domain (NHERF2∆P2) or
NHERF2 lacking the first PDZ domain
(NHERF2∆P1). Only the combined
expression of S422DSGK1 and wild-type
NHERF2 or NHERF2∆P1 increased the
TRPV5-dependent currents. * indicate
significant difference between expression
of TRPV5 alone and coexpression of
TRPV5, NHERF2 and SGK1. (n = 20 - 29)
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rylates the ubiquitin protein ligase Nedd4-2 (44). This phosphorylation reduces the
interaction between Nedd4-2 and ENaC, leading to decreased channel ubiquitiny-
lation and degradation, resulting in an increase in ENaC protein abundance with-
in the plasma membrane (42, 44, 45). The physiological significance of SGK1-
dependent regulation of ENaC is illustrated by experiments in the SGK1 knock-
out (sgk1-/-) mouse. Under normal supply of NaCl, the NaCl excretion of the
sgk1-/- mouse is virtually identical to the NaCl excretion of wild-type littermates
(sgk1+/+). Supply of a NaCl-deficient diet, however, discloses the impaired ability
of the sgk1-/- mouse to lower renal Na+ output. The renal NaCl loss is signifi-
cantly larger in sgk1-/- mice compared to sgk1+/+ littermates, despite increased in
plasma aldosterone concentrations, decreased in blood pressure, decreased in
glomerular filtration rate and enhanced proximal tubular Na+ reabsorption in the
sgk1-/- mice. In addition to a role in renal Na+ transport, SGK1 has more
pleotropic effects. For example, the SGK1 kinase has been implicated in diabetic
nephropathy (40), memory performance during spatial learning in rats (46), and a
polymorfism of SGK1 was linked to an increase in body mass index (47).
Alterered SGK1-mediated regulation of the glucose transporter SGLT1 was asso-
ciated with the latter phenotype (47).
Most recently, SGK1 has been shown to upregulate the epithelial Na+, H+
exchanger NHE3 (37) and ROMK1 (26). In contrast to the regulation of ENaC
(44) or SGLT1 (47), the regulation of NHE3 and ROMK1 does not require the
participation of Nedd4-2. Similar to SGK-dependent regulation of TRPV5, the
regulation of NHE3 (37) and ROMK1 (26) by SGK1 has been shown to depend
on NHERF2. In the present study, we further show that the TRPV5 carboxyl tail
interacts with NHERF2 and, to be effective, NHERF2 requires an intact second
PDZ domain. Similar to TRPV5, the sequence of ROMK1 has a PDZ binding
motif. Application of brefeldin A, to block cellular secretory mechanisms, result-
ed in a gradual decrease of ROMK1 channel activity and this process was signifi-
cantly inhibited upon coexpression with NHERF2 and SGK1. Furthermore,
SGK1/NHERF2 increases the plasma membrane abundance of ROMK1.
Together, this suggests that SGK1/NHERF2 stabilizes ROMK1 at the plasma
membrane. NHERF2 is thought to link membrane proteins to cytoskeletal pro-
teins through its PDZ domains (25). The binding to the cytoskeleton may serve to
stabilize the protein at the plasma membrane, providing a possible explanation of
the increased TRPV5 activity. NHERF2 alone is unable to activate TRPV5, but
requires SGK1 or of one of its isoforms. SGK1 expression is highly variable, as it
is upregulated by glucocorticoids (1), aldosterone (3-7), cell shrinkage (2) and a
wide variety of additional factors (9). Notably, SGK1 is under transcriptional con-
trol 1,25-dihydroxyvitamin D3 (16). It is thus tempting to speculate that SGK1 par-
ticipates in the regulation of TRPV5 by 1,25-dihydroxyvitamin D3. In conclusion,
TRPV5 is the target of a complex regulating mechanism involving NHERF2 and
the serine/threonine kinases SGK1 and 3. The concerted action of NHERF2 and
the kinases markedly upregulates the activity of this key channel in the regulation
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of the Ca2+ balance.
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ABSTRACT
The epithelial Ca2+ channels TRPV5 and TRPV6 play a pivotal role as the apical
Ca2+ influx pathway in epithelial Ca2+ transport. PDZ proteins have been demon-
strated to play a crucial role in the targeting or anchoring of ion channels and
transporters in the apical domain of the cell. In this study, we describe the identi-
fication of IKEPP/NaPi-Cap2 as a novel TRPV5- and TRPV6-associated PDZ
protein. IKEPP was identified using two separate yeast two-hybrid screens with
the carboxyl termini of TRPV5 and TRPV6 as bait. Binding of the carboxyl ter-
mini of TRPV5 and TRPV6 with IKEPP was confirmed by GST pull-down assays
using in vitro translated IKEPP or lysates of Xenopus laevis oocytes, expressing
IKEPP. Furthermore, the interaction was confirmed with full-length TRPV5 and
TRPV6 by GST pull-down and co-immunoprecipitation assays using in vitro trans-
lated TRPV5 and Xenopus oocytes or HEK293 cells co-expressing IKEPP and
TRPV5/TRPV6. The fourth PDZ domain of IKEPP was sufficient for the inter-
action, although PDZ domain 1 also contributed to the binding. The binding site
for IKEPP localized in a conserved region in the carboxyl terminus of TRPV5 and
was distinct from the binding site of the PDZ protein NHERF2. IKEPP pre-
dominantly localized at the plasma membrane of Xenopus oocytes. This localiza-
tion was independent of the presence of TRPV5. Therefore, we hypothesize a role
for this novel PDZ protein as a putative plasma membrane scaffold for the epithe-
lial Ca2+ channels.
INTRODUCTION
TRPV5 and TRPV6 (renamed after ECaC1 and ECaC2) form a distinct, highly
Ca2+ selective subfamily of the transient receptor potential (TRP) channel super-
family. This family fulfills a plurality of physiological functions, which vary from
phototransduction, nociception, olfaction, heat and cold sensation, to epithelial
Ca2+ transport (1).
A recent study using TRPV5 knockout mice has demonstrated the importance of
TRPV5 in renal Ca2+ handling (2). Furthermore, these mice display a dramatic
decrease in bone density and a compensatory hyperabsorption of Ca2+. The latter
correlated with an increase of duodenal TRPV6 expression (2). The functional
role of TRPV6 in intestinal Ca2+ absorption was recently addressed by inactiva-
tion of the mouse TRPV6 gene (3). TRPV6 knockout mice showed a significant
Ca2+ malabsorption suggesting that TRPV6 is indeed the rate-limiting step in vita-
min D-dependent Ca2+ absorption. Therefore, it is evident that understanding the
regulation of TRPV5 and TRPV6 is of utmost importance for our insight in Ca2+
homeostasis.
TRPV5 and TRPV6 are subjected to tight control at multiple levels, i.e. regulation
of protein abundance by various factors including vitamin D, estrogen and dietary
Ca2+ content (4). In adition, channel activity is controlled by a Ca2+-dependent
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inactivation mechanism, operating as negative feedback to protect the cell from
deleterious Ca2+ influx (5, 6). Furthermore, a significant subset of TRPV5 chan-
nels is localized subapically in distal convoluted and connecting tubules in the kid-
ney, suggesting a shuttling mechanism of the proteins to the plasma membrane (7).
Despite recent advances in the understanding of the mechanisms underlying chan-
nel activity (8, 9) and trafficking (10) of TRPV5 and TRPV6, several questions
regarding channel localization, activity and degradation remain to be answered. It
has been described that proteins containing post synaptic density-95, disc large,
zona occludens-1 (PDZ) domains can play an important role in apical targeting
and retention of several ion channels and transporters (11-14). Therefore, identi-
fication of PDZ proteins that interact with TRPV5 or TRPV6 could significantly
increase our knowledge about these channels.
In this study, we identified the intestine and kidney enriched PDZ protein (IKEPP)
as a TRPV5- and TRPV6-interacting protein. Biochemical and histological analy-
ses suggest a role for this protein in the anchoring  of TRPV5/6 at the plasma
membrane.
MATERIALS AND METHODS
DNA constructs and cRNA synthesis
The carboxyl terminus of mouse TRPV5 and TRPV6 and deletion mutants of
TRPV5 in pGEX6p-2 were obtained as described previously (10). Full-length
mouse IKEPP cDNA and several deletion mutants were prepared as described
(15), cloned into the AscI/XhoI restriction sites of the pTLN oocyte expression
vector, modified to contain the coding sequence for the VSV epitope tag at the 5’
end of the inserted cDNA. Subsequently, IKEPP cDNA was subcloned into
pGEX6p2 (Amersham Pharmacia Biotech) and pCINeo/IRES-GFP. All con-
structs were verified by sequence analysis. Oocyte expression constructs were lin-
earized and TRPV5 and IKEPP cRNA was synthesized in vitro using SP6 RNA
polymerase as described (16).
Yeast two-hybrid system 
The Y153 yeast strain (17) was first transformed to Trp prototrophy with pAS-1
containing the TRPV5 or TRPV6 carboxyl-termini. Yeast was subsequently trans-
formed with a mouse kidney cDNA library (Clontech, Palo Alto, CA) present in
the pACT2 vector, and screening of the library was performed as described (10).
Yeast two-hybrid results were confirmed using purified library plasmids and nega-
tive controls were carried out by replacing a binding partner with either a pAS-1
construct containing the amino-terminal tail (amino acids 1-53) of the γ subunit
of the rat epithelial Na+ channel (γENaC) or the empty pACT2 vector.
GST fusion protein and interaction assays
pGEX6p-2 constructs were transformed in Escherichia coli BL21 and GST fusion
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proteins were expressed and purified according to the manufacturer’s protocol
(Amersham Pharmacia Biotech). Xenopus laevis oocytes were injected with 10 ng
IKEPP cRNA. After 48-72 h oocytes were homogenized in PBS containing 1%
(v/v) Triton X-100 and centrifuged twice at 16,000 g and added to GST or GST-
fusion proteins immobilized on glutathione-Sepharose 4B beads (Amersham
Pharmacia Biotech AB) in PBS containing 1% (v/v) Triton X-100. [35S]Methionine
labeled full-length IKEPP or TRPV5/TRPV6 protein was prepared using a retic-
ulocyte lysate system and added to GST or GST-fusion proteins immobilized on
glutathione-Sepharose 4B beads in PBS containing 1% (v/v) Triton X-100. After
2 h incubation at room temperature, the beads were washed extensively and bound
proteins were eluted with SDS-PAGE loading buffer, subsequently separated on
SDS-PAGE gels and visualized by autoradiography or immunoblotting using mon-
oclonal anti-VSV (1:10,000, Sigma, St Louis, MO). The integrity and quantity of
GST and GST-fusion proteins was routinely assayed by Coomassie staining of the
SDS-PAGE gels, at the end of the binding assay.
Co-immunoprecipitation
Xenopus laevis oocytes were co-injected with 10 ng HA-TRPV5 and 10 ng VSV-
IKEPP cRNA or HEK293 cells were cotransfected with 1 µg TRPV5 and 4 µg
IKEPP cDNA in the pCINeo/IRES/GFP vector using Lipofectamine
(Invitrogen). After 48 h injected oocytes or HEK293 cells were lysed in sucrose
buffer containing 20 mM Tris pH 7.4, 5 mM EDTA, 135 mM NaCl, 0.5% (v/v)
Triton X-100 and 10% (w/v) sucrose, centrifuged at 100 g for 5 minutes and sub-
sequently incubated on ice for 60 min. The lysates were centrifuged for 30 min at
16,000 g and supernatants were incubated with monoclonal anti-HA or anti-VSV
antibodies (Sigma, St Louis, MO) immobilized on protein A-agarose beads (Kem-
En-Tec A/S, Kopenhagen, Denmark) for 16 h at 4 (C. After three washing steps
with sucrose buffer, immunoprecipitated proteins were eluted with SDS-PAGE
loading buffer, separated on SDS-PAGE gel and analyzed by immunoblotting.
Preparation of antibodies and immunohistochemistry
GST-IKEPP (full-length) was expressed in E.Coli BL21 bacteria and purified
using SDS-PAGE gel electrophoresis. Subsequently, guinea pigs and rabbits were
immunized with 250 or 400 µg GST-fusion protein in 50% (v/v) complete
Freunds adjuvant in PBS, respectively. Animals were re-injected three times with
125 or 200 µg protein in 50% (v/v) incomplete Freunds adjuvants at a three week
interval, before serum was collected. Preparation of guinea pig anti-TRPV5 and
rabbit anti-TRPV6 was described before (18, 19). Mouse kidney sections were
incubated for 16 h at 4 ºC with affinity-purified guinea pig antiserum against
TRPV5 and rabbit anti-IKEPP or rabbit anti-TRPV6 and guine pig serum against
IKEPP (20). To visualize TRPV5, TRPV6 and IKEPP, a goat anti-guinea pig Alexa
488 conjugated antibody (1:300) or a goat anti-rabbit Alexa 488 or Alexa 594 con-
jugated antibody (1:300) (Molecular Probes, Eugene, USA) was used. Xenopus lae-
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vis oocytes were injected with 5 ng HA-tagged TRPV5 with or without 10 ng
IKEPP cRNA. Two days after injection immunocytochemistry was performed as
described (16) using anti-HA and anti-IKEPP antibodies. Images were taken with
a Biorad MRC 1024 confocal microscope. All negative controls, including sections
incubated with preimmune serum or conjugated antibodies alone, were devoid of
any staining.
RT-PCR analysis
Total RNA from CaCo2 cells, grown confluent for 14 days, human kidney, and
HEK293 cells was isolated using Trizol (Gibco BRL). Total RNA (2 µg) was
reverse transcribed and PCR reactions for IKEPP was performed (forward 5’-
GCCGCAGATCTGCAGGACACA-3’ and reverse 5’-GTGGAAGCCAAAAC
TCTTGCC-3’ (expected amplicon size180 bp))
Plasma membrane isolation
Xenopus laevis oocytes were injected with 10 ng IKEPP cRNA only or co-injected
with 10 ng IKEPP cRNA and 2 or 5 ng TRPV5. After 48 h the follicle membrane
was manually removed and plasma membranes isolated according to Kamsteeg et
al. (21). Briefly, 12 oocytes were incubated in MBSS (20 mM 2-[N-
Morpholino]ethanesulfonic acid (MES), 80 mM NaCl (adjusted to pH 6.0 using
NaOH) containing 1% (v/v) positively charged colloidal silica (Ludox Cl, Aldrich,
Bornem, Belgium) at 4 (C for 30 min. Subsequently, oocytes were washed twice in
MBSS and incubated with 0.1% (v/v) sodiumpolyacrylicacid (Aldrich, Bornem,
Belgium) in MBSS at 4 (C for 30 min. Oocytes were homogenized in HBA buffer
(in mM: 20 Tris (pH 7.4). 5 MgCl2, 5 Na2HPO4, 1 EDTA, 80 sucrose) and plas-
ma membranes were isolated by serial centrifigation at 4x 10 g, 2x 20 g and 2x 40
g. One ml supernatant was exchanged with HBA buffer after each centrifugation
step. Finally, membranes were pelleted at 16,000 g for 30 min, dissolved in SDS
sample buffer and analyzed by immunoblotting.
RESULTS
Identification of IKEPP as a TRPV5- and TRPV6-associated protein
TRPV6 interacting proteins were identified with the carboxyl terminus as a bait to
screen a mouse kidney cDNA library using the yeast two-hybrid technique. From
4.6 million yeast transformants several positive clones were isolated. After
sequence analysis and BLAST searches, nine of these clones were identified as the
sodium-phosphate cotransporter associated protein 2 (NaPi-Cap2). Because of the
increasing number of target molecules associating with NaPi-Cap2, we propose to
use the name Intestine and Kidney Enriched PDZ Protein (IKEPP) for all ortho-
logues of this protein, as suggested by Scott et al., Hegedus et al. and Kato et al (22-
24). IKEPP was also identified in a separate yeast two-hybrid screen using the
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TRPV5 carboxyl terminus. To confirm the specificity of the interaction in the
yeast two-hybrid system, the binding of IKEPP was re-investigated with the car-
boxyl terminus of TRPV6, using γENaC as negative control. Full-length IKEPP
strongly interacted with TRPV6, whereas β-galactosidase activity could not be
detected with the negative control. In addition, β-galactosidase activity was not
observed in the absence of prey or after co-transformation of the bait with the
empty pACT2 (prey) vector (data not shown).
Exploration of the TRPV5 and TRPV6 interaction with IKEPP
The interaction between TRPV6 and IKEPP was further substantiated using GST
pull-down assays. Glutathione beads loaded with GST, GST-TRPV6 carboxyl ter-
minus and GST-TRPV5 carboxyl terminus were incubated with in vitro translated
[35S]IKEPP. IKEPP interacted with both TRPV5 and TRPV6, which confirmed
the initial yeast two-hybrid results (figure 1A). In addition, the binding was ana-
lyzed using the reverse GST pull-down assay, where GST-fused IKEPP was incu-
bated with in vitro translated [35S]TRPV5. This assay also resulted in specific bind-
ing between IKEPP and TRPV5 (figure 1B). Finally, the specificity for the car-
boxyl termini of TRPV5 and TRPV6 was further demonstrated using lysates from
Xenopus laevis oocytes injected with cRNA encoding VSV-tagged IKEPP. The bind-
ing of IKEPP to the carboxyl-, but not amino termini of TRPV5 and TRPV6 was
demonstrated by immunoblot analysis using monoclonal anti-VSV antibody (fig-
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Figure 1
Analysis of the association of IKEPP with TRPV5
and TRPV6. (A) GST- or GST-fused to the car-
boxyl terminus of TRPV5 or TRPV6 were immo-
bilized on glutathione-sepharose 4B beads and
incubated with in vitro translated radiolabeled
IKEPP. The bound fractions were resolved by
SDS-PAGE and visualized by autoradiography.
(B) Immobilzed GST or GST fused to full-length
IKEPP was incubated with in vitro translated
radiolabeled full-length TRPV5 and the bound
fraction analyzed by autoradiography. (C)
Xenopus laevis oocytes were injected with cRNA
encoding VSV-tagged full-length IKEPP. After 2
days, oocytes were homogenated and incubated
with imobilized GST or GST fused to the amino
or carboxyl termini of TRPV5 and TRPV6. The
bound fraction was analyzed by immunoblot
analysis using monoclonal anti-VSV antibodies.
IKEPP associates with the carboxyl termini of
TRPV5 and TRPV6, but not with GST or the
amino termini.
ure 1C). Non-injected oocytes gave no detectable signal, demonstrating the speci-
ficity of the antibody. The specificity of the interaction was confirmed using GST
alone, which failed to bind IKEPP, TRPV5 and TRPV6 (figure 1A - C).
Co-immunoprecipitation of IKEPP with TRPV5 and TRPV6
To substantiate the in vitro binding studies under more physiological conditions, the
interaction between IKEPP and TRPV5 was investigated by co-immunoprecipia-
tions. Xenopus laevis oocytes co-expressing HA-tagged TRPV5 and VSV-tagged
IKEPP were lysed and immunoprecipitated using anti-HA (figure 1A, left panel)
or anti-VSV antibodies (figure 1A, right panel). IKEPP co-precipitated with
TRPV5 using anti-HA antibodies. Similarly, TRPV5 was co-immunoprecipitated
with IKEPP, indicating that the interaction occurs in these oocytes (figure 1A,
right panel) and HEK293 cells (not shown). Furthermore, similar binding experi-
ments were performed in HEK293 cells using anti-HA antibodies to precipitate
TRPV5 or anti-TRPV6 antibodies. IKEPP was specifically co-immunoprecipitat-
ed with TRPV5 and TRPV6 from HEK293 cells (figure 1B, right panel). Although
IKEPP was equally expressed in all conditions (figure 1B, left panel), it was not
precipitated in the absence of TRPV5 or TRPV6, indicating the specificity of the
procedure (figure 1B, right panel).
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Figure 2
Co-immunoprecipitation of
IKEPP with TRPV5 and TRPV6 in
Xenopus laevis oocytes and
HEK293 cells. (A) Xenopus laevis
oocytes were co-injected with
cRNA encoding VSV-tagged
IKEPP and HA-tagged TRPV5.
IKEPP co-immunoprecipitated
with TRPV5 using anti-HA anti-
bodies (left panel). In the reverse
reaction, IKEPP was specifically
precipitated with anti-VSV anti-
bodies and co-precipitated TRPV5
was demonstrated using anti-HA
antibodies (right panel). Non-
injected oocytes were used to
demonstrate the specific signal for
IKEPP at ~50 kDa and at ~70 and
90 kDa for TRPV5. (B)
HEK293cells were transiently
transfected with cDNA encoding (untagged) IKEPP with or without cDNA encoding
TRPV6 or HA-TRPV5, lysed and subjected to imunoprecipitation using anti-HA anti-
bodies (TRPV5) or anti-TRPV6 antibodies. Bound fraction was subjected to immunoblot
analysis using guinea pig anti-IKEPP. IKEPP was equally expressed in all conditions
(left) and specifically co-immunoprecipitated with TRPV5 and TRPV6 (right).
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Elucidation of the TRPV5 and TRPV6 binding sites in IKEPP
IKEPP contains 4 PDZ domains, which are generally seen as protein-protein
interaction modules (25). We hypothesized that one or more of these modules
could bind TRPV5 or TRPV6. Therefore, truncation constructs were designed
with stepwise decreasing number of PDZ domains, as depicted in figure 3A. The
constructs were in vitro translated (figure 3B) or expressed as GST fusion proteins
(figure 3C). in vitro translated full-length IKEPP associated with the carboxyl ter-
minus of TRPV5, expressed as GST fusion protein, but not to GST alone. When
PDZ domain 4 was deleted from IKEPP, the interaction of PDZ domain 1 to 3
with both TRPV5 and TRPV6 reduced in efficiency. Removal of PDZ domain 2
and 3 had no additional effect, localizing the remaining affinity to PDZ domain 1.
These results were confirmed in the reverse experiment, in which in vitro translat-
ed TRPV5 or TRPV6 was incubated with immobilized GST-fused IKEPP PDZ
modules. In line with our binding results, described above, removal of PDZ
domain 4 significantly reduced the efficiency of the interaction, whereas further
deletion of PDZ domain 2 and 3 had no additional effect. GST alone showed no
binding. Furthermore, PDZ domain 4 was co-expressed with HA-tagged TRPV5
in HEK293 cells. PDZ domain 4 co-precipitated with TRPV5, confirming the
affinity for TRPV5 and TRPV6 of this particular IKEPP PDZ module.
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Figure 3
PDZ domain interactions of IKEPP
with the carboxyl terminus of TRPV5
and TRPV6. (A) Schematic overview of
in vitro translated or GST-fused PDZ
modules of IKEPP used for GST pull-
down binding assays. (B) Full-length or
truncated radiolabeled IKEPP was in
vitro translated (left 4 lanes) and incu-
bated with GST or GST fused to the car-
boxyl terminus of TRPV5. (C)
Radiolabeled, in vitro translated TRPV5
(left) or TRPV6 (right) was incubated
with immobilized GST or GST-fused to
full-length and truncated IKEPP.
Significant fraction of the binding was
lost when PDZ domain 4 was deleted.
(C) HA-tagged full-length TRPV5 was
co-expressed with VSV-tagged PDZ
domain 4 of IKEPP in HEK293 cells.
PDZ domain 4 precipitated with VSV
antibodies and co-precipitated with
anti-HA antibodies, demonstrating the
ability of this PDZ domain to associate with TRPV5. Immunopositive signal at >20 kDa
originated from reaction of the secondary (anti-mouse) antibody with the monoclonal
antibodies present in the immunoprecipitated samples.
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Identification of the IKEPP binding site in TRPV5
The binding site for IKEPP in TRPV5 was determined using progressively trun-
cated forms of the GST-fused TRPV5  carboxyl terminus as depicted in figure 4A.
Truncated forms of TRPV5 were expressed as GST fusion proteins and pull-
down experiments were performed as described above. The interaction with
IKEPP was lost when TRPV5 was truncated at position 596, whereas truncations
up to position 617 had no effect on the binding (figure 4B). These results were
compared with the binding characterisics of NHERF2, a homologous PDZ pro-
tein with 2 PDZ modules. It was previously described that NHERF2 binds to the
carboxyl terminus of TRPV5, but not TRPV6 (26). Removal of the last three
amino acids of the carboxyl terminus of TRPV5 abolished the interaction with
NHERF2 (figure 4C). Remarkably, truncation of TRPV5 at position 596, leaving
a consensus PDZ binding motif TTV at the end of the truncated carboxyl termi-
nus, resulted in a restoration of the NHERF2 association. This binding was abol-
ished when TRPV5 was truncated at position 591, removing an additional 5 amino
acids (figure 4C). Together, this demonstrates that two homologous PDZ proteins
can have distinct binding sites within a single target protein.
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Figure 4
Identification of distinct carboxyl ter-
minal and internal PDZ binding motifs
involved in the association with IKEPP
and NHERF2. (A) GST-fusion proteins
of the carboxyl terminus of TRPV5
were constructed according to the
schematic drawing. Consensus PDZ
binding motifs are depicted in pink. (B)
Xenopus laevis oocytes were injected
with cRNA encoding IKEPP,
homogenated and incubated with GST
or GST fused to the carboxyl terminus
of TRPV5. Imunoblot analysis of the
bound fraction demonstrates that
IKEPP binding is consistent with trun-
cation up to position 617, whereas
truncation at position 596 and 591 abol-
ishes the interaction. Non-injected
oocytes (NI) were used to confirm the
specificity of the imunoblot. (C)
Radiolabeled, in vitro translated
NHERF2 was incubated with imobi-
lized GST or GST-fused to the carboxyl terminus of TRPV5. Removal of the last three
amino acids of TRPV5 abolished the interaction with NHERF2. Truncation at position
596 unmasks the internal PDZ binding motif resulting in the association of NHERF2.
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Distribution of IKEPP in kidney, CaCo2 cells and Xenopus laevis oocytes
The localization of IKEPP remained largely elusive. Therefore, we determined the
expression and localization of this novel protein by RT-PCR, immunohistochem-
istry and immunoblot in intestine and kidney. Anti-IKEPP antiserum was obtained
from rabbits and guinea pigs immunized with full length IKEPP. The anti-IKEPP
antibodies were first tested on lysates from Xenopus laevis oocytes, either injected
with IKEPP cRNA or non-injected and they specifically stained a band at ~55 kD,
the correct size for VSV-tagged IKEPP (figure 5A). This size was confirmed using
monoclonal anti-VSV antibodies (not shown). Furthermore, the anti-IKEPP anti-
body recognized a band at the correct size in duodenal and kidney samples (figure
5A), indicative of their ability to specifically recognize endogenous IKEPP in
mice. Importantly, the duodenal samples were obtained as luminal scrapings and
is, therefore, enriched in epithelial cells. The immunopositive signal was abolished
when pre-immune serum or an excess competing antigen peptide was used (figure
5A). Subsequently, these antibodies were used for immunohistological analyses of
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Figure 5
Characterization of IKEPP antisera and
analysis of IKEPP localization. (A)
Lysates of HEK293 cells, transfected
with IKEPP cDNA or mouse duodenal
mucosa and kidney lysates were
resolved by SDS-PAGE analysis, blot-
ted onto PVDF membranes and incu-
bated with rabbit anti-IKEPP (K65),
guinea pig anti-IKEPP (gp45), pre-
immune serum of this guinea pig or
guinea pig anti-IKEPP in the presence
of 10 µg/ml antigen blocking peptide.
(B) IKEPP expression in human kidney
and intestinal epithelium (CaCo2) was
confirmed by RT-PCR. Specific signal
at the correct size of 180 bp was
observed. (C) Xenopus laevis oocytes
were co-injected with cRNA encoding
IKEPP and HA-tagged TRPV5, fixed
and double-labeled using guinea pig
anti-IKEPP (left) and mouse anti-HA
(right). Bar indicates 25 µm. (D) IKEPP
localization in the cytosol, total membrane (TM) or plasma membrane (PM) preparation
of Xenopus laevis oocytes, injected with 10 ng cRNA encoding IKEPP only or 10 ng
IKEPP together with 2 or 5 ng cRNA encoding TRPV5. Amounts of material loaded is
equivalent to 0.5 oocyte for cytosol or 4 oocytes for TM and PM preparations. (E) The
expression of TRPV5 in these Xenopus oocytes was confirmed by immunoblot analysis. 
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mouse kidney sections. The staining in mouse kidney was present in both cortex
and medulla. Positive staining was mainly present at the apical membrane of prox-
imal tubules (not shown). However, no significant co-localization of IKEPP and
TRPV5 or TRPV6 was observed in kidney. Therefore, we further investigated the
localization of IKEPP in intestine. To this end, CaCo2 cells were used as a  model
for the intestinal epithelium (27). Previously, TRPV6 expression in these cells was
demonstrated by Wood et al. (28). RT-PCR analysis demonstrated the endogenous
expression of IKEPP in these cells (figure 5B). Human kidney cDNA was used as
a positve control and showed a product of identical size at the expected height of
180 bp.
The subcellular localization of IKEPP was determined in Xenopus laevis oocytes.
Immunocytochemistry performed on oocyte sections showed a marked expression
of IKEPP at the plasma membrane, where it co-localized with TRPV5. Oocytes
injected with TRPV5 cRNA only or non-injected oocytes gave no IKEPP-stain-
ing, indicating the specificity of the signal. Subsequently, we compared the expres-
sion of IKEPP in cytosol, total membranes and highly purified plasma membranes
by western blot analysis. IKEPP was detected in all three fractions with the high-
est expression in cytosol (figure 5D). However, a significant amount of IKEPP
was found in the membranous fraction. Virtually all the membranous IKEPP was
localized at the plasma membrane as the intensity of the signal was approximate-
ly equal in the total membrane and plasma membrane preparation (n=3 different
oocyte batches). This data confirms the plasma membrane stainings obtained by
immunocytochemistry on these Xenopus laevis oocytes. Furthermore, we deter-
mined whether the localization of IKEPP was dependent on the expression of
TRPV5. To this end, IKEPP cRNA was injected alone or co-injected with 2 or 5
ng TRPV5 cRNA. TRPV5 expression was verified by immunoblot analysis (figure
5E). The distribution of IKEPP was independent of the presence of TRPV5 (fig-
ure 5D).
DISCUSSION
Our results show that IKEPP is a novel auxiliary protein for both TRPV5 and
TRPV6. IKEPP binds specifically to the carboxyl terminus of TRPV5 and TRPV6
and was co-immunoprecipitated with TRPV5 and TRPV6. Furthermore, IKEPP
is co-expressed with TRPV6 in intestinal epithelial cells. Finally, the prominent
plasma membrane localization of IKEPP suggests a role for this novel PDZ pro-
tein as a plasma membrane scaffold for the epithelial Ca2+ channels.
IKEPP specifically binds to a conserved region in the carboxyl terminus of
TRPV5 and TRPV6
IKEPP was identified in two independent yeast two-hybrid screens using the car-
boxyl termini of TRPV5 and TRPV6 as bait. The interaction was confirmed by
GST pull-down and co-imunoprecipitation assays, using in vitro translated proteins,
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Xenopus oocytes and HEK293 cells. The amino terminal tails of both TRPV5 and
TRPV6 were unable to bind IKEPP, showing specificity of the interaction to the
carboxyl terminus of the channels. Frequently, PDZ domain containing proteins
interact with specific motifs at the carboxyl terminus of their target proteins.
However, the last 30 amino acids of the carboxyl termini of TRPV5 and TRPV6
are not conserved, suggesting that the binding site for IKEPP is not located in this
region. We identified a conserved region of ~20 amino acids (596-617) that is crit-
ical for the interaction. This result was observed using both in vitro translated
IKEPP (data not shown) as well as lysates from IKEPP-expressing oocytes (figure
4B). Remarkably, we have previously identified 80K-H as a protein that shares this
particular binding region in TRPV5 but is not homologous to IKEPP (8). In addi-
tion, Chang and coworkers and Erler et al. (29) recently demonstrated that the
amino terminus of TRPV5 forms the main determinant for tetramer assembly.
However, Chang et al. also implicated an assembly region in the carboxyl terminus
of TRPV5 (30). The carboxyl terminal assembly signal is present within the
IKEPP-binding site identified in this study. Therefore, we cannot exclude that the
identified IKEPP-binding region is an important structural determinant for the
carboxyl terminus. However, this binding region does not contain a typical PDZ
binding motif (S/TXV; where X can be any amino acid), although such a motif
(TTV) is located immediately upstream of this region (594-596) and has been
implicated in the binding of S100A10 to TRPV5 and TRPV6 (10). It has been
demonstrated that some PDZ proteins are able to recognize internal PDZ motifs
(31). However, several studies have demonstrated that such an interaction requires
a “loop” structure at the site of the consensus  PDZ binding motif that docks into
the peptide binding groove of the PDZ domain (25). Therefore, it is possible that
truncation of TRPV5 at position 596 leaves the PDZ motif intact, although the
required tertiary structure for PDZ binding is disturbed, preventing the association
of the PDZ motif with IKEPP. In line with this hypothesis are our binding results
with a related PDZ protein, NHERF2. It was recently demonstrated that
NHERF2 is required for the stimulation of TRPV5 activity by the serum and glu-
cocorticoid inducible kinase SGK1 (32). NHERF2 specifically associates with
TRPV5, but not TRPV6 (26). Here, we demonstrate that NHERF2 associates with
the carboxyl terminal three amino acids of TRPV5, which form a type II PDZ
binding motif (hydrophic residue followed by a unspecified amino acid, followed
by a carboxylated hydrophobic residue) (25, 33). Deletion of these 3 residues in
TRPV5 completely abolishes NHERF2 binding. Remarkably, truncation of
TRPV5 at position 596 re-establishes the binding of NHERF2, in line with the
presence of a PDZ binding motif (TTV) at the final three amino acids of this
truncated protein. NHERF2 does not interact with these residues when TRPV5 is
truncated at other positions, demonstrating the requirement of a PDZ motif at
the end of the carboxyl terminus for NHERF2 binding. This result is in contrast
to IKEPP, which does not bind the type II PDZ motif at the carboxyl terminus
of TRPV5 and does not interact with the type I PDZ motif when this is carboxy-
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lated, as a result of truncation at position 596. Together, this suggests that IKEPP
binds to an internal conserved region in the carboxyl tail of TRPV5/6. Moreover,
to our knowledge this is the first example of two PDZ proteins that bind to dis-
tinct binding sites within a single target protein.
PDZ domains responsible for the interaction with TRPV5
Because the 4 PDZ domains of IKEPP likely form independent protein interac-
tion modules, we determined which of these modules show affinity for TRPV5
and could, therefore, contribute to the TRPV5 binding of IKEPP. GST pull down
studies with increasingly truncated forms of IKEPP showed that PDZ domain 4
forms a major contribution for the interaction with TRPV5. Co-immunoprecipi-
tation studies using only PDZ domain 4 confirmed the binding of TRPV5 to this
particular domain. PDZ domain 1 also showed affinity for the channels. However,
several clones were identified in the yeast two-hybrid screen that did not contain
the first PDZ domain, indicating that this part of IKEPP is not required for
TRPV5 and TRPV6 binding. All 4 PDZ domains of IKEPP show a similar level
of conservation between human and mouse, suggesting an equally important role
in the IKEPP protein. However, sequence comparison of the IKEPP PDZ
domains with other PDZ domain containing proteins using BLAST demonstrated
that PDZ domain 1 to 3 share ~40% identity with other PDZ proteins, including
PDZK1, NHERF1 and NHERF2, whereas PDZ domain 4 is less homologous to
other PDZ proteins. Furthermore, PDZ domains recognize PDZ motifs at the
end of the carboxyl terminal tails of ligands via the conserved sequence R/K-X-
X-X-G-L-G-F in their carboxylate-binding pocket (25). However, the R/K
residue, involved in the coordination of the ligand terminal carboxylate group, is
not present in PDZ domain 4 of IKEPP (instead a proline residue in human and
mouse IKEPP), in contrast to the other PDZ domains of IKEPP (24).
Remarkably, PDZ domain 4 forms the main link of IKEPP with TRPV5 and
TRPV6. Together, this is in line with the binding of PDZ domain 4 to an internal
IKEPP-binding motif in TRPV5/6, that does not involve coordination of a car-
boxyl group.
IKEPP localization in intestine and kidney 
Although IKEPP binds both TRPV5 and TRPV6, the relevance for this interac-
tion could be different for these channels in the physiological situation. As TRPV5
and TRPV6 have distinct expression patterns in the kidney (19), we initially eluci-
dated the distribution of IKEPP in this organ. However, IKEPP did not show co-
localization with either TRPV5 or TRPV6, but localized primarily in proximal
tubules, where the type II Na/Pi cotransporter (Npt2) is present (15). These results
are in line with previous observations from Gisler et al., who showed a prominent
co-localization of mouse IKEPP with Npt2 in the apical domain of proximal
tubules (15). However, we could demonstrate by RT-PCR and immunoblot analy-
sis that IKEPP is present in Ca2+-transporting intestinal epithelial cells, which co-
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express TRPV6 (28) and to a lesser extent TRPV5 (18). In addition, Scott and
coworkers demonstrated the presence of IKEPP in the apical region of polarized
CaCo2 cells, grown on permeable filter supports (24). Moreover, TRPV6 is main-
ly localized in the apical domain in enterocytes (34), where IKEPP is also present
(24). Because TRPV6 expression is prominent in intestine and TRPV5 expression
is limited in this tissue (34, 35), these data suggest that IKEPP is primarily impor-
tant in the regulation and activity of TRPV6 present in intestine.
Putative function of IKEPP as a plasma membrane scaffold for the epithe-
lial Ca2+ channels
PDZ domain containing proteins have been described to play a key role in the reg-
ulation of ion channel subunit assembly and subsequent localization at the plasma
membrane. For instance TRPC4 associates with PDZ proteins via the last three
carboxyl terminal amino acids of the channel, controlling the subcellular localiza-
tion and surface expression in HEK293 cells (14). One of the best-studied PDZ-
containing proteins is InaD, which plays an essential role in the Drosophila pho-
totransduction pathway (12, 36, 37). An important strategy employed by the pho-
toreceptors to increase the speed of vision and fine tune the light response is the
organization of all molecules required for a fast signaling cascade, including the
TRPC1 Ca2+ channel, into a multimolecular complex that is specifically localized
in so-called transducisomes (37). The PDZ protein InaD plays a coordinating role
in the assembly of this complex (36). There is currently no evidence of a fast sig-
naling cascade following or preceding the opening of TRPV5 or TRPV6 channels.
The co-localization of the epithelial Ca2+ channels with IKEPP at the plasma
membrane suggests that IKEPP has a function at the plasma membrane. It is,
therefore, possible that IKEPP acts as scaffold to bring TRPV5/6 together with
other PDZ-associated proteins at the plasma membrane. To date, IKEPP associa-
tion has been demonstrated for the organic cation transporter OCTN1 and
OCTN2 (22), Npt2 (15), the ATP-dependent organic anion efflux pump MRP2
(23) and the cystic fibrosis transmembrane regulator CFTR (23). However, the
functional relevance for the interaction of IKEPP with these proteins remains elu-
sive. In addition, Scott and coworkers recently demonstrated the interaction
between IKEPP and guanylyl cyclase C (GCC), the heat stable enterotoxin (Sta)
receptor (24). STa-mediated  activation of GCC was significantly lowered upon
overexpression of IKEPP. It was demonstrated that PDZ domain 3 of IKEPP
associates with the carboxyl terminal 4 amino acids of GCC (24). This implies that
IKEPP can bind carboxylated termini (PDZ3 and GCC) as well as internal PDZ
motifs (PDZ4 and TRPV5/6) of target proteins. In this respect it is relevant to
note that transepithelial Ca2+ transport in CNT/CCD cells of the kidney is posi-
tively regulated by cyclic GMP (38), suggesting a functional link between GCC and
TRPV5/6. Ligand binding and functional studies suggest that GCC is expressed
in the kidney (39). The cGMP-dependent stimulation of transcellular Ca2+ trans-
port in the kidney requires the presence of cGMP-dependent kinase type II (cGK
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II) (38). It has been demonstrated that cGK II is also shows present in duodenum
and jejenum (40), where it is coexpressed with TRPV5/6 (34, 41, 42), GCC (24,
43) and IKEPP (24). Further studies need to be conducted to investigate a func-
tional connection between the IKEPP-associated proteins TRPV5/6 and GCC.
Together, these results demonstrate the association of the novel PDZ protein
IKEPP with TRPV5 and TRPV6, co-expression with TRPV6 in intestinal epithe-
lia and prominent co-localization at the plasma membrane, in line with the puta-
tive role as a plasma membrane scaffold for these epithelial Ca2+ channels.
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INTRODUCTION
Transcellular Ca2+ (re)absorption is a pivotal process in the maintenance of the
extracellular Ca2+ balance. It allows the organism to respond to fluctuations in
dietary Ca2+ and adapt to the body’s demand during processes such as growth,
pregnancy, lactation and aging. The first step of transcellular transport is the
influx of Ca2+ across the apical plasma membrane of the epithelial cell, which is
a fine-tuned mechanism. Ca2+ that enters the cell is sequestered by specialized pro-
teins called calbindins in order to maintain low cytosolic Ca2+ concentrations.
Subsequently, bound Ca2+ moves to the basolateral side of the cell where it is
extruded into the blood stream via the Na+/Ca2+ exchanger (NCX1) and plasma
membrane Ca2+ ATPase (PMCA1b). The molecular identification of two mem-
bers of the Transient Receptor Potential (TRP) superfamily TRPV5 (1) and
TRPV6 (2) boosted the research addressing the molecular mechanism of epithe-
lial Ca2+ transport. The physiological role of these channels has been substantiat-
ed in several mouse models of Ca2+-related disorders, including vitamin D-defi-
ciency rickets type I (VDDR-I) (3, 4) and vitamin D-resistant rickets type II (5)
(VDDR-II). Furthermore, TRPV5 (6) and TRPV6 (7) knockout mice show signif-
icant disturbances in their Ca2+ homeostasis. TRPV5 primarily fulfills the role as
gatekeeper of epithelial Ca2+ transport in the kidney (8), while TRPV6 forms the
main Ca2+ influx pathway in small intestine (9). Therefore, detailed insight into the
molecular regulation of these channels is pivotal for our understanding of Ca2+
homeostasis. The activity of TRPV5/6 can be controlled by four distinct regula-
tory mechanisms (10). First, the expression level of TRPV5/6 is regulated by hor-
mones. Second, the activity of TRPV5/6 at the plasma membrane is subject to
pH- and Ca2+-dependent regulatory mechanisms. Third, transport of TRPV5/6 to
the luminal plasma membrane is essential to exert its biological activity. Fourth, the
identification of channel-associated proteins with diverse characteristics, as
described in this thesis, has provided important new insight into the regulation of
TRPV5 and TRPV6. This chapter will discuss and summarize the findings of these
studies.
REGULATION OF TRPV5 AND TRPV6 BY CHANNEL-ASSOCIATED PRO-
TEINS
A number of regulatory proteins that modify properties of ion channels and trans-
porters by direct interactions has recently been described (11-17). These newly
identified associated proteins have facilitated the elucidation of important molec-
ular pathways modulating transport activity. Similarly, identification of the molec-
ular players associating with TRPV5 and TRPV6 could be pivotal in our under-
standing of the regulation of these Ca2+ channels. In this thesis several auxiliary
proteins for TRPV5 and/or TRPV6, i.e. S100A10-annexin 2 (Chapter 2), Rab11a
(Chapter 3), BSPRY (Chapter 4), NHERF2 (Chapter 5) and IKEPP (Chapter 6),
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are identified and subsequently characterized. Furthermore, calmodulin and 80K-
H have recently been described as new interacting partners (18-20) and will, there-
fore, also be discussed.
S100A10/annexin 2
S100A10 (also known as p11 or annexin 2 light chain) was identified as an auxil-
iary protein for TRPV5 and TRPV6 using a yeast two-hybrid system (Chapter 2).
S100A10 is a 97 amino acid protein member of the S100 superfamily that is pres-
ent in a large number of organisms including vertebrates, insects, nematodes and
plants. S100A10 is a distinct member of this family, since its two EF-hands carry
mutations that render it Ca2+ insensitive. S100A10 is predominantly present as a
heterotetrameric complex with annexin 2, which has been implicated in several
biological processes including endocytosis, exocytosis and membrane-cytoskeleton
interactions (21). Annexin 2 interacts with actin and is postulated to bind the cyto-
plasmic face of membrane rafts to stabilize these domains, thereby providing a link
to the actin cytoskeleton (21). Chapter 2 provides the first evidence of a regulato-
ry role for the S100A10-annexin 2 heterotetramer in vitamin D-mediated Ca2+
(re)absorption in general and in particular in TRPV5 and TRPV6 functioning. It
was shown that S100A10, annexin 2 and TRPV5 or TRPV6 co-localize in Ca2+-
transporting cells of the kidney and small intestine (22). The association of
S100A10 with TRPV5 and TRPV6 is restricted to a short peptide sequence
VATTV located in the carboxyl-termini of these channels. This stretch is con-
served among all identified species of TRPV5 and TRPV6. Interestingly, the TTV
sequence in the S100A10 binding motif resembles an internal type I PDZ con-
sensus binding sequence, which is S/TXV (23). However, S100A10 does not con-
tain PDZ domains, indicating that the TRPV5-S100A10 interaction has a different
nature. The first threonine of the S100A10 interaction motif is a crucial determi-
nant for binding. Furthermore, the activity of TRPV5 and TRPV6 is abolished
when this particular threonine is mutated, demonstrating that this motif is essen-
tial for channel function. Malfunctioning of these mutant channels is accompanied
by a major disturbance in their subcellular localization, indicating that the
S100A10-annexin 2 heterotetramer facilitates the translocation of TRPV5 and
TRPV6 channels to the plasma membrane. The importance of annexin 2 in this
process was demonstrated by a siRNA-based approach. Downregulation of
annexin 2 significantly inhibits the currents through TRPV5 and TRPV6, indicat-
ing that annexin 2, in conjunction with S100A10, is crucial for TRPV5 and TRPV6
activity. Interestingly, an association of annexin 2 with TRPV5 was only shown in
the presence of S100A10, demonstrating that anexin 2 binds indirectly to the
channel, with S100A10 most likely operating as a bridge between TRPV5 and
annexin 2. In line with the submembranous localization of annexin 2 and its pos-
tulated function in organizing membrane domains, these findings provide the first
functional evidence for a regulatory role of annexin 2 controlling Ca2+ channel
trafficking. Interestingly, previous studies indicated that the background K+ chan-
111
Chapter 7
nel (TASK1) is associated with S100A10 via its carboxyl-terminal sequence SSV
(24). The S100A10 interaction promotes the translocation of TASK1 to the plas-
ma membrane producing functional K+ channels (24). This sequence resembles
the binding motif in TRPV5 and TRPV6 identified in the present study, suggest-
ing a shared structural S100A10 binding pocket. However, this motif is absent in
the tetrodotoxin-insensitive voltage-gated Na+ channel (Nav1.8), which has been
shown to bind S100A10 via its amino-terminus. The binding of S100A10 is essen-
tial for plasma membrane trafficking of this Na+ channel (12). Taken together, our
findings show that the S100A10-annexin 2 complex is a significant component for
trafficking of ion channels to the plasma membrane in general and in particular a
major regulator of TRPV5 and TRPV6 function and, therefore, the Ca2+ home-
ostasis.
Rab11
Rab11a was identified as a TRPV5- and TRPV6-associated protein, as described in
Chapter 3. Rab11a is a small GTPase involved in trafficking via recycling endo-
somes (25, 26). Although the role of Rab GTPases in protein trafficking has long
been recognized, the underlying mechanism is far from understood. Rab11a co-
localizes with TRPV5 and TRPV6 in Ca2+ transporting epithelial cells of the kid-
ney. Here, both TRPV5 and Rab11a are present in vesicular structures underneath
the apical plasma membrane. Using a combination of GST pull-down and co-
immunoprecipitation assays a direct interaction between Rab11a and the epithelial
Ca2+ channels was demonstrated, hinting at a novel mechanism of Rab11a-medi-
ated trafficking (Chapter 3). Other Rab GTPases, including Rab7 and Rab22b do
not bind TRPV5/6 indicating the specificity of the interaction. Furthermore, it
was demonstrated that TRPV5 and TRPV6 preferentially interact with Rab11a in
its GDP-bound conformation. Expression of a mutant Rab11a protein, locked in
the GDP-bound state, results in a marked decrease of channels at the cell surface,
indicating a direct role of Rab11a in the trafficking of TRPV5/6 towards the plas-
ma membrane. The interaction of Rab11a is localized to a conserved (-helical
region of only ~30 amino acids. The interaction between Rab11a and TRPV5 is
diminished when 5 amino acids (MLERK) at the carboxyl terminal end of this
region are removed by truncation or mutation into glycines. Mutagenesis of these
5 amino acids abolishes channel activity at the plasma membrane, resulting from
impaired trafficking to the cell surface. Together, this data demonstrates the role
of Rab11a in the targeting of TRPV5 and TRPV6 towards the plasma membrane.
The Rab GTPase exerts this function in a novel fashion, operating via direct cargo
interaction.
BSPRY
Chapter 4 demonstrates the identification and characterization of BSPRY as a
novel TRPV5- and TRPV6-associated regulatory protein. The name BSPRY orig-
inates from the presence of two putative protein-protein interaction modules
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called a B-box and SPRY domain (27, 28). BSPRY was identified as a zyxin and 14-
3-3 associated protein (29, 30). However, the function of BSPRY was not eluci-
dated in these studies. Zyxin is a cytoskeletal protein present in focal adhesions
(31), whereas 14-3-3 proteins are characterized as phosphopeptide-binding pro-
teins (32). We identified BSPRY in a yeast two-hybrid screen using the carboxyl-
terminus of TRPV6 as bait. Using GST pull-down and co-immunoprecipitation
assays we demonstrated that also TRPV5 associates with this novel protein. The
physiological relevance of the interaction is  suggested by a predominant tubular
co-localization of TRPV5 and BSPRY in mouse kidney. In these immunopositive
tubules, previously characterized as distal convoluted and connecting tubules (33,
34), TRPV5 was restricted to the apical domain of the cell, whereas BSPRY stain-
ing is dispersed throughout the cell, with highest intensity at the apical side of the
cell. In HeLa cells, VSV-tagged BSPRY is distributed between a membrane and
cytosol fraction. TRPV5 activity is strongly inhibited upon co-expression with
BSPRY, as demonstrated in stably transfected MDCK cells. These results demon-
strate the first physiological role of BSPRY in the regulation of epithelial Ca2+
influx by direct association with TRPV5 and TRPV6.
NHERF2
In Chapter 5 is demonstrated that TRPV5 activity increases upon co-expression
with the PDZ domain containing protein NHERF2 and the serum and glucocor-
ticoid inducible kinase (SGK1 and SGK3) in Xenopus laevis oocytes. Similarly, the
co-expression of SGK1 with NHERF2 stimulates the activity of ROMK1, a K+
channel involved in renal K+ handling (35). This stimulation results from a stabi-
lization of ROMK1 in the plasma membrane (35). Whether this mechanism also
applies to TRPV5 remains to be elucidated. Using GST pull-down and overlay
assays, the specific interaction of NHERF2 with the carboxyl terminal end of
TRPV5 was demonstrated (36), whereas TRPV6 does not bind NHERF2. These
findings suggest that NHERF2-SGK is not involved in the regulation of TRPV6.
It is currently not clear whether TRPV5 is coexpressed with NHERF2 in the kid-
ney. Therefore, the physiological relevance of these findings needs to be further
explored.
IKEPP
The Intestine and Kidney Enriched PDZ Protein (IKEPP) was identified in two
independent yeast two-hybrid screens, using the carboxyl-termini of TRPV5 and
TRPV6, as described in Chapter 6. IKEPP binds to the carboxyl-termini of
TRPV5 and TRPV6 using its fourth PDZ domain and colocalizes with these chan-
nels at the plasma membrane when these proteins are co-expressed in Xenopus lae-
vis oocytes. IKEPP is present in the apical membrane of cells lining the intestinal
lumen, where it is co-expressed with TRPV6. IKEPP and TRPV5/6 in display
only minor cellular colocalization in the kidney. Therefore, the interaction between
the epithelial Ca2+ channels and IKEPP is probably physiologically less relevant in
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renal compared to intestinal epithelia. It can, therefore, be postulated that TRPV5
and TRPV6 associate with distinct PDZ proteins. TRPV5 may bind NHERF2 in
the kidney, while TRPV6 and IKEPP associate in intestine. It is interesting to note
that the binding sites of these PDZ proteins in TRPV5/6 are distinct. NHERF2
associates with the last three amino acids of the carboxyl-terminus of TRPV5,
whereas IKEPP-binding localizes to a conserved internal motif in the carboxyl-
terminus, ~100 amino acids upstream of the NHERF2-binding site. IKEPP has
been implicated in the regulation of guanylyl cyclase (37). The latter protein is the
receptor for the Escherichia coli enterotoxin STa, generating cGMP upon binding
to its ligand. IKEPP is also known as Na+-Pi Cotransporter II-associated protein
2 (Na-Pi Cap2) (38) that possibly plays a role in the regulation of phosphate trans-
port in the proximal tubule of the kidney. PDZ proteins have been implicated in
the organization of multiprotein complexes (39-42). In particular, they have been
suggested to form a docking platform for complexes of apically targeted proteins.
For example, the PDZ protein InaD, which functions in Drosophila vision, coor-
dinates a signaling complex (signalplex) consisting of at least 7 proteins including
TRPC1, rhodopsin, PKC, phospholipase C and calmodulin. Furthermore, the
InaD/TRPC1 complex forms the core unit required for the localization of the sig-
nalplex to the phototransducing organelle of the photoreceptor cell (39, 43).
Similarly, identification of novel IKEPP-associated proteins will be necessary to
study the putative role of IKEPP as a membrane scaffold protein for TRPV6.
Calmodulin
Calmodulin (CaM) is a ubiquitous protein, well-known to be involved in Ca2+-
dependent feedback regulation for several ion channels (44). It was demonstrated
that TRPV6 interacts in a Ca2+-dependent manner with CaM (18, 19). Niemeyer
and coworkers initially identified a region in TRPV6 that is essential for CaM inter-
action. Removal of this CaM binding-site in TRPV6 results in a significant reduc-
tion of the slow component of channel inactivation, revealing a role of CaM in
TRPV6 regulation (18). Interestingly, binding of Ca2+-CaM is prevented by PKC-
mediated phosphorylation of a threonine residue within the CaM binding site.
Niemeyer and coworkers suggested that PKC activity acts as a switch that regulates
the amount of Ca2+ influx through TRPV6 channels by altering their inactivation
behavior (18). The described mechanism of competitive regulation of TRPV6 by
PKC and CaM is, however, restricted to human TRPV6 since this particular PKC
site in the CaM-binding motif is not conserved in the other species (45). Recently,
the corresponding region in mouse TRPV6 was shown to bind CaM (45). Detailed
analysis of the binding region predicted a caseine kinase motif, but no significant
phosphorylation was detected in this particular domain (45).
The regulation of TRPV6 by CaM was recently confirmed by Lambers and
coworkers (19). CaM consists of four Ca2+-binding EF-hand structures, which are
localized in the amino- and carboxyl-terminus. It was demonstrated that TRPV6
activity is significantly decreased upon expression of CaM(34), a dominant nega-
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tive form of CaM with mutated EF-hand 3 and 4 located in the high Ca2+ affini-
ty CaM carboxyl-terminus (19). CaM(34) has no obvious effect on the inactivation
kinetics of TRPV6, but decreases both the Na+ and Ca2+ currents of TRPV6.
CaM(34) expression has no effect on TRPV5. The latter finding is remarkable
given the high homology between both channels, similar Ca2+-dependent regula-
tion of channel activity and binding of CaM to both channels.
80K-H
In a microarray screen to identify novel proteins that respond similarly to vitamin
D and/or altered dietary Ca2+ intake as TRPV5, Gkika and coworkers identified
80K-H (20). 80K-H was originally cloned as a PKC substrate of 80 kDa and was
subsequently associated with intracellular signaling (46). However, these studies
did not resolve the biological function of this protein. 80K-H contains two puta-
tive EF-hand structures, a highly negatively charged glutamate stretch, that might
be a Ca2+-interacting region, and a  putative ER-targeting signal (HDEL). Using
GST pull-down assays and co-immunoprecipitations, a physical interaction
between 80K-H and TRPV5 was demonstrated. Furthermore, this study demon-
strated co-localization of both proteins in a subset of tubular segments in the kid-
ney and similar transcriptional regulation by 1,25-(OH)2D3 and dietary Ca
2+ (20).
Electrophysiological studies using 80K-H mutants showed that three domains of
80K-H (the two EF-hand structures, the glutamate stretch, and the HDEL
sequence) are critical determinants for TRPV5 activity. 80K-H directly binds Ca2+,
which is abolished upon inactivation of its two EF-hand structures. Importantly,
inactivation of the EF-hand pair also reduces the TRPV5-mediated Ca2+ current
and increased the TRPV5 sensitivity to intracellular Ca2+, accelerating the feedback
inhibition of the channel. Therefore, it is hypothesized that 80K-H acts a Ca2+
sensor to regulate TRPV5.
INTEGRATION OF TRPV5/6 REGULATION
The identification of protein-protein interactions of TRPV5/6 and characteriza-
tion of their functional importance, as described in this thesis, is an emerging field
that has contributed significantly to our knowledge of channel regulation (Figure
1). For instance, the identification of S100A10 and Rab11a as channel-associated
molecules provides valuable information about the trafficking of TRPV5 and
TRPV6 towards the plasma membrane. Based on the subcellular localization of
IKEPP and the functional role of NHERF2/SGK1 on ROMK (35), it is hypoth-
esized that these TRPV5-associated proteins exert their function at the plasma
membrane. Furthermore, preliminary experiments suggest that BSPRY does not
influence the plasma membrane expression of TRPV5, although the channel is sig-
nificantly inhibited upon BSPRY co-expression (chapter 4). This suggests that
BSPRY modulates the channel properties of TRPV5, resulting in decreased Ca2+
influx. Although the exact role of IKEPP, NHERF2 and BSPRY or the mecha-
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nism underlying their function need to be further explored, their identification and
initial characterization has provided new tools to investigate the regulation of the
epithelial Ca2+ channels. Here, I will describe unifying features of currently iden-
tified regulatory proteins based on: the coordinated regulation of TRPV5/6 and
the overlap in bindings site(s).
Coordinated regulation of channel expression, trafficking and activity
As described above, TRPV5/6 can be controlled by mechanisms aiming at the
expression, trafficking or activity of the channels. The identification and charac-
terization of channel-associated proteins reveals two interesting relationships
between TRPV5/6-regulatory mechanisms. First, various observations suggest
that S100A10/annexin 2 and Rab11 employ identical pathways to regulate
TRPV5/6. For instance, Zobiack and coworkers have demonstrated that the
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Figure 1
Integrated model of TRPV5- & TRPV6 regulation by channel-associated proteins.
TRPV5/6 is synthesized in the ER and is subsequently transported towards the plasma
membrane. Rab11 and S100A10/annexin 2 mediate the trafficking of TRPV5/6 to/from
the plasma membrane. Based on a homologous mechanism for ROMK, NHERF2 is
hypothesized to enhance the stability of TRPV5 in the plasma membrane. Calmodulin
(CaM) and 80K-H act in the  Ca2+-dependent regulation of TRPV6 and TRPV5, respec-
tively. The mechanism underlying the BSPRY-mediated inhibition of TRPV5, and pos-
sibly TRPV6 is currently unknown.  IKEPP is postulated as a scaffold for TRPV6,
recruiting channel-modulating PDZ-binding proteins to the plasma membrane.
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annexin 2-S100A10 complex controls the distribution of Rab11-positive endo-
somes (47). These endosomes have previously been identified as recycling endo-
somes, involved in the transport of internalized membrane proteins back to the
cell surface (25). Furthermore, annexin 2 was shown to be enriched in these
Rab11-containing structures (48). Therefore, impaired transport of TRPV5 from
recycling endosomes to the plasma membrane could explain the inhibitory effect
of annexin 2 down-regulation on TRPV5/6-mediated currents. This suggests that
two crucial pathways controlling the cell surface expression of TRPV5 and
TRPV6 intersect.
Second, it was recently demonstrated that S100A10 and annexin 2 are co-regulat-
ed by the calciotropic hormone vitamin D in a similar fashion as TRPV5 (22). This
indicates that vitamin D exerts its physiological function by concertedly regulating
the expression of the apical Ca2+ influx proteins and stimulation of the insertion
of these proteins into the plasma membrane. Similarly, Chen and coworkers
recently demonstrated that Rab11 is regulated in an estrogen-dependent manner
(49). Furthermore, 80K-H responds like TRPV5 to alterations in vitamin D levels
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Figure 2
Binding sites of channel-associated proteins depicted in the predicted topology of
TRPV5/6. NHERF2 binds to the extreme carboxyl terminus of TRPV5, but not TRPV6.
S100A10 associates with a PDZ-like motif VATTV. This site flankes a completely con-
served region in TRPV5 and TRPV6 which is required for the association with Rab11a,
80K-H and IKEPP.
and dietary Ca2+ intake (20). Finally, preliminary results suggest that BSPRY is neg-
atively regulated by vitamin D (Van de Graaf, unpublished results). Together, this
suggests that changes in channel expression, trafficking to the plasma membrane
and channel activity are modulated in a well-orchestrated manner to control the
function of TRPV5/6.
The binding site(s) of TRPV5/6 auxiliary proteins
The second remarkable feature of the identified auxiliary proteins is their binding
site. The binding region of Rab11 in TRPV5/6 is described in  Chapter 3. Five
amino acid residues (MLERK) within this area were identified as a critical region
for binding of Rab11. However, the interaction with 80K-H is localized to the
same region (20), suggesting a possible common binding site in TRPV5/6.
Remarkably, Chang and coworkers have also identified this 5 amino acids motif as
one of the components that plays a role in assembly of the tetrameric channel
(50). Finally, the binding of IKEPP was also impaired upon deletion of this region,
whereas S100A10, NHERF2 and CaM associate with distinct regions of the car-
boxyl-terminus. This suggests that the MLERK region is either a critical element
for the general folding of the carboxyl-terminus of TRPV5/6 or that several of
these associated proteins indeed recognize motifs within this region. The latter
hypothesis could imply that these proteins compete for binding at this region. The
occupancy of this site would depend on the relative concentrations and affinities
of the proteins. Future examination of channel structure or studies that investigate
binding competition among multiple channel associated proteins are required to
clarify this issue.
REFLECTION ON METHODOLOGICAL APPROACHES
The yeast two-hybrid system is a commonly used genetic method to identify pro-
teins that interact with a protein of interest (51), and was, therefore, a logical tool
to use in the studies described in this thesis. However, other strategies have been
successfully applied to define auxiliary regulating factors for proteins of interest
(52). These techniques can be employed in the future to identify novel components
of the TRPV5/6 “interactome” and/or novel regulators of the apical Ca2+ influx
step of transcellular Ca2+ transport. Firstly, protein-protein associations can be
identified using biochemical approaches including pull-down assays, using parts of
TRPV5/6 fused to GST. This technique requires the use of soluble parts of
TRPV5/6, similar to the yeast two-hybrid approach that was applied in this thesis.
Isolation of channel-associated proteins by means of co-immunoprecipitation
experiments using antibodies directed against full-length TRPV5/6 may circum-
vent this problem. As TRPV5/6 are relatively low abundant proteins, the amount
of an associated protein, isolated via biochemical techniques, might be too low for
their identification. However, identification of channel-associated proteins has
recently become more attainable as new developments in mass spectrometry pro-
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vide ultra-high mass resolution, mass accuracy and sensitivity (53). Second, novel
developments in the yeast two-hybrid technique (54) enable the use of full-length
TRPV5/6 to identify proteins that bind these channels at the plasma membrane.
In this system, the mammalian guanyl nucleotide exchange factor (GEF) SOS is
recruited to the yeast plasma membrane upon binding of an auxiliary protein to
TRPV5/6, allowing growth at the nonpermissive temperature. Thirdly, a number
of new fluorescent imaging-based biophysical techniques including Fluorescence
Resonance Energy Transfer (FRET), Fluorescence Correlation spectroscopy
(FCS), and Bimolecular Fluorescence Complementation (BiFC) has been further
developed for studying protein-protein interactions (reviewed in (52)). The main
advantage of these techniques is that they provide better spatial information of the
interaction and can be used at the single cell level. Fourthly, micro-array or pro-
teome analysis can be applied to find proteins that respond similarly as TRPV5/6
to various treatments. The value of this fourth novel approach to find regulators
for TRPV5 was demonstrated by Gkika et al. (20). Finally, RNA interference can
be used to perform loss-of-function genetic screens (55) to identify modulators of
TRPV5/6. Libraries of plasmids encoding small hairpin RNAs are transfected into
cells, either pooled or using an arrayed format and screened for effects on
TRPV5/6 regulation. However, this approach requires the establishment of a reli-
able high-throughput readout of TRPV5/6 channel activity or localization.
FUTURE DIRECTIONS
The recent elucidation of TRPV5- and TRPV6-associated proteins has signifi-
cantly contributed to our understanding of the regulation of apical Ca2+ influx in
epithelial cells. Some of the newly identified proteins operate at the plasma mem-
brane, while others are involved in the intracellular route leading to and from this
membrane. Our findings provide new information about the physiological func-
tion of TRPV5/6 channel-interacting proteins and point to novel mechanisms reg-
ulating apical Ca2+ influx in Ca2+-transporting epithelia. Identification of the pro-
teins that interact with TRPV5/6 is only a first step in a long endeavor. The major
challenges of the future are to obtain further insight into TRPV5/6 trafficking and
to establish a comprehensive view of TRPV5/6 interacting proteins and their rel-
ative contribution to channel regulation. Perhaps most importantly, to fully under-
stand the functional significance of these protein interactions in daily regulation of
TRPV5/6, we have to reveal the complex relation between protein interactions
and signaling processes involved in epithelial Ca2+ transport.
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Samenvatting 
(Summary in Dutch)
De beschikbare hoeveelheid calcium in het lichaam wordt nauwgezet gereguleerd
in een samenspel van darm (opname), nier (uitscheiding) en skelet (opslag).
Wanneer de calciumconcentratie in het bloed verhoogd is spreken we van een
hypercalciëmie. Deze verhoging kan effecten hebben op de werking van de nieren,
leiden tot nierstenen en duiden op een afname van de botmassa. Bij een verlaagde
calciumconcentratie in het bloed spreken we van een hypocalciëmie en dit versterkt
onder andere de neuromusculaire prikkelbaarheid. Dagelijks worden we gecon-
fronteerd met een wisselende hoeveelheid calcium in de voeding. Daarnaast
vereisen processen als groei, zwangerschap en borstvoeding een aanpassing van de
hoeveelheid calcium in ons lichaam. Epitheelcellen in darm en nier (en cellen aan
de buitenkant van het bot) stellen het lichaam in staat met deze variaties om te
gaan. Een deel van deze cellen transporteert een gecontroleerde hoeveelheid calci-
um van het lumen (zijde waar voeding (darm) of voorurine (nier) zich bevindt)
naar de bloedzijde. Dit proces wordt transcellulair of transepitheliaal calcium-
transport genoemd en bestaat uit drie discrete stappen. Allereerst komt calcium de
cel binnen via de epitheliale calciumkanalen TRPV5 en TRPV6. Vervolgens wordt
calcium gebonden door gespecialiseerde calciumbindende eiwitten, waarna het
naar de bloedzijde van de cel diffundeert. Daar worden de calciumionen tenslotte
naar buiten gepompt door twee energieverbruikende systemen, een natrium/calci-
umuitwisselaar en een calciumpomp. De activiteit van TRPV5 en TRPV6 bepaalt
in grote mate de hoeveelheid calcium die door de cel wordt getransporteerd.
Daarom worden deze eiwitten ook wel de poortwachters van het transcellulair cal-
ciumtransport genoemd. TRPV5 vervult deze rol voornamelijk in de nier, terwijl
TRPV6 van belang is voor calciumtransport in de darm. Het vergaren van kennis
omtrent de regulatie van deze eiwitten zal meer inzicht kunnen geven in de manier
waarop de  calciumbalans in ons lichaam wordt gehandhaafd. Er zijn diverse reg-
ulerende mechanismen die bepalen hoeveel calcium via TRPV5 of TRPV6 de cel
instroomt. Ten eerste reguleren hormonen, zoals vitamine D, de totale hoeveel-
heid TRPV5 en TRPV6 eiwitten in de cel. Ten tweede bepalen transportprocessen
in de cel het aantal TRPV5 en TRPV6 kanalen op hun werkplek, de plasmamem-
braan. Ten derde is de activiteit van deze kanalen gevoelig voor de locale zuurgraad
en onderhevig aan calciumafhankelijke regulatiemechanismen. Tenslotte zijn er
eiwitten, die TRPV5 en TRPV6 binden en beïnvloeden, welke samen een vierde
categorie van regulatie vormen. Dit laatste hoofdstuk vat de rol van deze eiwitten
bij de regulatie van TRPV5 en TRPV6, zoals beschreven in dit proefschrift, samen.
De identificatie van S100A10 als een nieuw TRPV5- en TRPV6-geassocieerd eiwit
wordt beschreven in hoofdstuk 2. S100A10 vormt een hetero-tetrameer met
annexin 2, welke in verband wordt gebracht met processen als endo- en exocytose
en met membraan-cytoskeletverbindingen. S100A10, annexin 2 komen samen met
TRPV5 of TRPV6 tot expressie in calciumtransporterende cellen van de nier en
darm. S100A10 bindt aan een geconserveerd deel van de carboxylterminus van
TRPV5 en TRPV6. Wanneer een threonine residu  in dit deel wordt veranderd
naar een alanine bindt S100A10 niet meer. Hierdoor bereiken TRPV5 en TRPV6
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de plasmamembraan niet meer, zodat calcium de cel niet meer in kan stromen.
Ook het verwijderen van annexin 2 uit de cel met behulp van siRNA-oligo's remt
de instroom van calcium door deze kanalen. Tezamen wijzen deze resultaten op
een rol van het S100A10/annexin 2-complex bij het transport van TRPV5 en
TRPV6 naar de plasmamembraan en daarom op een rol in de regulatie van het cal-
ciumtransport.
Het tweede eiwit dat geïdentificeerd werd als een nieuw TRPV5- en TRPV6-geas-
socieerd eiwit is Rab11a, zoals beschreven in hoofdstuk 3. Rab11a is met name
aanwezig in recycling-endosomen, bepaalde celorganellen die betrokken zijn bij
het transport van eiwitten naar de plasmamembraan. TRPV5 colokaliseert met
Rab11a in cellen van de nier die calcium transporteren. TRPV5 en TRPV6 binden
direct aan GDP-gebonden Rab11a, terwijl GTP-gebonden Rab11a weinig tot geen
associatie met deze kanalen vertoont. Expressie van een mutant van Rab11a, welke
geblokkeerd is in de GDP-status, of verwijdering van de bindingsplaats van
Rab11a in TRPV5 resulteert in een significante afname van de hoeveelheid TRPV5
op de plasmamembraan. Deze bevindingen suggereren dat Rab11a betrokken is bij
het transport van TRPV5 en TRPV6 naar de plasmamembraan.
In hoofdstuk 4 wordt de identificatie en karakterisering van BSPRY (spreek uit:
biespree) als een nieuw TRPV5- en TRPV6-geassocieerd eiwit beschreven. BSPRY
bindt aan de carboxylterminus van beide calciumkanalen. Verder komt BSPRY tot
expressie in TRPV5-bevattende cellen van de nier. Bovendien werd aangetoond
dat BSPRY de activiteit van TRPV5 remt in MDCK cellen. Op welke wijze deze
remming tot stand komt is vooralsnog onduidelijk.
Hoofdstuk 5 beschrijft de rol van het serum- en glucocorticoïd-geïnduceerde
kinase (SGK) op de activiteit van TRPV5. De stimulatie van de activiteit van
TRPV5 door SGK is afhankelijk van de aanwezigheid van NHERF2. NHERF2
bezit twee PDZ-domeinen, welke betrokken zijn bij eiwit-eiwit interacties.
NHERF2 bindt aan de carboxylterminus van TRPV5, maar niet aan TRPV6.
Wanneer het tweede PDZ-domein van NHERF2 wordt verwijderd, blijft de stim-
ulatie van de TRPV5-activiteit door SGK uit. Voorgaande studies hebben aange-
toond dat SGK aan het tweede PDZ-domein van NHERF2 bindt. De stimulatie
van TRPV5 door NHERF2/SGK kan daarom mogelijk worden verklaard door de
binding van zowel SGK als TRPV5 aan NHERF2.
De interactie van TRPV5 en TRPV6 met een tweede PDZ-eiwit wordt beschreven
in hoofdstuk 6. Dit eiwit heet IKEPP (Intestine and Kidney Enriched PDZ
Protein) en komt met name tot expressie in (de luminale zijde van) epitheelcellen
in darm en nier. IKEPP bevat 4 PDZ-domeinen en met name het vierde domein
is betrokken bij de binding aan TRPV5 en TRPV6. IKEPP colokaliseert niet met
TRPV5 en TRPV6 in de nier, maar wel met TRPV6 in darm. Daarom lijkt de rol
van IKEPP op transcellulair calciumtransport vooral van belang in dit laatste weef-
sel. IKEPP is zowel aanwezig in het cytosol van de cel als op de plasmamembraan.
IKEPP speelt mogelijk een rol bij de formatie van een eiwitcomplex betrokken bij
de regulatie van TRPV5 of TRPV6, zoals beschreven voor een ander PDZ-eiwit
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en TRP kanaal (InaD en TRPC1) in Drosophila (fruitvlieg). Vergelijking van de
PDZ-eiwitten NHERF2 en IKEPP laat zien dat deze eiwitten op verschillende
plaatsen aan de carboxylterminus van TRPV5 binden. De binding van NHERF2
vereist een eindstandig PDZ-bindingsmotief, terwijl IKEPP op een intern deel van
de carboxylterminus bindt.
De ontdekking van nieuwe eiwitten die aan TRPV5 en TRPV6 binden en deze
beïnvloeden, zoals beschreven in dit proefschrift, geeft een beter inzicht in de
werking van deze calciumkanalen. Bovendien blijkt dat er overeenkomsten zijn in
de regulatie van deze geassocieerde eiwitten en de calciumkanalen. Zo wordt de
expressie van de eiwitten S100A10 en annexin 2 gereguleerd door vitamine D. Dit
hormoon beïnvloedt ook de expressie van TRPV5 en TRPV6. Dit suggereert dat
vitamine D transcellulair calciumtransport reguleert door zowel de expressie van
de kanalen die calciuminstroom verzorgen te verhogen, als het transport van deze
eiwitten naar de plasmamembraan, te stimuleren.
De voornaamste wetenschappelijke uitdagingen in de nabije toekomst zijn het
verkrijgen van een beter inzicht in het transport van TRPV5 en TRPV6 van/naar
de plasmamembraan, het verwerven van een overzicht van alle eiwitten die deze
kanalen reguleren en opheldering van hun rol. Wellicht de belangrijkste uitdaging
is het doorgronden van het verband tussen de hier beschreven eiwit-eiwit-associ-
aties en signalen van het lichaam, die aangeven dat de calciumbalans verstoord
dreigt te worden. De identificatie van eiwitten die betrokken zijn bij de regulatie
van TRPV5 en TRPV6 is de eerste, essentiële, stap om deze doelen te verwezen-
lijken.
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